[go: up one dir, main page]

WO2024154597A1 - Oil-in-water composition for second agent of coating-type film-forming agent - Google Patents

Oil-in-water composition for second agent of coating-type film-forming agent Download PDF

Info

Publication number
WO2024154597A1
WO2024154597A1 PCT/JP2024/000054 JP2024000054W WO2024154597A1 WO 2024154597 A1 WO2024154597 A1 WO 2024154597A1 JP 2024000054 W JP2024000054 W JP 2024000054W WO 2024154597 A1 WO2024154597 A1 WO 2024154597A1
Authority
WO
WIPO (PCT)
Prior art keywords
agent
less
film
oil
mass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2024/000054
Other languages
French (fr)
Japanese (ja)
Inventor
美佳 近藤
俊 久保田
喜郎 貞神
亨 岡本
知子 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP2024571701A priority Critical patent/JPWO2024154597A1/ja
Priority to CN202480005779.8A priority patent/CN120417873A/en
Publication of WO2024154597A1 publication Critical patent/WO2024154597A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/894Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/895Polysiloxanes containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Definitions

  • This disclosure relates to an oil-in-water type composition for use as the second agent in a paint-on film-forming agent.
  • a topical film-forming agent is known that can be applied to the body surface to form a film that can correct wrinkles, scars, etc. while protecting the skin.
  • Patent Document 1 discloses a formulation for application to the skin, comprising: a) a reactive component including (i) at least one high viscosity vinyl-terminated organopolysiloxane having a viscosity of 100,000 to 500,000 cst or cP at 25°C, at least one low viscosity vinyl-terminated organopolysiloxane having a viscosity of 500 to 50,000 cst or cP at 25°C, and at least one hydride-functionalized polysiloxane; and (ii) a reactive reinforcing component including a reinforcing component; and b) a crosslinking component including a platinum catalyst; wherein the crosslinking component promotes crosslinking of the reactive reinforcing component in situ, resulting in the formation of a film on the skin.
  • a reactive component including (i) at least one high viscosity vinyl-terminated organopolysiloxane having a viscosity of 100,000 to 500,000
  • the subject of this disclosure is therefore to provide an oil-in-water composition for the second agent of a paint-on film-forming agent that can reduce or prevent defects such as uneven application and shine on the film.
  • a dispersion medium comprising water and a microgel; an oil-in-water composition comprising oil droplets dispersed in the dispersion medium; and a silicone-based surface tension modifier
  • the oil droplets contain an oil component and a catalyst as a cross-linking component
  • the surface tension modifier has a surface tension of 30.0 mN/m or less at 25° C. in an aqueous solution containing the surface tension modifier at 1% by mass, It is used as the second agent of a coating-type film-forming agent including a first agent containing a crosslinking reactive component that constitutes a film and a second agent containing a crosslinking component that crosslinks the crosslinking reactive component, Oil-in-water compositions.
  • composition according to aspect 1, wherein the microgel is at least one selected from the group consisting of dimethylacrylamide/sodium acryloyldimethyltaurate crosspolymer, ammonium acryloyldimethyltaurate/VP copolymer, ammonium acryloyldimethyltaurate/beheneth-25 methacrylate crosspolymer, and agar.
  • Aspect 3 The composition according to aspect 1 or 2, wherein the surface tension modifier is at least one selected from the group consisting of polyoxyethylene-methylpolysiloxane copolymer, dimethylpolysiloxane-methyl(polyoxyethylene)siloxane copolymer, and bisPEG-18 methyl ether dimethylsilane.
  • the surface tension modifier is at least one selected from the group consisting of polyoxyethylene-methylpolysiloxane copolymer, dimethylpolysiloxane-methyl(polyoxyethylene)siloxane copolymer, and bisPEG-18 methyl ether dimethylsilane.
  • Aspect 4 Aspect 4.
  • the oil comprises a first unsaturated organopolysiloxane or a first hydride-functionalized polysiloxane.
  • Aspect 7 The composition according to any one of the preceding aspects, wherein the catalyst is at least one selected from the group consisting of platinum carbonylcyclovinylmethylsiloxane complex, platinum divinyltetramethyldisiloxane complex, platinum cyclovinylmethylsiloxane complex, and platinum octanaldehyde/octanol complex.
  • a coating-type film-forming agent comprising a first agent and a second agent
  • the first agent comprises at least one selected from the group consisting of a second unsaturated organopolysiloxane and a second hydride-functionalized polysiloxane
  • the second agent is the oil-in-water composition according to any one of Aspects 1 to 7,
  • the first agent contains only the second unsaturated organopolysiloxane among the second unsaturated organopolysiloxane and the second hydride-functionalized polysiloxane
  • the second agent contains the first hydride-functionalized polysiloxane
  • the second agent contains the first unsaturated organopolysiloxane
  • a paint-type film-forming agent When the first agent contains only the second hydride-functionalized polysiloxane among the second unsaturated organopolysiloxane and the second hydride-functionalized polysiloxane, the second agent contains the first unsaturated organopol
  • ⁇ Aspect 9> 9. The forming agent of claim 8, wherein the oil-in-water composition comprises non-porous particles.
  • Aspect 10 The forming agent according to aspect 8 or 9, wherein the first unsaturated organopolysiloxane and the second unsaturated organopolysiloxane are at least one selected from the group consisting of organopolysiloxanes having vinyl groups, vinyl-terminated organopolysiloxanes, and vinylated branched organopolysiloxanes.
  • first unsaturated organopolysiloxane and the second unsaturated organopolysiloxane are at least one member selected from the group consisting of vinyl terminated polydimethylsiloxane, vinyl terminated diphenylsiloxane-dimethylsiloxane copolymer, vinyl terminated polyphenylmethylsiloxane, vinylphenylmethyl terminated vinylphenylsiloxane-phenylmethylsiloxane copolymer, vinyl terminated trifluoropropylmethylsiloxane-dimethylsiloxane copolymer, vinyl terminated diethylsiloxane-dimethylsiloxane copolymer, vinylmethylsiloxane-dimethylsiloxane copolymer, trimethylsiloxy terminated vinylmethylsiloxane-dimethylsiloxane copolymer, silanol terminated vinylmethylsiloxane-di
  • ⁇ Aspect 12> A forming agent according to any one of aspects 8 to 11, wherein the first hydride-functionalized polysiloxane and the second hydride-functionalized polysiloxane are non-terminally and/or terminally hydroxylated organopolysiloxanes.
  • first hydride-functionalized polysiloxane and the second hydride-functionalized polysiloxane are at least one selected from the group consisting of hydride-terminated polydimethylsiloxane, hydride-terminated polyphenyl-(dimethylhydrosiloxy)siloxane, hydride-terminated methylhydrosiloxane-phenylmethylsiloxane copolymer, trimethylsiloxy-terminated methylhydrosiloxane-dimethylsiloxane copolymer, polymethylhydrosiloxane, trimethylsiloxy-terminated polyethylhydrosiloxane, triethylsiloxane, methylhydrosiloxane-phenyloctylmethylsiloxane copolymer, and methylhydrosiloxane-phenyloctylmethylsiloxane terpolymer.
  • ⁇ Aspect 14> A kit in which the first agent and the second agent according to any one of aspects 8 to 13 are contained in separate containers, or are contained separately in each compartment of a container having two or more compartments.
  • ⁇ Aspect 15> A method of using the forming agent according to any one of aspects 8 to 13, comprising the steps of: The first agent is applied to a body surface to form a first agent layer, and then the second agent is applied onto the first agent layer and crosslinked to form a film. The second agent is applied to the body surface to form a second agent layer, and then the first agent is applied onto the second agent layer and crosslinked to form a film; or After preparing a mixture by mixing the first agent and the second agent, the mixture is applied to a body surface and crosslinked to form a film.
  • the first agent is applied to a body surface to form a first agent layer, a cosmetic is applied onto the first agent layer, and then the second agent is applied so as to cover the cosmetic.
  • the second agent is applied to a body surface to form a second agent layer, a cosmetic is applied onto the second agent layer, and then the first agent is applied to cover the cosmetic; or After forming the film, a cosmetic is applied to the film.
  • the present disclosure provides an oil-in-water composition for the second agent of a paint-on film-forming agent that can reduce or prevent defects such as uneven application and shine on the film.
  • FIG. 1 is a photograph showing the state of repelling of the second agent when a conventional paint-type film-forming agent is used. In order to make the repelling phenomenon easier to understand, a red dye is blended into the aqueous phase of the second agent.
  • FIG. 2 is a photograph of a film formed using a paint-on film-forming agent including a second agent (a second agent including a microgel and a specific surface tension modifier) according to one embodiment of the present disclosure.
  • FIG. 3 is a graph showing the gloss level, which is an indicator of the shine of each of the resulting films.
  • FIG. 1A is a photograph of a film of Comparative Example 1 formed by applying a conventional paint-on film-forming agent to artificial skin
  • FIG. 1B is a photograph of a film of Example 20 formed by applying a paint-on film-forming agent containing a second agent according to an embodiment of the present disclosure to artificial skin.
  • the oil-in-water composition of the present disclosure comprises a dispersion medium containing water and a microgel, oil droplets dispersed in the dispersion medium, and a silicone-based surface tension modifier, and the surface tension modifier has a surface tension of 30.0 mN/m or less at 25°C in an aqueous solution containing 1% by mass of the surface tension modifier, and is used as the second agent of a coating-type film-forming agent that comprises a first agent containing a cross-linking reactive component that forms a film, and a second agent containing a cross-linking component that cross-links the cross-linking reactive component.
  • the applied film-forming agent of the present disclosure includes a first agent containing a cross-linking reactive component that constitutes the film, and a second agent containing a cross-linking component that cross-links the cross-linking reactive component. Therefore, when preparing a film using such a first agent and second agent, if uneven application occurs, it is thought that unevenness will also occur in the thickness of the obtained film. As a result, as shown in Figure 1, reflective parts are formed in the obtained film, which is thought to cause problems such as shine.
  • the inventors therefore first investigated the effect of the viscoelasticity of the second agent using various thickeners in order to improve coating unevenness.
  • thickeners that can exert their thickening effect through a moderate packing effect (friction between microgel particles), such as microgels, are more effective than general thickeners that exert their thickening effect through a network structure of polymer chains.
  • thickeners alone were not able to sufficiently improve coating unevenness.
  • the inventor further investigated the effect of the surface tension of the second agent.
  • various surface tension modifiers such as surfactants
  • a specific silicone-based surface tension modifier when a specific silicone-based surface tension modifier is blended with a microgel in an oil-in-water composition used as the second agent of a spread-type film-forming agent, uneven application is improved, and as a result, problems such as shine on the film can be reduced or prevented.
  • This is believed to be a unique phenomenon that occurs due to the thickening action caused by the appropriate packing effect of the microgel and the synergistic effect of using it in combination with a specific silicone-based surface tension modifier.
  • the oil-in-water composition of the present disclosure which contains a microgel and a specific silicone-based surface tension modifier, is used as the second agent of a spread-type film-forming agent
  • problems such as uneven application and shine on the film can be reduced or prevented.
  • the inventors have also found that if you want to improve even the slightest shine, such as that shown in the dashed frame in Figure 2, it is effective to further blend nonporous particles into the second agent.
  • porous particles tend to scatter light due to the multiple holes formed in them, so it was thought that the incorporation of porous particles would be effective in preventing shine on the film.
  • the incorporation of porous particles made it easier for uneven application to occur, and as a result, problems such as shine on the film were likely to occur. This is thought to be because when porous particles are incorporated into the oil-in-water composition of the present disclosure, at least one of the microgel and the specific silicone-based surface tension modifier incorporated into the composition to improve uneven application is absorbed by the porous particles, making it impossible to exhibit the desired function. Therefore, it is thought that the incorporation of non-porous particles, rather than porous particles, is effective in the oil-in-water composition of the present disclosure.
  • a “body correction coating” refers to a coating that is intended to provide a natural skin appearance when applied to the skin of a subject.
  • natural skin appearance means that when applied to the skin, the body correction coating provides similar or identical performance to at least one of the appearance, feel, and texture of actual skin, e.g., the treated skin can provide the physical properties (e.g., elasticity and firmness) of actual (e.g., current) skin.
  • body correction means to mask, conceal or cover a body or skin imperfection of a subject to visually and/or tactilely improve the body or skin imperfection, but does not include methods of surgery, treatment or diagnosis of a human.
  • body imperfection can mean, for example, such part of the subject's body that the subject perceives as a blemish or blemish, or that a person skilled in the art, e.g., a dermatologist, esthetician or plastic surgeon, would consider to be a blemish or blemish.
  • Body imperfection includes skin imperfections and loose soft tissues of the body (e.g., loose or sagging skin, looseness of breasts, buttocks, abdomen, chin, neck, etc.), and the like. Also, “skin imperfection” includes those items of the subject's skin that the subject perceives as a blemish or blemish.
  • nevus flammeus or nevus flameus e.g., hemangioma simplex or midline nevus flammeus
  • melasma wrinkles, age spots
  • acne moles
  • scars tattoos
  • birthmarks skin deformities
  • birthmarks sun damage
  • aging uneven skin tone, loose skin, rough skin, hyperpigmentation, enlarged pores, telangiectasias, redness, shine, cellulite, stretch marks, or reduced skin elasticity.
  • oil-in-water composition refers to a composition in which oil droplets are dispersed in a water-containing dispersion medium.
  • examples of such compositions include a composition in which oil droplets are forcibly dispersed in a water-containing dispersion medium by shaking a liquid in a state in which the water and oil are separated, and an emulsion composition in which an emulsifier is added to disperse oil droplets in a water-containing dispersion medium.
  • viscosity refers to a measure of the resistance of a fluid to being deformed by either shear or tensile stress.
  • the viscosity of the first and second parts of a paint-on film former affects the thickness, spreadability, and uniformity and/or uniformity of the layer formed on a substrate.
  • Viscosity can be reported as either dynamic viscosity (also known as absolute viscosity, typical units are Pa ⁇ s, poise, P, cP) or kinematic viscosity (typical units are cm 2 /s, stokes, St, cst), which is the dynamic viscosity divided by the density of the measured fluid.
  • the viscosity ranges of the components disclosed herein are generally provided by the suppliers of each component in units of kinematic viscosity (e.g., cst) measured using a rheometer or a Cannon-Fenske tube viscometer, although the viscosity of a fluid can also be measured using, for example, a rheometer (e.g., a linear shear rheometer or a dynamic shear rheometer) or a viscometer (a viscometric meter, also called, for example, a capillary viscometer or a rotational viscometer).
  • a rheometer e.g., a linear shear rheometer or a dynamic shear rheometer
  • a viscometer a viscometric meter, also called, for example, a capillary viscometer or a rotational viscometer.
  • microgel refers to a type of thickener that forms a water-swellable, three-dimensionally crosslinked microgel in an aqueous phase and thickens due to friction between the swollen microgel particles.
  • the microgel may typically contain a solvent.
  • crosslinking also includes the concept commonly referred to as “curing.”
  • body surface means the skin surface of the body.
  • Oil-in-water Composition (sometimes simply referred to as the "composition") can be used as the second agent of a spread-type film-forming agent that includes a first agent containing a crosslinkable reactive component that constitutes a film, and a second agent containing a crosslinking component that crosslinks the crosslinkable reactive component, and can reduce or prevent defects such as shine in the resulting film.
  • a film prepared using the oil-in-water composition of the present disclosure can achieve a gloss at a reflection angle (sometimes called the "light receiving angle") of 45° or 50° of 100 or less, 95 or less, 90 or less, 85 or less, 80 or less, 75 or less, or 70 or less.
  • a reflection angle sometimes called the "light receiving angle”
  • the dispersion medium in the oil-in-water composition of the present disclosure comprises water and a microgel.
  • the amount of water to be blended is not particularly limited, and from the viewpoints of, for example, the effect of improving coating unevenness, usability, crosslinking reactivity, and the like, the amount of water can be 10 mass % or more, 15 mass % or more, 20 mass % or more, 30 mass % or more, 40 mass % or more, 50 mass % or more, 60 mass % or more, 70 mass % or more, or 80 mass % or more, and can be 90 mass % or less, 80 mass % or less, 70 mass % or less, 60 mass % or less, or 50 mass % or less, relative to the total amount of the composition.
  • Water that can be used in the oil-in-water composition of the present disclosure is not particularly limited, but may be, for example, water used in cosmetics or quasi-drugs.
  • water used in cosmetics or quasi-drugs For example, ion-exchanged water, distilled water, ultrapure water, and tap water can be used.
  • the amount of the microgel is not particularly limited, and from the viewpoints of, for example, the effect of improving coating unevenness, usability, crosslinking reactivity, and the like, the amount can be 0.1 mass % or more, 0.3 mass % or more, 0.5 mass % or more, 0.7 mass % or more, or 1.0 mass % or more relative to the total amount of the composition, and can be 10 mass % or less, 8.0 mass % or less, 5.0 mass % or less, or 3.0 mass % or less.
  • microgel there are no particular limitations on the microgel, and it may be, for example, one that itself forms microgel particles in the aqueous phase, or one that is made by crushing a gel-like material prepared in advance into microgel particles. Microgels may be used alone or in combination of two or more kinds.
  • the microgel particles are preferably spherical particles from the viewpoints of the effect of improving coating unevenness, usability, crosslinking reactivity, etc.
  • "spherical" in the case of microgel particles includes true spheres, nearly spherical, and spheroids, and even if the surface is uneven, the particle falls under the "spherical" category in this disclosure as long as the overall shape of the particle can be determined to be spherical.
  • the "spherical particles” in the case of microgel particles are not limited to true spheres, and can include particles whose minor axis/major axis ratio (ellipticity) is 3.0 or less, 2.5 or less, 2.0 or less, or 1.5 or less. The lower limit of such a ratio can be, for example, 1.0 or more, more than 1.0, or 1.2 or more.
  • the microgel particles have an equivalent circle diameter of 100 ⁇ m or less, 70 ⁇ m or less, 50 ⁇ m or less, 30 ⁇ m or less, 10 ⁇ m or less, 5.0 ⁇ m or less, or 1.0 ⁇ m or less.
  • the lower limit of such particle diameter can be, for example, 0.01 ⁇ m or more, 0.05 ⁇ m or more, 0.1 ⁇ m or more, or 0.5 ⁇ m or more.
  • the equivalent circle diameter can mean, for example, the particle diameter when converted into a circular particle having the same area as the projected area of the microgel particle observed with a transmission electron microscope. Such equivalent circle diameter can be defined as the average value of 10 or more particles.
  • the material constituting the microgel is not particularly limited, and examples thereof include at least one selected from the group consisting of (dimethylacrylamide/sodium acryloyldimethyltaurate) crosspolymer, (ammonium acryloyldimethyltaurate/VP) copolymer, (ammonium acryloyldimethyltaurate/beheneth-25 methacrylate) crosspolymer, and Kanten.
  • (dimethylacrylamide/sodium acryloyldimethyltaurate) crosspolymer is preferred from the viewpoint of improving coating unevenness.
  • the oil phase or oil droplets as the dispersed phase in the oil-in-water composition contain an oil component and a catalyst as a cross-linking component.
  • the amount of the oil to be blended is not particularly limited, and from the standpoint of usability, crosslinking reactivity, and the like, for example, it can be 0.01 mass% or more, 0.03 mass% or more, 0.05 mass% or more, 0.07 mass% or more, 0.1 mass% or more, 0.3 mass% or more, 0.5 mass% or more, 0.7 mass% or more, 1.0 mass% or more, 3.0 mass% or more, 5.0 mass% or more, 7.0 mass% or more, 10 mass% or more, 15 mass% or more, or 20 mass% or more, relative to the total amount of the composition, and can be 50 mass% or less, 40 mass% or less, 30 mass% or less, 20 mass% or less, 15 mass% or less, or 10 mass% or less.
  • the oil is not particularly limited, and examples thereof include liquid oils, solid oils, waxes, hydrocarbon oils, silicone oils, and polar oils.
  • the oils can be used alone or in combination of two or more.
  • silicone oil is preferred from the viewpoint of affinity with the first agent layer formed by the first agent described below.
  • the proportion of silicone oil in the oil is not particularly limited, and can be, for example, 50% by mass or more, 60% by mass or more, 70% by mass or more, 80% by mass or more, or 90% by mass or more relative to the total amount of oil. There is no particular limit to the upper limit of such a proportion, but it can be, for example, 100% by mass or less, less than 100% by mass, 98% by mass or less, or 95% by mass or less.
  • the composition of the present disclosure may contain a first unsaturated organopolysiloxane, which is a type of silicone oil, as an oil component.
  • the first unsaturated organopolysiloxane may function as a constituent material of the coating, and may also function as a dispersant for the catalyst.
  • the first unsaturated organopolysiloxane is not particularly limited, and may be, for example, one or more organopolysiloxanes having at least two carbon-carbon double bonds or at least one carbon-carbon triple bond in the molecule.
  • Such unsaturated organopolysiloxanes are preferably one or more organopolysiloxanes having an average of at least two alkenyl functional groups and a viscosity of 10,000 to 2,000,000 cst at 25°C.
  • the "carbon-carbon double bond” and the "carbon-carbon triple bond” may be simply referred to as "double bond” and "triple bond".
  • the first unsaturated organopolysiloxane may be used alone or in combination of two or more kinds.
  • Such organopolysiloxanes may contain unsaturated portions (double bonds or triple bonds) in the terminal units of the polymer, in the non-terminal monomer units of the polymer, or in a combination of these, and it is particularly preferred that they are contained in the non-terminal monomer units of the polymer.
  • the double bond-containing monomer units in the organopolysiloxane may be spaced apart, on average, by 40 monomer units or more, 200 monomer units or more, 400 monomer units or more, 1,000 monomer units or more, or 2,000 monomer units or more.
  • the amount of double- or triple-bond-containing monomer units in the organopolysiloxane having a double bond or triple bond can be, for example, 0.01% by weight or more or 0.03% by weight or more, and 2% by weight or less or 0.6% by weight or less.
  • the vinyl equivalent of the organopolysiloxane having double or triple bonds can be, for example, 0.005 or more, or 0.01 or more, and 0.5 or less, or 0.25 or less per kilogram.
  • the approximate molar amount of unsaturated double or triple bonds in the organopolysiloxane can be calculated based on the average molecular weight of the organopolysiloxane.
  • the average molecular weight or molecular mass of each component disclosed herein is generally provided by the supplier of each component and can be expressed in units of Daltons (Da) or its equivalent in g/mol.
  • the content of unsaturated portions of the unsaturated organopolysiloxane can be 0.001 mmol/g or more, 0.005 mmol/g or more, 0.010 mmol/g or more, 0.050 mmol/g or more, or 0.10 mmol/g or more, and can be 5.0 mmol/g or less, 3.0 mmol/g or less, 1.0 mmol/g or less, 0.50 mmol/g or less, 0.40 mmol/g or less, 0.30 mmol/g or less, 0.25 mmol/g or less, 0.20 mmol/g or less, or 0.15 mmol/g or less.
  • the first unsaturated organopolysiloxane can have a viscosity of 10,000 to 2,000,000 cst at 25° C.
  • the lower limit of the viscosity is preferably 20,000 cst or more, 40,000 cst or more, 60,000 cst or more, 80,000 cst or more, or 100,000 cst or more, and more preferably 125,000 cst or more or 150,000 cst or more.
  • the upper limit of the viscosity is preferably 1,000,000 cst or less, 500,000 cst or less, 450,000 cst or less, 400,000 cst or less, 350,000 cst or less, 300,000 cst or less, or 250,000 cst or less, more preferably 200,000 cst or less or 180,000 cst or less, and even more preferably 165,000 cst or less.
  • the first unsaturated organopolysiloxane can have an average molecular weight of 60,000 Da to 500,000 Da.
  • the lower limit of the average molecular weight is preferably 72,000 Da or more, 84,000 Da or more, 96,000 Da or more, or 100,000 Da or more, and more preferably 140,000 Da or more or 150,000 Da or more.
  • the upper limit of the average molecular weight is preferably 200,000 Da or less, 190,000 Da or less, 180,000 Da or less, or 170,000 Da or less, more preferably 160,000 Da or less, and even more preferably 155,000 Da or less.
  • the first unsaturated organopolysiloxane for example, at least one unsaturated organopolysiloxane selected from the group consisting of organopolysiloxanes having vinyl groups, vinyl-terminated organopolysiloxanes, and vinylated branched organopolysiloxanes can be used.
  • vinyl-terminated polydimethylsiloxane vinyl-terminated diphenylsiloxane-dimethylsiloxane copolymer
  • vinyl-terminated polyphenylmethylsiloxane vinylphenylmethyl-terminated vinylphenylsiloxane-phenylmethylsiloxane copolymer
  • vinyl-terminated trifluoropropylmethylsiloxane-dimethylsiloxane copolymer vinyl-terminated diethylsiloxane-dimethylsiloxane copolymer, vinylmethylsiloxane-dimethylsiloxane copolymer, trimethylsiloxy-terminated vinylmethylsiloxane-dimethylsiloxane copolymer, silanol-terminated vinylmethylsiloxane-dimethylsiloxane copolymer, vinylmethylsiloxane homopolymer, vinyl T-structure polymer, vinyl Q-structure polymer, mono
  • the first unsaturated organopolysiloxane can be used alone or in combination of two or more. Among these, vinyl-terminated polydimethylsiloxane is preferred, and vinyl dimethicone (divinyl dimethicone) is more preferred.
  • terminal refers to either one terminal or both terminals. When distinguishing between these, it can be written as "vinyl one terminal” or “vinyl both terminals", for example.
  • composition of the present disclosure may include a first hydride-functionalized polysiloxane, which is a type of silicone oil, as an oil component.
  • the first hydride-functionalized polysiloxane may function as a constituent material of the coating.
  • the first hydride-functionalized polysiloxane is not particularly limited, and may be, for example, a compound represented by the following formula 1.
  • the first hydride-functionalized polysiloxane may be used alone or in combination of two or more kinds:
  • R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b are each independently selected from hydrogen, C 1-20 alkyl, C 2-20 alkenyl, C 5-10 aryl, hydroxyl, or C 1-20 alkoxy, and m and n are each independently an integer from 10 to 6,000, provided that at least one of R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b is hydrogen.
  • At least one of R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b is hydrogen, and the remainder are C 1-20 alkyl.
  • R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b are hydrogen (e.g., two Si—H units per functionalized hydridopolysiloxane molecule).
  • R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b are hydrogen (e.g., three Si—H units per functionalized hydridopolysiloxane molecule).
  • R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b are hydrogen (e.g., two Si—H units per functionalized hydridopolysiloxane molecule), and the remainder are C 1-20 alkyl.
  • R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b are hydrogen (e.g., three Si—H units per functionalized hydridopolysiloxane molecule), and the remainder are C 1-20 alkyl.
  • At least two of R 4b , R 5b , R 9b and R 10b are hydrogen (eg, two Si—H units per functionalized hydridopolysiloxane molecule), and the remainder are C 1-20 alkyl.
  • R 4b , R 5b , R 9b and R 10b are hydrogen (eg, three Si—H units per functionalized hydridopolysiloxane molecule), and the remainder are C 1-20 alkyl.
  • the sum of m and n is an integer between 10 and 1,300, between 10 and 1,100, between 10 and 600, between 15 and 500, between 15 and 400, between 20 and 300, between 20 and 200, between 25 and 100, between 25 and 75, between 30 and 50, or between 40 and 45.
  • the first hydride-functionalized polysiloxane can be a non-terminally and/or terminally hydrogenated organopolysiloxane, which is composed of one or more organopolysiloxanes having at least two Si-H units in the molecule, preferably one or more organopolysiloxanes having an average of at least two Si-H units and having a viscosity of 2 to 100,000 cst at 25°C.
  • the organopolysiloxane having Si—H units may contain such Si—H units in a terminal unit of the polymer, in a non-terminal monomer unit of the polymer, or in a combination thereof. Of these, it is preferred that the Si—H units are contained in a non-terminal monomer unit of the polymer.
  • the first hydride-functionalized polysiloxane may be alkyl-terminated. For example, in formula 1, one or both of R 2b and R 7b may be a C 1-20 alkyl.
  • one, two, three, four, five or six of R 1b , R 2b , R 3b , R 6b , R 7b and R 8b may be C 1-20 alkyl.
  • R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b and R 10b are each C 1-20 alkyl, for example C 1 alkyl (for example methyl), and R 9b may be hydrogen.
  • R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b and R 9b are each C 1-20 alkyl, for example C 1 alkyl (for example methyl), and R 10b may be hydrogen.
  • the Si-H containing monomer units in the organopolysiloxane may be spaced apart, on average, by 1 monomer unit or more, 2 monomer units or more, 5 monomer units or more, 10 monomer units or more, 20 monomer units or more, 40 monomer units or more, 200 monomer units or more, 400 monomer units or more, 1,000 monomer units or more, or 2,000 monomer units or more.
  • the amount of Si-H-containing monomer units in the organopolysiloxane having Si-H units can be 0.003% by weight or more, 0.01% by weight or more, 0.1% by weight or more, 1% by weight or more, 3% by weight or more, 5% by weight or more, 10% by weight or more, 20% by weight or more, or 26% by weight or more, and can be 50% by weight or less, 45% by weight or less, 40% by weight or less, 35% by weight or less, 30% by weight or less, or 27% by weight or less.
  • the Si-H content of the organopolysiloxane having Si-H units can be 0.1 mmol/g or more, 0.5 mmol/g or more, 1 mmol/g or more, 2 mmol/g or more, 3 mmol/g or more, or 4 mmol/g or more, and can be 20 mmol/g or less, 10 mmol/g or less, 9 mmol/g or less, 8 mmol/g or less, 7 mmol/g or less, 6 mmol/g or less, or 5 mmol/g or less.
  • the approximate molar amount of Si-H units in the organopolysiloxane can be calculated based on the average molecular weight of the organopolysiloxane.
  • the first hydride-functionalized polysiloxane can have a viscosity of 2 to 500,000 cst at 25° C.
  • the lower limit of the viscosity is preferably 3 cst or more, 4 cst or more, 5 cst or more, 10 cst or more, 12 cst or more, 15 cst or more, 20 cst or more, 25 cst or more, or 30 cst or more, and more preferably 40 cst or more.
  • the upper limit of the viscosity is preferably 200,000 cst or less, 100,000 cst or less, 50,000 cst or less, 20,000 cst or less, 10,000 cst or less, 5,000 cst or less, 2,000 cst or less, or 1,000 cst or less, and more preferably 500 cst or less.
  • the viscosity of the hydride-functionalized polysiloxane is particularly preferably in the range of 45 to 100 cst or 45 to 50 cst at 25°C.
  • the hydride-functionalized polysiloxane can have an average molecular weight of 400 to 500,000 Da.
  • the lower limit of such average molecular weight is preferably 500 Da or more, 800 Da or more, 900 Da or more, 1,000 Da or more, 1,200 Da or more, 1,400 Da or more, 1,600 Da or more, 1,800 Da or more, 2,000 Da or more, or 2,200 Da or more, and more preferably 2,300 Da or more.
  • the upper limit of the average molecular weight is preferably 250,000 Da or less, 140,000 Da or less, 100,000 Da or less, 72,000 Da or less, 62,700 Da or less, 60,000 Da or less, 50,000 Da or less, 49,500 Da or less, 36,000 Da or less, 28,000 Da or less, 25,000 Da or less, 20,000 Da or less, 15,000 Da or less, 10,000 Da or less, 5,000 Da or less, or 4,000 Da or less, and more preferably 2,500 Da or less.
  • the first hydride-functionalized polysiloxane may be, but is not limited to, at least one selected from the group consisting of hydride-terminated polydimethylsiloxane, hydride-terminated polyphenyl-(dimethylhydrosiloxy)siloxane, hydride-terminated methylhydrosiloxane-phenylmethylsiloxane copolymer, trimethylsiloxy-terminated methylhydrosiloxane-dimethylsiloxane copolymer, polymethylhydrosiloxane, trimethylsiloxy-terminated polyethylhydrosiloxane, triethylsiloxane, methylhydrosiloxane-phenyloctylmethylsiloxane copolymer, and methylhydrosiloxane-phenyloctylmethylsiloxane terpolymer.
  • hydride-terminated polydimethylsiloxane is
  • the other silicone oils other than the first unsaturated organopolysiloxane and the first hydride-functionalized polysiloxane are not particularly limited, and for example, chain silicones such as dimethylpolysiloxane (dimethicone), methylphenylpolysiloxane, and methylhydrogenpolysiloxane; cyclic silicones such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, and dodecamethylcyclohexasiloxane, etc. can be used.
  • the other silicone oils can be used alone or in combination of two or more kinds.
  • the catalyst is not particularly limited, and may be, for example, any substance capable of causing, promoting, or initiating a physical and/or chemical crosslinking reaction of the unsaturated organopolysiloxane and hydride-functionalized polysiloxane, which are crosslinking reactive components constituting the coating.
  • the catalyst may or may not undergo permanent physical and/or chemical changes during or at the end of the process.
  • the catalyst may be, but is not limited to, a metal catalyst capable of initiating and/or promoting crosslinking at or below body temperature, such as Group VIII metal catalysts, for example, platinum catalysts, rhodium catalysts, palladium catalysts, cobalt catalysts, nickel catalysts, ruthenium catalysts, osmium catalysts, and iridium catalysts, and Group IVA metal catalysts, for example, germanium catalysts and tin catalysts. Of these, platinum catalysts, rhodium catalysts, and tin catalysts are preferred.
  • the catalysts may be used alone or in combination of two or more.
  • Platinum catalysts include, for example, platinum carbonylcyclovinylmethylsiloxane complexes, platinum divinyltetramethyldisiloxane complexes, platinum cyclovinylmethylsiloxane complexes, platinum octanaldehyde/octanol complexes, and other Pt(0) catalysts, such as Karstedt's catalyst, platinum-alcohol complexes, platinum-alkoxide complexes, platinum-ether complexes, platinum-aldehyde complexes, platinum-ketone complexes, platinum-halogen complexes, platinum-sulfur complexes, platinum-nitrogen complexes, platinum-phosphorus complexes, platinum-phosphorus complexes, platinum-carbon double bond complexes, platinum-carbon triple bond complexes, platinum-imido complexes, platinum-amide complexes, platinum-ester complexes, platinum-phosphate ester complexes, platinum-thiol ester complexes, platinum lone
  • At least one selected from the group consisting of platinum carbonylcyclovinylmethylsiloxane complex, platinum divinyltetramethyldisiloxane complex, platinum cyclovinylmethylsiloxane complex, and platinum octanaldehyde/octanol complex is preferred.
  • Rhodium catalysts include, for example, tris(dibutylsulfide)rhodium trichloride and rhodium trichloride hydrate.
  • tin catalysts include tin(II) octanoate, tin(II) neodecanoate, dibutyltin diisooctylmaleate, di-n-butyl bis(2,4-pentanedionate)tin, di-n-butylbutoxychlorotin, dibutyltin dilaurate, dimethyltin dineodecanoate, dimethylhydroxy(oleate)tin, and tin(II) oleate.
  • platinum catalysts are more preferred, with platinum divinyltetramethyldisiloxane complexes being particularly preferred.
  • the amount of catalyst in the oil-in-water composition may be adjusted appropriately according to the required film performance, and is not particularly limited.
  • the amount of catalyst may be 0.001% by mass or more, 0.005% by mass or more, or 0.010% by mass or more, and 1.0% by mass or less, 0.10% by mass or less, or 0.050% by mass or less, based on the total amount of the composition.
  • the oil-in-water composition of the present disclosure can contain an emulsifier.
  • the emulsifier in the present disclosure refers to an agent having emulsifying function (surface activity), and can also include agents generally called surfactants.
  • the oil-in-water composition containing an emulsifier can be called an oil-in-water emulsion composition.
  • the amount of emulsifier used there is no particular limit to the amount of emulsifier used, and from the standpoint of emulsion stability, for example, it can be 0.01 mass% or more, 0.05 mass% or more, 0.1 mass% or more, or 0.2 mass% or more relative to the total amount of the composition.
  • the upper limit of the amount of emulsifier used but from the standpoint of film durability, for example, it is preferable that the amount of emulsifier used is 5.0 mass% or less, 4.0 mass% or less, 3.0 mass% or less, 2.0 mass% or less, or 1.0 mass% or less.
  • emulsifier for example, anionic, cationic, amphoteric, or nonionic emulsifiers can be used.
  • the emulsifiers can be used alone or in combination of two or more kinds.
  • emulsifier examples include at least one selected from the group consisting of hydrocarbon surfactants, silicone surfactants, polymeric emulsifiers, and amphiphilic powders.
  • hydrocarbon surfactants include polyoxyethylene alkyl ethers, polyoxyethylene steryl ethers, polyoxyethylene fatty acid esters, polyoxyethylene polyhydric alcohol fatty acid esters, polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan fatty acid esters, glycol fatty acid esters, glycerin fatty acid esters, sorbitan fatty acid esters, sucrose fatty acid esters, and polyglycerin fatty acid esters.
  • silicone surfactants include polyether-modified silicones and alkyl-co-modified polyether-modified silicones. If a silicone surfactant exhibits a surface tension of 30.0 mN/m or less at 25°C in an aqueous solution containing 1% by mass of the surfactant, the silicone surfactant can be considered a silicone surface tension adjuster, as described below.
  • polymer emulsifiers are preferred from the viewpoints of uniform dispersion (emulsifying ability) of the catalyst in the composition and storage stability of the catalyst.
  • Polymer emulsifiers typically have a larger molecular weight and are intended to be emulsifiers (surfactants) with lower emulsifying ability than general emulsifiers (surfactants).
  • Polymer emulsifiers may be used in combination with the emulsifiers mentioned above.
  • the weight average molecular weight of the polymer emulsifier may be 500 or more, 700 or more, 1,000 or more, 1,500 or more, or 2,000 or more from the viewpoint of emulsifying properties, etc.
  • the upper limit of the weight average molecular weight of the polymer emulsifier is not particularly limited, and may be, for example, 1,000,000 or less, 100,000 or less, 10,000 or less, or 5,000 or less.
  • the weight average molecular weight of the emulsifier is a polystyrene-equivalent value obtained by dissolving the emulsifier in N,N-dimethylformamide (DMF) to prepare a 0.5% solution, and using this to measure by GPC (gel permeation chromatography) under the following conditions: Column: Two ⁇ -M columns (Showa Denko KK) were connected in series. Eluent: 60 mmol/L H 3 PO 4 and 50 mmol/L LiBr in DMF Flow rate: 1.0 mL/min Column temperature: 40° C. Detector: RI Calibration curve: Prepared using polystyrene.
  • the polymer emulsifier is not particularly limited, and examples thereof include at least one selected from the group consisting of (acrylates/alkyl acrylate (C10-30)) crosspolymer, (ammonium acryloyldimethyltaurate/beheneth-25 methacrylate) crosspolymer, (hydroxyethyl acrylate/sodium acryloyldimethyltaurate) copolymer, PEG-modified crosspolymer/copolymer siloxane, polyether-modified crosspolymer/copolymer siloxane, stearoxyhydroxypropylmethylcellulose, and polyoxyethylene.
  • (acrylates/alkyl acrylate (C10-30)) crosspolymer is preferred.
  • the amount of polymer emulsifier may be 0.01% by mass or more, 0.05% by mass or more, 0.1% by mass or more, or 0.2% by mass or more relative to the total amount of the composition, from the viewpoint of uniform dispersion (emulsification) of the catalyst in the composition, and may be 30% by mass or less, 25% by mass or less, 20% by mass or less, 15% by mass or less, 10% by mass or less, 5% by mass or less, 3% by mass or less, or 1% by mass or less.
  • the weight average molecular weight of a typical emulsifier (surfactant) other than a polymer emulsifier can be less than 500, 450 or less, or 400 or less, and can be 100 or more, 150 or more, or 200 or more.
  • the HLB of common emulsifiers (surfactants) other than polymer emulsifiers can be 2.0 or more, 3.0 or more, or 4.0 or more, and can be 10.0 or less, 9.0 or less, or 8.0 or less.
  • the oil-in-water composition of the present disclosure contains a silicone-based surface tension modifier (sometimes simply referred to as a "surface tension modifier").
  • a surface tension modifier exhibits a surface tension of 30.0 mN/m or less at 25°C in an aqueous solution containing 1% by mass of the surface tension modifier.
  • the surface tension modifier may be used alone or in combination of two or more kinds.
  • the surface tension is the average value of values obtained by measuring three times at 25°C using a Wilhelmy plate.
  • the surface tension of the surface tension adjuster is preferably 29.0 mN/m or less, 28.5 mN/m or less, 28.0 mN/m or less, 27.5 mN/m or less, or 27.0 mN/m or less.
  • the lower limit of such surface tension can be, for example, 20.0 mN/m or more, 21.0 mN/m or more, 22.0 mN/m or more, 23.0 mN/m or more, 24.0 mN/m or more, or 25.0 mN/m or more.
  • the amount of the surface tension modifier is preferably 0.01% by mass or more, 0.03% by mass or more, 0.05% by mass or more, 0.07% by mass or more, or 0.1% by mass or more, based on the total amount of the composition.
  • the upper limit of the amount can be, for example, 10% by mass or less, 7.0% by mass or less, 5.0% by mass or less, 3.0% by mass or less, or 1.0% by mass or less.
  • the surface tension modifier there are no particular limitations on the surface tension modifier, so long as it is a silicone-based agent (an agent containing a silicone component such as a silicone chain) with a predetermined surface tension, and it may be, for example, a silicone-based surfactant with emulsifying ability (surface activity ability) as described above, or an agent without emulsifying ability.
  • the surface tension modifier is a silicone-based surfactant with emulsifying ability
  • the surface tension modifier may be contained in the interface between the oil droplets and the dispersion medium, but when it is an agent without emulsifying ability, the surface tension modifier may be contained in the dispersion medium. In this way, the surface tension modifier may be contained in the dispersion medium and/or the oil droplets described above.
  • surface tension adjusters are preferably at least one selected from the group consisting of polyoxyethylene-methylpolysiloxane copolymer, dimethylpolysiloxane-methyl(polyoxyethylene)siloxane copolymer, and bisPEG-18 methyl ether dimethylsilane, from the viewpoint of improving coating unevenness.
  • silicone surfactants such as polyoxyethylene-methylpolysiloxane copolymer and dimethylpolysiloxane-methyl(polyoxyethylene)siloxane copolymer are more preferred, polyoxyethylene-methylpolysiloxane copolymer is even more preferred, and PEG-10 methyl ether dimethicone and PEG-11 methyl ether dimethicone are particularly preferred.
  • the oil-in-water composition of the present disclosure comprises non-porous particles.
  • a composition comprising non-porous particles is used as the second agent, the shine of the resulting film can be further reduced or prevented.
  • the first agent of the coating-type film-forming agent is applied to the body surface to form a first agent layer, and then the second agent is applied, it is preferable to use an oil-in-water composition comprising non-porous particles as the second agent.
  • the non-porous particles contained in the second agent are easily arranged near the surface of the film, so that the shine of the film can be further reduced or prevented.
  • the non-porous particles can be used alone or in combination of two or more kinds.
  • non-porous means substantially non-porous, and is not limited to the case where there are no holes at all.
  • the non-porous particles of the present disclosure may refer to particles having a BET specific surface area measured by the BET method (gas adsorption method) of 100 m 2 /g or less, 80 m 2 /g or less, 50 m 2 /g or less, 30 m 2 /g or less, or 25 m 2 /g or less.
  • BET specific surface area There is no particular restriction on the lower limit of the BET specific surface area, and it may be, for example, 0 m 2 /g or more, more than 0 m 2 /g, 1 m 2 /g or more, or 2 m 2 /g or more.
  • the amount of non-porous particles is preferably 1.0% by mass or more, 2.0% by mass or more, 3.0% by mass or more, 4.0% by mass or more, 5.0% by mass or more, 6.0% by mass or more, 7.0% by mass or more, 8.0% by mass or more, or 9.0% by mass or more, based on the total amount of the composition, from the viewpoint of suppressing shine.
  • the upper limit of such amount is preferably 20% by mass or less, 15% by mass or less, 13% by mass or less, 12% by mass or less, 11% by mass or less, or 10% by mass or less, from the viewpoint of preventing defects such as uneven application, for example.
  • the nonporous particles there are no particular limitations on the size of the nonporous particles, and from the viewpoint of suppressing shine, for example, it is preferable for the nonporous particles to have an equivalent circle diameter of 1.0 ⁇ m or more, 1.5 ⁇ m or more, 2.0 ⁇ m or more, 2.5 ⁇ m or more, 3.0 ⁇ m or more, or 3.5 ⁇ m or more, 10 ⁇ m or less, 9.0 ⁇ m or less, 8.0 ⁇ m or less, 7.0 ⁇ m or less, 6.0 ⁇ m or less, or 5.0 ⁇ m or less.
  • the equivalent circle diameter can mean, for example, the particle diameter when converted into a circular particle having the same area as the projected area of the nonporous particle observed under a transmission electron microscope. Such equivalent circle diameter can be defined as the average value of 10 or more particles.
  • the nonporous particles may be, for example, solid nonporous particles or hollow nonporous particles. From the viewpoint of suppressing shine, solid nonporous particles are preferred. From the viewpoint of suppressing shine, the nonporous particles are preferably spherical particles, and preferably particles exhibiting a refractive index of 1.4 to 1.6.
  • the term "spherical" in nonporous particles includes true spheres, nearly spherical shapes, and spheroids, and even if the surface is uneven, the particle falls under the category of "spherical" in this disclosure as long as the overall shape of the particle can be determined to be spherical.
  • the term "spherical particles" in nonporous particles is not limited to true spheres, and may include particles whose minor axis/major axis ratio (ellipticity) is 1.5 or less, 1.2 or less, or 1.1 or less.
  • the lower limit of such a ratio may be, for example, 1.0 or more, more than 1.0, or 1.2 or more.
  • the material of the non-porous particles is not particularly limited, and may be an inorganic material or a resin material.
  • specific examples of such materials include inorganic oxides (e.g., zinc oxide, titanium oxide, aluminum oxide, and silicon oxide), boron nitride, magnesium carbonate, magnesium hydroxide, barium sulfate, kaolin, perlite, talc, mica, silicone resin, polyamide resin, and (meth)acrylic resin.
  • inorganic oxides e.g., zinc oxide, titanium oxide, aluminum oxide, and silicon oxide
  • boron nitride boron nitride
  • magnesium carbonate magnesium hydroxide
  • barium sulfate magnesium hydroxide
  • barium sulfate kaolin
  • perlite talc
  • mica kaolin
  • perlite talc
  • silicone resin polyamide resin
  • (meth)acrylic resin e.g., silicone resin, polyamide resin, and (meth)acrylic resin.
  • the nonporous particles may be particles that have been hydrophobized with a surface treatment agent, or may not be hydrophobized. If hydrophobization is performed, there are no particular limitations on the treatment, and examples include dimethylsilylation treatment and trimethylsilylation treatment.
  • porous particles are blended into the oil-in-water composition of the present disclosure, uneven application may occur, and as a result, problems such as shininess of the film may occur.
  • the porous particles are preferably blended at a ratio of 10% by mass or less, 8.0% by mass or less, 5.0% by mass or less, 3.0% by mass or less, 1.0% by mass or less, 0.5% by mass or less, or 0.1% by mass or less with respect to the total amount of the composition, and it is more preferable that the porous particles are not blended into the oil-in-water composition.
  • the porous particles refer to particles having a larger number of holes on the surface than the non-porous particles of the present disclosure, and may refer to particles having a BET specific surface area measured by the BET method (gas adsorption method) of 300 m 2 /g or more, 500 m 2 /g or more, or
  • the oil-in-water composition of the present disclosure can be suitably used as the second agent of a coating-type film-forming agent (sometimes simply referred to as a "forming agent") that includes a first agent and a second agent.
  • a coating-type film-forming agent (sometimes simply referred to as a "forming agent") that includes a first agent and a second agent.
  • Such a forming agent can form a film, for example, by coating the first agent on a body surface to form a first agent layer, and then coating the second agent on the first agent layer to crosslink the first agent layer.
  • the film obtained by the coating-type film-forming agent of the present disclosure may be a body correcting film having a body correcting function, or may be a film without a body correcting function.
  • the application performance of the first agent of the spread-type film-forming agent can be evaluated by viscosity using a Brookfield viscometer (Shibaura Systems Co., Ltd., Vismetron (trademark)).
  • the viscosity of the first agent in the spread-type film-forming agent of the present disclosure e.g., the viscosity immediately after preparation measured under conditions of 25°C and 60 rpm (rotor No. 3 or No.
  • 4) is, for example, 100 mPa ⁇ s or more, 500 mPa ⁇ s or more, 1,000 mPa ⁇ s or more, 2,000 mPa ⁇ s or more, 5,000 mPa ⁇ s or more, 7,500 mPa ⁇ s or more, 10,000 mPa ⁇ s or more, or 15,000 mPa ⁇ s or more.
  • the viscosity can be 1,000,000 mPa ⁇ s or more, and can be 1,000,000 mPa ⁇ s or less, 750,000 mPa ⁇ s or less, 500,000 mPa ⁇ s or less, 250,000 mPa ⁇ s or less, 200,000 mPa ⁇ s or less, 175,000 mPa ⁇ s or less, 150,000 mPa ⁇ s or less, 125,000 mPa ⁇ s or less, 100,000 mPa ⁇ s or less, or 80,000 mPa ⁇ s or less.
  • the first agent of the paint-on film-forming agent preferably has a viscosity of 20,000 mPa ⁇ s or less, 15,000 mPa ⁇ s or less, or 10,000 mPa ⁇ s or less immediately after preparation, and preferably has a viscosity of 3,000 mPa ⁇ s or more, 5,000 mPa ⁇ s or more, or 7,000 mPa ⁇ s or more.
  • the application performance of the second agent of the paint-on film-forming agent can be evaluated by viscosity using a Brookfield viscometer (Shibaura Systems Co., Ltd., Vismetron (trademark)).
  • the viscosity of the second agent in the paint-on film-forming agent of the present disclosure (e.g., the viscosity immediately after preparation) measured under conditions of 25°C and 10 revolutions per minute (rotor No. 7) can be, for example, 10,000 mPa ⁇ s or more, 20,000 mPa ⁇ s or more, 30,000 mPa ⁇ s or more, 40,000 mPa ⁇ s or more, or 50,000 mPa ⁇ s or more, and can be 1,000,000 mPa ⁇ s or more.
  • the viscosity can be set to 750,000 mPa.s or less, 500,000 mPa.s or less, 250,000 mPa.s or less, 200,000 mPa.s or less, 175,000 mPa.s or less, 150,000 mPa.s or less, 125,000 mPa.s or less, 120,000 mPa.s or less, 115,000 mPa.s or less, or 110,000 mPa.s or less.
  • the second agent of the paint-on film-forming agent preferably has a viscosity of 20,000 mPa ⁇ s or more, 30,000 mPa ⁇ s or more, 40,000 mPa ⁇ s or more, or 50,000 mPa ⁇ s or more immediately after preparation, and preferably has a viscosity of 200,000 mPa ⁇ s or less, 175,000 mPa ⁇ s or less, 150,000 mPa ⁇ s or less, 125,000 mPa ⁇ s or less, 120,000 mPa ⁇ s or less, 115,000 mPa ⁇ s or less, or 110,000 mPa ⁇ s or less.
  • the first agent constituting the paint-on type film-forming agent of the present disclosure contains at least one selected from the group consisting of the second unsaturated organopolysiloxane and the second hydride-functionalized polysiloxane.
  • the second agent when the first agent contains only the second unsaturated organopolysiloxane among the second unsaturated organopolysiloxane and the second hydride-functionalized polysiloxane, the second agent composed of the above-mentioned oil-in-water composition contains the above-mentioned first hydride-functionalized polysiloxane, and when the first agent contains only the second hydride-functionalized polysiloxane among the second unsaturated organopolysiloxane and the second hydride-functionalized polysiloxane, the second agent contains the first unsaturated organopolysiloxane.
  • the dosage form of the first agent is not particularly limited, and may be, for example, a single-phase system composed of an oil phase, a non-emulsified oil-in-water or water-in-oil two-phase system, or a two-phase system composed of an oil-in-water emulsion composition or a water-in-oil emulsion composition.
  • a single-phase system composed of an oil phase is typically an anhydrous form.
  • “anhydrous” not only means that the composition does not contain water, but also means that the water content is low, i.e., 10% by mass or less, 5% by mass or less, 2% by mass or less, 1% by mass or less, or 0.1% by mass or less.
  • a non-emulsified two-phase system may include a water-in-oil composition in which water droplets are forcibly dispersed in a dispersion medium containing oil by shaking a liquid in a state in which the water and oil are separated, or an oil-in-water composition in which oil droplets are forcibly dispersed in a dispersion medium containing water.
  • Each of these formulations can be prepared appropriately by conventional methods using a crosslinking reactive component and, optionally, known materials such as oils, emulsifiers, and water, as described below.
  • the first agent can be applied to the body surface by painting or the like, so from the viewpoint of application performance, it preferably has a glass transition temperature below body temperature.
  • the glass transition temperature can be 37°C or lower, 25°C or lower, 10°C or lower, or 0°C or lower.
  • There is no particular restriction on the lower limit of the glass transition temperature but it can be, for example, -30°C or higher, -20°C or higher, or -10°C or higher.
  • glass transition temperature refers to the temperature at which a transition from a solid state to a liquid state occurs, and can be measured, for example, using a differential scanning calorimeter (DSC) in accordance with ASTM D3418-03.
  • DSC differential scanning calorimeter
  • the amount of the second unsaturated organopolysiloxane in the first agent can be adjusted appropriately according to the required film performance, etc., and is not particularly limited.
  • the amount of the second unsaturated organopolysiloxane can be 5% by mass or more, 10% by mass or more, 20% by mass or more, 30% by mass or more, 35% by mass or more, or 40% by mass or more, and can be 90% by mass or less, 80% by mass or less, 70% by mass or less, 60% by mass or less, 50% by mass or less, or 45% by mass or less, based on the entire first agent.
  • the second hydride-functionalized polysiloxane can be the same material as the first hydride-functionalized polysiloxane described above.
  • the amount of the second hydride-functionalized polysiloxane in the first agent can be adjusted appropriately according to the required film performance, etc., and is not particularly limited.
  • the amount of the second hydride-functionalized polysiloxane can be 1 mass% or more, 3 mass% or more, or 5 mass% or more, and 75 mass% or less, 60 mass% or less, 50 mass% or less, 40 mass% or less, 30 mass% or less, 20 mass% or less, or 10 mass% or less, based on the entire first agent.
  • the first agent may optionally contain other polymers other than the second unsaturated organopolysiloxane and the second hydride-functionalized polysiloxane.
  • the other polymers may be used alone or in combination of two or more.
  • the other polymer can have a viscosity of 0.7 cst to 50,000 cst at 25° C.
  • the lower limit of such viscosity can be 1 cst or more, 6 cst or more, 10 cst or more, 20 cst or more, 50 cst or more, 100 cst or more, 200 cst or more, 300 cst or more, 400 cst or more, 750 cst or more, 1,000 cst or more, 1,500 cst or more, 2,000 cst or more, 2,500 cst or more, 3,000 cst or more, 3,500 cst or more, or 4,000 cst or more.
  • the upper limit of the viscosity can be 45,000 cst or less, 40,000 cst or less, 35,000 cst or less, 30,000 cst or less, 25,000 cst or less, 20,000 cst or less, 15,000 cst or less, 12,000 cst or less, 10,000 cst or less, 5,000 cst or less, 4,000 cst or less, 2,000 cst or less, 1,500 cst or less, or 1,000 cst or less.
  • the other polymer can have an average molecular weight of 180 Da to 80,000 Da.
  • the lower limit of the average molecular weight can be 500 Da or more, 800 Da or more, 1,500 Da or more, 3,000 Da or more, 6,000 Da or more, 9,400 Da or more, 10,000 Da or more, 15,000 Da or more, 20,000 Da or more, 30,000 Da or more, 40,000 Da or more, 50,000 Da or more, 55,000 Da or more, 60,000 Da or more, or 62,000 Da or more.
  • the upper limit of the average molecular weight can be 75,000 Da or less, 70,000 Da or less, 65,000 Da or less, or 63,000 Da or less.
  • the other polymer may preferably be one or more organopolysiloxanes having, on average, at least one alkenyl functional group and a viscosity of 0.7 to 50,000 cst at 25°C.
  • polymers include vinyl-terminated polydimethylsiloxane, vinyl-terminated diphenylsiloxane-dimethylsiloxane copolymer, vinyl-terminated polyphenylmethylsiloxane, vinylphenylmethyl-terminated vinylphenylsiloxane-phenylmethylsiloxane copolymer, vinyl-terminated trifluoropropylmethylsiloxane-dimethylsiloxane copolymer, vinyl-terminated diethylsiloxane-dimethylsiloxane copolymer, vinylmethylsiloxane-dimethylsiloxane copolymer, trimethylsiloxy-terminated vinylmethylsiloxane-dimethylsiloxane copolymer, silanol-terminated vinylmethylsiloxane-dimethylsiloxane copolymer, At least one selected from vinyl siloxane copolymer, vinyl-terminated vinyl rubber, vinyl
  • the amount of the other polymer in the first agent is not particularly limited and may be adjusted as appropriate depending on the required film performance, etc.
  • the amount of the other polymer may be 0.01% by mass or more, 0.1% by mass or more, 0.3% by mass or more, or 0.5% by mass or more relative to the entire first agent, and may be 20% by mass or less, 15% by mass or less, or 10% by mass or less.
  • the molar ratio of Si—H functional groups from the second hydride-functionalized polysiloxane to alkenyl functional groups from the second unsaturated organopolysiloxane is preferably from 60:1 to 1:5, more preferably from 45:1 to 15:1.
  • the molar ratio of Si-H functional groups from the second hydride-functionalized polysiloxane to alkenyl functional groups from the other polymer is preferably from 60:1 to 1:5, more preferably from 45:1 to 15:1.
  • the molar ratio of the alkenyl functional groups derived from the second unsaturated organopolysiloxane to the alkenyl functional groups derived from the other polymer is preferably from 100:1 to 1:100, and more preferably from 10:1 to 1:10.
  • the spreadable film-forming agent of the present disclosure uses the oil-in-water composition of the present disclosure described above as the second agent.
  • the second agent can also contain other polymers that can be blended into the first agent, as described above.
  • the functional group ratios thereof can be the same as the functional group ratios in the second unsaturated organopolysiloxane and other polymers described above.
  • paint-type film-forming agent of the present disclosure various components can be appropriately blended into the first agent and/or the second agent within a range that does not adversely affect the effects of the present disclosure.
  • the optional components are not particularly limited, but examples include feel modifiers, adhesion modifiers, spreadability promoters, diluents, adhesion modifiers, emulsifiers (surfactants), emollients, solvents, film-forming agents, humectants, preservatives, fibers, pigments, dyes, components that thicken the aqueous or oil phase (thickeners), protective colloids, fillers, skin permeation enhancers, optical modifiers, scattering agents, dispersants, adsorbents, magnetic materials, gas transport modifiers, liquid transport modifiers, pH modifiers, sensitization modifiers, and aesthetic modifiers.
  • the optional components can be used alone or in combination of two or more. In particular, when a dispersant such as sodium hexametaphosphate is blended with non-porous particles in the second agent, shine can be further suppressed.
  • compositions of the present disclosure may further comprise one or more drugs in addition to the first agent and/or the second agent.
  • drugs may include, for example, cosmetic agents, therapeutic agents, stimuli-responsive agents, and drug delivery agents.
  • Suitable cosmetic agents include, for example, moisturizers, UV absorbers, skin protectants, skin soothing agents, skin whitening agents, skin brighteners, skin emollients, skin smoothing agents, skin bleaching agents, skin exfoliants, skin tightening agents, beauty agents, vitamins, antioxidants, cell signaling agents, cell regulating agents, cell interacting agents, skin tanning agents, anti-aging agents, anti-wrinkle agents, spot reducers, alpha-hydroxy acids, beta-hydroxy acids, and ceramides.
  • Suitable therapeutic agents include, for example, pain relievers, analgesics, antipruritic agents, antiacne agents (e.g., beta-hydroxy acids, salicylic acid, benzoyl peroxide), anti-inflammatory agents, antihistamines, corticosteroids, NSAIDs (nonsteroidal anti-inflammatory drugs), antiseptics, antibiotics, antibacterial agents, antifungal agents, antiviral agents, antiallergy agents, antiirritants, insect repellents, phototherapy agents, blood clotting agents, antineoplastic agents, immune system enhancers, immune system suppressants, coal tar, anthralin, fluocinonide, methotrexate, cyclosporine, pimecrolimus, tacrolimus, azathioprine, fluorouracil, ceramides, counterirritants, and skin cooling compounds.
  • pain relievers e.g., analgesics, antipruritic agents, antiacne agents (e.g.,
  • Suitable agents can include, for example, antioxidants, vitamins, vitamin D3 analogs, retinoids, minerals, mineral oil, petrolatum, fatty acids, plant extracts, polypeptides, antibodies, proteins, sugars, humectants, and emollients.
  • the spreadable film-forming agent of the present disclosure can be used, for example, for cosmetic or medical purposes.
  • the method of using the spreadable film-forming agent of the present disclosure does not include methods for surgery, treatment, or diagnosis of humans.
  • the method of using the coating-type film-forming agent of the present disclosure is not particularly limited, and examples of the method include a method in which the first agent is applied to the body surface to form a first agent layer, and then the second agent is applied on the first agent layer and crosslinked to form a film; a method in which the second agent is applied to the body surface to form a second agent layer, and then the first agent is applied on the second agent layer and crosslinked to form a film; or a method in which the first agent and the second agent are mixed to prepare a mixture, and then the mixture is applied to the body surface and crosslinked to form a film.
  • a preferred method of use is a method in which the first agent is applied to the body surface to form a first agent layer, and then the second agent is applied on the first agent layer and crosslinked to form a film.
  • the materials described above can be used for the first agent and the second agent in the same manner.
  • This method may be performed once, or may be performed multiple times (e.g., two or more times, or three or more times) on the formed coating.
  • the method may include, for example, any of the following operations: Applying a first agent to the formed coating to form a first agent layer, and then applying a second agent onto the first agent layer to further form a coating; or An operation in which a second agent is applied to the formed coating to form a second agent layer, and then a first agent is applied onto the second agent layer to further form a coating; or an operation in which the first agent and the second agent are mixed to prepare a mixture, and then the mixture is applied to the formed coating to further form a coating.
  • a cosmetic may be applied to the body surface before applying the first agent, the second agent, or a mixture containing the first agent and the second agent to the body surface; a first agent may be applied to the body surface to form a first agent layer, a cosmetic may be applied onto the first agent layer, and then the second agent may be applied to cover the cosmetic; a second agent may be applied to the body surface to form a second agent layer, a cosmetic may be applied onto the second agent layer, and then the first agent may be applied to cover the cosmetic; or a film may be formed, and then the cosmetic may be applied to the film.
  • cosmetics there are no particular limitations on the cosmetics that can be used, and examples of such cosmetics include skin care cosmetics such as serums, lotions, and emulsions, sunscreen cosmetics (sun protection cosmetics), base cosmetics, and make-up cosmetics such as foundations, glosses, lipsticks, eye shadows, and nail polishes, or cosmetics that combine the functions of two or more of these cosmetics.
  • skin care cosmetics such as serums, lotions, and emulsions
  • sunscreen cosmetics unsun protection cosmetics
  • base cosmetics such as foundations, glosses, lipsticks, eye shadows, and nail polishes, or cosmetics that combine the functions of two or more of these cosmetics.
  • make-up cosmetics such as foundations, glosses, lipsticks, eye shadows, and nail polishes, or cosmetics that combine the functions of two or more of these cosmetics.
  • the method of using the applied film-forming agent of the present disclosure can also be used as a cosmetic method.
  • a cosmetic method For example, when skin is exposed to dryness, moisture is unknowingly lost, and the stratum corneum on the skin surface may not be able to maintain its moisture content.
  • the skin lacks moisture it is no longer able to effectively produce the moisturizing components (Natural Moisturizing Factors (NMFs)) that it produces itself.
  • NMFs Natural Moisturizing Factors
  • the occlusion effect of the film allows the skin to be well moisturized.
  • the skin's own production function of moisturizing ingredients is improved, and turnover problems in the stratum corneum are also improved, making skin problems such as roughness less likely to occur, and improving the cosmetic effect.
  • the term "cosmetic method" refers to applying the applied film-forming agent of the present disclosure to the skin to form a film and beautify the skin's condition, or a method for beautifying the skin's condition, and is different from a method of surgery, treatment, or diagnosis of humans.
  • the method for applying the first or second agent to the skin, the cosmetic application layer, or the first or second agent layer there are no particular limitations on the method for applying the first or second agent to the skin, the cosmetic application layer, or the first or second agent layer, and for example, methods such as spreading with fingers, spray application, and transfer can be used.
  • first and/or second agents are separated into water and oil, it is preferable to shake these agents to forcibly turn them into a two-phase system (oil-in-water type or water-in-oil type) from the viewpoint of improving coating unevenness, etc.
  • the applied film-forming agent of the present disclosure can be applied to any part of the skin surface of any part of the body, that is, any part of the body surface.
  • it can be appropriately applied to the skin surface of the head, face (lips, eyes, nose, cheeks, forehead, etc.), neck, ears, hands, arms, legs, feet, chest, abdomen, back, buttocks, etc.
  • the skin also includes nails that have hardened due to changes in the keratin of the epidermis of the skin.
  • the paint-type film-forming agent of the present disclosure can be provided as a kit having the first and second agents that constitute the agent.
  • the kit may also have optional agents such as agents for facilitating application of the first agent or the like to the body surface, or the various cosmetics described above, or may be used in combination with these agents.
  • Such optional components include, for example, an instruction manual, a spatula-shaped applicator, a brush, a cotton swab, a cutter, scissors, the various cosmetics mentioned above, a remover for removing film from the body surface, a mirror, etc.
  • "instructions for use” can include not only general instructions for use that are attached in the form of a document within the kit, but also, for example, instructions for use printed on a packaging container that contains the kit, or on a packaging container such as a tube for injecting the first agent, etc.
  • the kit may include, for example, the first and second agents packaged in separate containers or in separate compartments of a container having two or more compartments to prevent contact between the first and second agents.
  • the packaged agents may be configured to be applied one at a time or to be mixed together before or during use.
  • the thickness of the film prepared using the coating-type film-forming agent of the present disclosure described above is not particularly limited, and can be appropriately adjusted in consideration of, for example, breathability, invisibility, compressibility, occlusion to the skin, etc.
  • the thickness of the film can be, for example, 0.5 ⁇ m or more, 1 ⁇ m or more, 10 ⁇ m or more, 30 ⁇ m or more, 40 ⁇ m or more, 50 ⁇ m or more, 70 ⁇ m or more, or 100 ⁇ m or more.
  • the thickness can be defined as the average value calculated by measuring the thickness of any part of the film five times using a high-precision digital micrometer (MDH-25MB, manufactured by Mitutoyo Corporation).
  • the thickness of the coating refers to the thickness of the coating prepared using the coating-type coating-forming agent after it has been thoroughly dried (for example, after it has been dried in an atmosphere at room temperature for 6 hours or more).
  • a test sample for surface tension evaluation was prepared by adding the test material as a surface tension regulator to ion-exchanged water at a blending ratio of 1 mass %.
  • the surface tension of the test sample was measured three times by the Wilhelmy method using a dynamic contact angle measuring device (DCAT21, manufactured by Data Physics) in an atmosphere of 25 ° C.
  • the surface tension values listed in the table are the average values obtained by measuring three times.
  • ⁇ viscosity> The viscosity of the test sample was measured using a Brookfield viscometer (Vismetron (trademark), manufactured by Shibaura Semtec Co., Ltd.) at 25° C., rotor No. 7, and 10 rpm.
  • the viscosity values shown in the table are the average values obtained by measuring three times.
  • the first agent of the paint-on film-forming agent was applied to the backs of the hands of 20 expert panelists to form a first agent layer, and then each test sample was applied to this first agent layer.
  • the unevenness of the application was evaluated according to the following criteria: (Evaluation criteria) S: 19 or more out of 20 expert panelists evaluated that the test sample was evenly applied to the back of the hand with no repellency. A: 17 to 18 expert panelists out of 20 evaluated that the test sample was evenly applied to the back of the hand and did not repel. B: 14 to 16 expert panelists out of 20 evaluated that the test sample was evenly applied to the back of the hand and did not repel.
  • C 10 to 13 expert panelists out of 20 evaluated that the test sample was evenly applied to the back of the hand and did not repel.
  • D Nine or fewer expert panelists out of 20 judged that the test sample was evenly applied to the back of the hand with no repellency.
  • a first agent of a coating-type film-forming agent was applied to black artificial leather (Saplare (trademark), Idemitsu Fine Techno Co., Ltd.) to form a first agent layer, and then a test sample was applied as a second agent to this first agent layer to form a film having a thickness of about 100 ⁇ m after drying at room temperature for 6 hours, thereby preparing a test sample for evaluating gloss.
  • the obtained test sample was set in a goniophotometer (Gonio SPECTROPHOTOMETER GSP-1B, Murakami Color Research Laboratory Co., Ltd.) and the gloss was measured in the reflection angle range of -25° to 75°.
  • Test Example 1 Effect of Surface Tension Adjuster In Test Example 1, the effect of different surface tension modifiers in the second agent applied to the first agent layer of the paint-on film-forming agent on coating unevenness was examined. The results are shown in Table 1. Note that the test samples of Reference Examples 1 to 8 contain only a surface tension modifier and water, and do not contain any catalyst or other components, and are therefore listed as Reference Examples.
  • the first agent was prepared by uniformly mixing 30 parts by weight of 165,000 cst divinyl dimethicone as the second unsaturated organopolysiloxane, 7 parts by weight of 45 cst hydrogen dimethicone as the second hydride-functionalized polysiloxane, 6 parts by weight of silylated silica as a filler, and 57 parts by weight of a mixture of dimethicone and trisiloxane as an oil.
  • a second agent such as an oil-in-water composition was produced by the following method using the formulation shown in Table 1.
  • the numbers shown below correspond to the numbers indicating the components on the left side of the formulation in Table 1.
  • Comparative Example 1 The materials No. 1 to No. 4 and No. 9 to No. 11 were uniformly mixed to prepare an aqueous phase part, and then the materials No. 5 to No. 8 were added to this aqueous phase part and mixed uniformly to prepare the second agent of the oil-in-water composition of Comparative Example 1.
  • Reference Examples 1 to 8 Test samples of Reference Examples 1 to 8 were prepared by mixing each surface tension modifier with water.
  • Test Example 2 Effect of thickener In Test Example 2, the effect of different thickeners in the second agent of a paint-on film-forming agent on coating unevenness was examined. The results are shown in Table 2. Note that the composition of the formulation shown in Table 2 does not contain a surface tension modifier.
  • Test Example 3 Effect of combined use of specific surface tension adjuster and thickener
  • Test Example 3 the effect of the combination of a silicone-based surface tension regulator having a specified surface tension and a microgel-type thickener in the second agent of a paint-on film-forming agent on uneven application was investigated. The results are shown in Tables 3 and 4.
  • Examples 1 to 9 and Comparative Examples 11 to 13 Except for changing the formulations to those shown in Tables 3 and 4, the second parts of the oil-in-water compositions of Examples 1 to 9 and Comparative Examples 11 to 13 were prepared in the same manner as in Comparative Example 1. The surface tension modifier and thickener were added when the aqueous phase part was prepared.
  • Test Example 4 Effect of combined use of specific surface tension adjusters, thickeners, and particles
  • Test Example 4 the effect of using a silicone-based surface tension regulator having a specific surface tension and a microgel-type thickener and particles in the second agent of a coating-type film-forming agent on coating unevenness and shininess was examined.
  • Tables 5 and 6. Note that the reference comparative example in Table 5 is actually an example because this composition also contains a specific surface tension regulator and thickener, but it is an example used to compare a composition containing porous particles with a composition containing non-porous particles, so it is referred to as a reference comparative example.
  • Examples 10 to 21 and Reference Comparative Examples 1 to 4 Except for changing the formulations to those shown in Tables 5 and 6, the second agents of the oil-in-water compositions of Examples 10 to 21 and Reference Comparative Examples 1 to 4 were prepared in the same manner as in Comparative Example 1. The surface tension modifier, thickener, and particles were added during the preparation of the aqueous phase part.
  • Test Example 5 Glossiness of the coating
  • the first agent of Test Example 1 was used as the first agent of the paint-on film-forming agent
  • the oil-in-water compositions of Comparative Example 1 and Example 20 were used as the second agent of the paint-on film-forming agent, and the gloss evaluation was carried out as described above. The results are shown in Figures 3 and 4.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

Provided is an oil-in-water composition for a second agent of a coating-type film-forming agent with which it is possible to reduce or prevent problems such as coating unevenness and film shine. The oil-in-water composition of the present disclosure contains a dispersion medium containing water and a microgel, oil droplets dispersed in the dispersion medium, and a silicone-based surface tension adjustment agent. The surface tension adjustment agent has a surface tension of 30.0 mN/m or less at 25°C in an aqueous solution containing 1 mass% of the surface tension adjustment agent, and the oil-in-water composition of the present disclosure is used as the second agent of a coating-type film-forming agent that contains a first agent containing a crosslinking-reactive component that constitutes the film and a second agent containing a crosslinking component that crosslinks the crosslinking-reactive component.

Description

塗布型皮膜形成剤の第2剤用水中油型組成物Oil-in-water type composition for use as second agent in paint-on type film-forming agent

 本開示は、塗布型皮膜形成剤の第2剤用水中油型組成物に関する。 This disclosure relates to an oil-in-water type composition for use as the second agent in a paint-on film-forming agent.

 体表に塗布して皮膚を保護しながら、しわ、傷跡などを補正可能な皮膜を形成し得る、塗布型の皮膜形成剤が知られている。 A topical film-forming agent is known that can be applied to the body surface to form a film that can correct wrinkles, scars, etc. while protecting the skin.

 特許文献1には、皮膚に塗布するための配合物であって、a)(i)25℃にて100,000~500,000cst又はcPの粘度を有する高粘度のビニル末端化されたオルガノポリシロキサンの少なくとも1種、25℃にて500~50,000cst又はcPの粘度を有する低粘度のビニル末端化されたオルガノポリシロキサンの少なくとも1種、及び少なくとも1種のヒドリド官能化ポリシロキサンを含む反応性要素;並びに(ii)補強要素を含む反応性補強成分;及びb)白金触媒を含む架橋成分;を含み、架橋成分は、in situで反応性補強成分の架橋を促進し、その結果、皮膜が皮膚に形成される、配合物が開示されている。 Patent Document 1 discloses a formulation for application to the skin, comprising: a) a reactive component including (i) at least one high viscosity vinyl-terminated organopolysiloxane having a viscosity of 100,000 to 500,000 cst or cP at 25°C, at least one low viscosity vinyl-terminated organopolysiloxane having a viscosity of 500 to 50,000 cst or cP at 25°C, and at least one hydride-functionalized polysiloxane; and (ii) a reactive reinforcing component including a reinforcing component; and b) a crosslinking component including a platinum catalyst; wherein the crosslinking component promotes crosslinking of the reactive reinforcing component in situ, resulting in the formation of a film on the skin.

特許第6105468号公報Patent No. 6105468

 特許文献1に記載されるような塗布型の皮膜形成剤を皮膚に適用して架橋させると、皮膚表面に皮膜が形成される。 When a coating-type film-forming agent such as that described in Patent Document 1 is applied to the skin and cross-linked, a film is formed on the skin surface.

 従来の塗布型皮膜形成剤は、皮膚などに対してはじいてしまい、塗布ムラが生じてしまう場合があった。その結果、例えば、図1に示すように、第2剤成分のうちの油相成分が過剰になった箇所などにおいて局所的にテカリが強調されるような場合があった。このような塗布ムラ及びテカリは、不自然な外観を誘発し得るため、かかる不具合の改善が望まれていた。  Conventional paint-on film-forming agents tend to repel skin and other skincare products, resulting in uneven application. As a result, as shown in Figure 1, for example, there are cases where shine is accentuated locally in areas where the oil phase components of the second agent are in excess. Such uneven application and shine can lead to an unnatural appearance, and so there has been a demand for improvements to these problems.

 したがって、本開示の主題は、塗布ムラ、及び皮膜のテカリ等の不具合を低減又は防止し得る塗布型皮膜形成剤の第2剤用の水中油型組成物を提供することである。 The subject of this disclosure is therefore to provide an oil-in-water composition for the second agent of a paint-on film-forming agent that can reduce or prevent defects such as uneven application and shine on the film.

〈態様1〉
 水及びミクロゲルを含む分散媒、
 前記分散媒中に分散している油滴、並びに
 シリコーン系表面張力調整剤
を含む、水中油型組成物であって、
 前記油滴は、油分、及び架橋成分としての触媒を含み、
 前記表面張力調整剤は、該表面張力調整剤を1質量%含む水溶液における25℃での表面張力が30.0mN/m以下であり、
 皮膜を構成する架橋反応性成分を含む第1剤及び前記架橋反応性成分を架橋させる架橋成分を含む第2剤を含む塗布型皮膜形成剤の第2剤として用いられる、
水中油型組成物。
〈態様2〉
 前記ミクロゲルが、(ジメチルアクリルアミド/アクリロイルジメチルタウリンNa)クロスポリマー、(アクリロイルジメチルタウリンアンモニウム/VP)コポリマー、(アクリロイルジメチルタウリンアンモニウム/メタクリル酸ベヘネス-25)クロスポリマー及びカンテンからなる群から選択される少なくとも一種である、態様1に記載の組成物。
〈態様3〉
 前記表面張力調整剤が、ポリオキシエチレン・メチルポリシロキサン共重合体、ジメチルポリシロキサン・メチル(ポリオキシエチレン)シロキサン共重合体、及びビスPEG-18メチルエーテルジメチルシランからなる群から選択される少なくとも一種である、態様1又は2に記載の組成物。
〈態様4〉
 無孔質粒子を含む、態様1~3のいずれかに記載の組成物。
〈態様5〉
 前記油分が、第1の不飽和オルガノポリシロキサン又は第1のヒドリド官能化ポリシロキサンを含む、態様1~4のいずれかに記載の組成物。
〈態様6〉
 高分子乳化剤を含む、態様1~5のいずれかに記載の組成物。
〈態様7〉
 前記触媒が、白金カルボニルシクロビニルメチルシロキサン錯体、白金ジビニルテトラメチルジシロキサン錯体、白金シクロビニルメチルシロキサン錯体、及び白金オクタンアルデヒド/オクタノール錯体からなる群から選択される少なくとも一種である、態様1~6のいずれかに記載の組成物。
〈態様8〉
 第1剤及び第2剤を含む、塗布型皮膜形成剤であって、
 前記第1剤が、第2の不飽和オルガノポリシロキサン及び第2のヒドリド官能化ポリシロキサンからなる群から選択される少なくとも一種を含み、
 前記第2剤が、態様1~7のいずれかに記載の水中油型組成物であり、
 前記第1剤が、前記第2の不飽和オルガノポリシロキサン及び前記第2のヒドリド官能化ポリシロキサンのうち、前記第2の不飽和オルガノポリシロキサンのみを含む場合には、前記第2剤は、前記第1のヒドリド官能化ポリシロキサンを含み、
 前記第1剤が、前記第2の不飽和オルガノポリシロキサン及び前記第2のヒドリド官能化ポリシロキサンのうち、前記第2のヒドリド官能化ポリシロキサンのみを含む場合には、前記第2剤は、前記第1の不飽和オルガノポリシロキサンを含む、
塗布型皮膜形成剤。
〈態様9〉
 前記水中油型組成物が、無孔質粒子を含む、態様8に記載の形成剤。
〈態様10〉
 前記第1の不飽和オルガノポリシロキサン及び前記第2の不飽和オルガノポリシロキサンが、ビニル基を有するオルガノポリシロキサン、ビニル末端化されたオルガノポリシロキサン、及びビニル化された分岐鎖を有するオルガノポリシロキサンからなる群から選択される少なくとも一種である、態様8又は9に記載の形成剤。
〈態様11〉
 前記第1の不飽和オルガノポリシロキサン及び前記第2の不飽和オルガノポリシロキサンが、ビニル末端ポリジメチルシロキサン、ビニル末端ジフェニルシロキサン-ジメチルシロキサンコポリマー、ビニル末端ポリフェニルメチルシロキサン、ビニルフェニルメチル末端ビニルフェニルシロキサン-フェニルメチルシロキサンコポリマー、ビニル末端トリフルオロプロピルメチルシロキサン-ジメチルシロキサンコポリマー、ビニル末端ジエチルシロキサン-ジメチルシロキサンコポリマー、ビニルメチルシロキサン-ジメチルシロキサンコポリマー、トリメチルシロキシ末端ビニルメチルシロキサン-ジメチルシロキサンコポリマー、シラノール末端ビニルメチルシロキサン-ジメチルシロキサンコポリマー、ビニルメチルシロキサンホモポリマー、ビニルT-構造ポリマー、ビニルQ-構造ポリマー、モノビニル末端ポリジメチルシロキサン、ビニルメチルシロキサンターポリマー、及びビニルメトキシシランホモポリマーからなる群から選択される少なくとも一種である、態様10に記載の形成剤。
〈態様12〉
 前記第1のヒドリド官能化ポリシロキサン及び前記第2のヒドリド官能化ポリシロキサンが、非末端及び/又は末端で水酸化されたオルガノポリシロキサンである、態様8~11のいずれかに記載の形成剤。
〈態様13〉
 前記第1のヒドリド官能化ポリシロキサン及び前記第2のヒドリド官能化ポリシロキサンが、ヒドリド末端ポリジメチルシロキサン、ヒドリド末端ポリフェニル-(ジメチルヒドロシロキシ)シロキサン、ヒドリド末端メチルヒドロシロキサン-フェニルメチルシロキサンコポリマー、トリメチルシロキシ末端メチルヒドロシロキサン-ジメチルシロキサンコポリマー、ポリメチルヒドロシロキサン、トリメチルシロキシ末端ポリエチルヒドロシロキサン、トリエチルシロキサン、メチルヒドロシロキサン-フェニルオクチルメチルシロキサンコポリマー、及びメチルヒドロシロキサン-フェニルオクチルメチルシロキサンターポリマーからなる群から選択される少なくとも一種である、態様12に記載の形成剤。
〈態様14〉
 態様8~13のいずれかに記載の前記第1剤及び前記第2剤が、別々の容器に内包されている、又は2つ以上の区画を有する容器の各区画内に別々に内包されているキット。
〈態様15〉
 態様8~13のいずれかに記載の形成剤の使用方法であって、
 前記第1剤を体表に適用して第1剤層を形成した後に、該第1剤層上に前記第2剤を適用し、架橋させて皮膜を形成する、
 前記第2剤を体表に適用して第2剤層を形成した後に、該第2剤層上に前記第1剤を適用し、架橋させて皮膜を形成する、又は、
 前記第1剤及び前記第2剤を混合して混合物を調製した後に、該混合物を体表に適用し、架橋させて皮膜を形成する、
使用方法。
〈態様16〉
 前記第1剤、前記第2剤、又は前記混合物を体表に適用する前に、化粧料を体表に適用する、
 前記第1剤を体表に適用して第1剤層を形成し、該第1剤層上に化粧料を適用した後に、該化粧料を覆うように前記第2剤を適用する、
 前記第2剤を体表に適用して第2剤層を形成し、該第2剤層上に化粧料を適用した後に、該化粧料を覆うように前記第1剤を適用する、又は、
 皮膜を形成した後に、該皮膜に化粧料を適用する、
態様15に記載の使用方法。
<Aspect 1>
A dispersion medium comprising water and a microgel;
an oil-in-water composition comprising oil droplets dispersed in the dispersion medium; and a silicone-based surface tension modifier,
The oil droplets contain an oil component and a catalyst as a cross-linking component,
The surface tension modifier has a surface tension of 30.0 mN/m or less at 25° C. in an aqueous solution containing the surface tension modifier at 1% by mass,
It is used as the second agent of a coating-type film-forming agent including a first agent containing a crosslinking reactive component that constitutes a film and a second agent containing a crosslinking component that crosslinks the crosslinking reactive component,
Oil-in-water compositions.
<Aspect 2>
The composition according to aspect 1, wherein the microgel is at least one selected from the group consisting of dimethylacrylamide/sodium acryloyldimethyltaurate crosspolymer, ammonium acryloyldimethyltaurate/VP copolymer, ammonium acryloyldimethyltaurate/beheneth-25 methacrylate crosspolymer, and agar.
Aspect 3
The composition according to aspect 1 or 2, wherein the surface tension modifier is at least one selected from the group consisting of polyoxyethylene-methylpolysiloxane copolymer, dimethylpolysiloxane-methyl(polyoxyethylene)siloxane copolymer, and bisPEG-18 methyl ether dimethylsilane.
<Aspect 4>
Aspect 4. The composition of any of aspects 1-3, comprising non-porous particles.
<Aspect 5>
Aspect 5. The composition of any of the preceding aspects, wherein the oil comprises a first unsaturated organopolysiloxane or a first hydride-functionalized polysiloxane.
<Aspect 6>
Aspect 6. The composition of any one of aspects 1 to 5, comprising a polymeric emulsifier.
Aspect 7
The composition according to any one of the preceding aspects, wherein the catalyst is at least one selected from the group consisting of platinum carbonylcyclovinylmethylsiloxane complex, platinum divinyltetramethyldisiloxane complex, platinum cyclovinylmethylsiloxane complex, and platinum octanaldehyde/octanol complex.
<Aspect 8>
A coating-type film-forming agent comprising a first agent and a second agent,
The first agent comprises at least one selected from the group consisting of a second unsaturated organopolysiloxane and a second hydride-functionalized polysiloxane;
The second agent is the oil-in-water composition according to any one of Aspects 1 to 7,
When the first agent contains only the second unsaturated organopolysiloxane among the second unsaturated organopolysiloxane and the second hydride-functionalized polysiloxane, the second agent contains the first hydride-functionalized polysiloxane,
When the first agent contains only the second hydride-functionalized polysiloxane among the second unsaturated organopolysiloxane and the second hydride-functionalized polysiloxane, the second agent contains the first unsaturated organopolysiloxane;
A paint-type film-forming agent.
<Aspect 9>
9. The forming agent of claim 8, wherein the oil-in-water composition comprises non-porous particles.
Aspect 10
The forming agent according to aspect 8 or 9, wherein the first unsaturated organopolysiloxane and the second unsaturated organopolysiloxane are at least one selected from the group consisting of organopolysiloxanes having vinyl groups, vinyl-terminated organopolysiloxanes, and vinylated branched organopolysiloxanes.
<Aspect 11>
11. The forming agent of claim 10, wherein the first unsaturated organopolysiloxane and the second unsaturated organopolysiloxane are at least one member selected from the group consisting of vinyl terminated polydimethylsiloxane, vinyl terminated diphenylsiloxane-dimethylsiloxane copolymer, vinyl terminated polyphenylmethylsiloxane, vinylphenylmethyl terminated vinylphenylsiloxane-phenylmethylsiloxane copolymer, vinyl terminated trifluoropropylmethylsiloxane-dimethylsiloxane copolymer, vinyl terminated diethylsiloxane-dimethylsiloxane copolymer, vinylmethylsiloxane-dimethylsiloxane copolymer, trimethylsiloxy terminated vinylmethylsiloxane-dimethylsiloxane copolymer, silanol terminated vinylmethylsiloxane-dimethylsiloxane copolymer, vinylmethylsiloxane homopolymer, vinyl T-structure polymer, vinyl Q-structure polymer, monovinyl terminated polydimethylsiloxane, vinylmethylsiloxane terpolymer, and vinylmethoxysilane homopolymer.
<Aspect 12>
A forming agent according to any one of aspects 8 to 11, wherein the first hydride-functionalized polysiloxane and the second hydride-functionalized polysiloxane are non-terminally and/or terminally hydroxylated organopolysiloxanes.
<Aspect 13>
13. The forming agent of claim 12, wherein the first hydride-functionalized polysiloxane and the second hydride-functionalized polysiloxane are at least one selected from the group consisting of hydride-terminated polydimethylsiloxane, hydride-terminated polyphenyl-(dimethylhydrosiloxy)siloxane, hydride-terminated methylhydrosiloxane-phenylmethylsiloxane copolymer, trimethylsiloxy-terminated methylhydrosiloxane-dimethylsiloxane copolymer, polymethylhydrosiloxane, trimethylsiloxy-terminated polyethylhydrosiloxane, triethylsiloxane, methylhydrosiloxane-phenyloctylmethylsiloxane copolymer, and methylhydrosiloxane-phenyloctylmethylsiloxane terpolymer.
<Aspect 14>
A kit in which the first agent and the second agent according to any one of aspects 8 to 13 are contained in separate containers, or are contained separately in each compartment of a container having two or more compartments.
<Aspect 15>
A method of using the forming agent according to any one of aspects 8 to 13, comprising the steps of:
The first agent is applied to a body surface to form a first agent layer, and then the second agent is applied onto the first agent layer and crosslinked to form a film.
The second agent is applied to the body surface to form a second agent layer, and then the first agent is applied onto the second agent layer and crosslinked to form a film; or
After preparing a mixture by mixing the first agent and the second agent, the mixture is applied to a body surface and crosslinked to form a film.
how to use.
<Aspect 16>
applying a cosmetic to a body surface before applying the first agent, the second agent, or the mixture to the body surface;
The first agent is applied to a body surface to form a first agent layer, a cosmetic is applied onto the first agent layer, and then the second agent is applied so as to cover the cosmetic.
The second agent is applied to a body surface to form a second agent layer, a cosmetic is applied onto the second agent layer, and then the first agent is applied to cover the cosmetic; or
After forming the film, a cosmetic is applied to the film.
A method of use according to aspect 15.

 本開示によれば、塗布ムラ、及び皮膜のテカリ等の不具合を低減又は防止し得る塗布型皮膜形成剤の第2剤用の水中油型組成物を提供することができる。 The present disclosure provides an oil-in-water composition for the second agent of a paint-on film-forming agent that can reduce or prevent defects such as uneven application and shine on the film.

図1は、従来の塗布型皮膜形成剤を用いたときの第2剤がはじいている様子を示す写真である。なお、はじき現象を分かりやすくするために、第2剤の水相中には、赤い染料を配合している。Figure 1 is a photograph showing the state of repelling of the second agent when a conventional paint-type film-forming agent is used. In order to make the repelling phenomenon easier to understand, a red dye is blended into the aqueous phase of the second agent. 図2は、本開示の一実施態様の第2剤(ミクロゲル及び特定の表面張力調整剤を含む第2剤)を含む塗布型皮膜形成剤を用いて形成した皮膜の写真である。FIG. 2 is a photograph of a film formed using a paint-on film-forming agent including a second agent (a second agent including a microgel and a specific surface tension modifier) according to one embodiment of the present disclosure. 図3は、得られた各皮膜のテカリの指針となる光沢度に関するグラフである。FIG. 3 is a graph showing the gloss level, which is an indicator of the shine of each of the resulting films. (a)は、従来の塗布型皮膜形成剤を人工皮膚に適用して形成した比較例1の皮膜の写真であり、(b)は、本開示の一実施態様の第2剤を含む塗布型皮膜形成剤を人工皮膚に適用して形成した実施例20の皮膜の写真である。FIG. 1A is a photograph of a film of Comparative Example 1 formed by applying a conventional paint-on film-forming agent to artificial skin, and FIG. 1B is a photograph of a film of Example 20 formed by applying a paint-on film-forming agent containing a second agent according to an embodiment of the present disclosure to artificial skin.

 以下、本開示の実施の形態について詳述する。本開示は、以下の実施の形態に限定されるものではなく、発明の本旨の範囲内で種々変形して実施できる。 The following describes in detail the embodiments of the present disclosure. The present disclosure is not limited to the embodiments below, and can be modified in various ways within the scope of the invention.

 本開示の水中油型組成物は、水及びミクロゲルを含む分散媒、この分散媒中に分散している油滴、並びにシリコーン系表面張力調整剤を含み、この表面張力調整剤は、表面張力調整剤を1質量%含む水溶液における25℃での表面張力が30.0mN/m以下であり、皮膜を構成する架橋反応性成分を含む第1剤及び架橋反応性成分を架橋させる架橋成分を含む第2剤を含む塗布型皮膜形成剤の第2剤として用いられる。 The oil-in-water composition of the present disclosure comprises a dispersion medium containing water and a microgel, oil droplets dispersed in the dispersion medium, and a silicone-based surface tension modifier, and the surface tension modifier has a surface tension of 30.0 mN/m or less at 25°C in an aqueous solution containing 1% by mass of the surface tension modifier, and is used as the second agent of a coating-type film-forming agent that comprises a first agent containing a cross-linking reactive component that forms a film, and a second agent containing a cross-linking component that cross-links the cross-linking reactive component.

 原理によって限定されるものではないが、本開示の水中油型組成物を塗布型皮膜形成剤の第2剤として使用したときに、塗布ムラ及び得られる皮膜のテカリを低減又は防止し得る作用原理は以下のとおりであると考える。 Although not limited by the theory, it is believed that the principle of action that can reduce or prevent uneven application and shine in the resulting film when the oil-in-water composition disclosed herein is used as the second agent in a paint-on film-forming agent is as follows.

 本開示の塗布型皮膜形成剤は、皮膜を構成する架橋反応性成分を含む第1剤と、架橋反応性成分を架橋させる架橋成分を含む第2剤とを含んでいる。したがって、このような第1剤及び第2剤を用いて皮膜を調製するときに、塗布ムラが生じると、得られる皮膜の厚みなどにおいてもムラが生じると考えられる。その結果、図1に示すように、得られた皮膜において反射部が生じ、それがテカリ等の不具合を生じさせていると考えられる。ここで、図1では、第1剤層に対して第2剤がはじいてしまう結果、例えば、第2剤成分のうちの触媒を含む油相成分が点在し、架橋反応が進行しやすくなる箇所が局所的に形成されるため、得られる皮膜にムラが生じて反射部が形成されてしまったと考えられる。 The applied film-forming agent of the present disclosure includes a first agent containing a cross-linking reactive component that constitutes the film, and a second agent containing a cross-linking component that cross-links the cross-linking reactive component. Therefore, when preparing a film using such a first agent and second agent, if uneven application occurs, it is thought that unevenness will also occur in the thickness of the obtained film. As a result, as shown in Figure 1, reflective parts are formed in the obtained film, which is thought to cause problems such as shine. Here, in Figure 1, as a result of the second agent being repelled by the first agent layer, for example, the oil phase component containing a catalyst of the second agent components is scattered, and parts where the cross-linking reaction is likely to proceed are formed locally, which is thought to cause unevenness in the obtained film and the formation of reflective parts.

 そこで、本発明者はまず、塗布ムラを改善するために、種々の増粘剤を用いて第2剤の粘弾性の影響について検討した。その結果、塗布型皮膜形成剤の第2剤として使用する水中油型組成物においては、高分子鎖によるネットワーク構造によって増粘作用を発現する一般的な増粘剤よりも、ミクロゲルのような適度なパッキング効果(ミクロゲル粒子同士の摩擦作用)で増粘性を発現し得るタイプの増粘剤が有効であることを見出した。しかしながら、かかる増粘剤だけでは、塗布ムラを十分に改善することはできなかった。 The inventors therefore first investigated the effect of the viscoelasticity of the second agent using various thickeners in order to improve coating unevenness. As a result, they found that in oil-in-water compositions used as the second agent of paint-on film-forming agents, thickeners that can exert their thickening effect through a moderate packing effect (friction between microgel particles), such as microgels, are more effective than general thickeners that exert their thickening effect through a network structure of polymer chains. However, such thickeners alone were not able to sufficiently improve coating unevenness.

 それを踏まえ、本発明者はさらに、第2剤の表面張力の影響について検討した。その結果、種々ある表面張力調整剤(例えば界面活性剤等)のうち、所定のシリコーン系表面張力調整剤を、塗布型皮膜形成剤の第2剤として使用する水中油型組成物にミクロゲルとともに配合すると、塗布ムラが改善され、その結果、皮膜のテカリ等の不具合を低減又は防止し得ることを見出した。これは、ミクロゲルの適度なパッキング効果による増粘作用と、特定のシリコーン系表面張力調整剤との併用に伴う相乗効果によって生じ得た特異的な現象であると考えている。 Based on this, the inventor further investigated the effect of the surface tension of the second agent. As a result, it was found that among various surface tension modifiers (such as surfactants), when a specific silicone-based surface tension modifier is blended with a microgel in an oil-in-water composition used as the second agent of a spread-type film-forming agent, uneven application is improved, and as a result, problems such as shine on the film can be reduced or prevented. This is believed to be a unique phenomenon that occurs due to the thickening action caused by the appropriate packing effect of the microgel and the synergistic effect of using it in combination with a specific silicone-based surface tension modifier.

 上述したように、ミクロゲルと特定のシリコーン系表面張力調整剤とを含む本開示の水中油型組成物を塗布型皮膜形成剤の第2剤として用いた場合には、塗布ムラ、及び皮膜のテカリ等の不具合を低減又は防止することができる。しかしながらさらに、図2の破線枠内に示すようなわずかなテカリさえも改善したい場合には、第2剤に対して無孔質粒子をさらに配合することが有効であることも、本発明者は見出している。 As described above, when the oil-in-water composition of the present disclosure, which contains a microgel and a specific silicone-based surface tension modifier, is used as the second agent of a spread-type film-forming agent, problems such as uneven application and shine on the film can be reduced or prevented. However, the inventors have also found that if you want to improve even the slightest shine, such as that shown in the dashed frame in Figure 2, it is effective to further blend nonporous particles into the second agent.

 一般的に、多孔質粒子は、形成されている複数の孔によって光を散乱させやすいため、皮膜のテカリに対しては多孔質粒子の配合が有効であろうと考えていた。しかしながら、本開示の水中油型組成物においては、意外にも、多孔質粒子を配合すると、塗布ムラが生じやすくなり、その結果、皮膜のテカリ等の不具合が生じやすかった。これは、本開示の水中油型組成物に多孔質粒子を配合すると、塗布ムラを改善するために組成物に配合したミクロゲル及び特定のシリコーン系表面張力調整剤の少なくとも一方が、多孔質粒子に吸収されてしまい、所望の機能を発現できなくなったためであると考えられる。したがって、本開示の水中油型組成物においては、多孔質粒子ではなく、無孔質粒子を配合することが有効であると考えている。 Generally, porous particles tend to scatter light due to the multiple holes formed in them, so it was thought that the incorporation of porous particles would be effective in preventing shine on the film. However, in the oil-in-water composition of the present disclosure, unexpectedly, the incorporation of porous particles made it easier for uneven application to occur, and as a result, problems such as shine on the film were likely to occur. This is thought to be because when porous particles are incorporated into the oil-in-water composition of the present disclosure, at least one of the microgel and the specific silicone-based surface tension modifier incorporated into the composition to improve uneven application is absorbed by the porous particles, making it impossible to exhibit the desired function. Therefore, it is thought that the incorporation of non-porous particles, rather than porous particles, is effective in the oil-in-water composition of the present disclosure.

 本開示における用語の定義は以下のとおりである。 The definitions of terms used in this disclosure are as follows:

 本開示において「身体補正皮膜」とは、対象者の皮膚に形成されたときに、皮膜が自然な皮膚の外観を呈するようにすることを意図した皮膜を意味する。ここで、「自然な皮膚の外観」とは、皮膚に適用された場合、身体補正皮膜が、実際の皮膚の外見、感触、及び質感から選択される少なくとも一種と類似又は同一の性能を呈し、例えば、皮膜処理した皮膚が、実際の(例えば、現状の)皮膚の物理特性(例えば、弾力性及び硬さ)を呈し得ることを意味する。 In this disclosure, a "body correction coating" refers to a coating that is intended to provide a natural skin appearance when applied to the skin of a subject. In this context, "natural skin appearance" means that when applied to the skin, the body correction coating provides similar or identical performance to at least one of the appearance, feel, and texture of actual skin, e.g., the treated skin can provide the physical properties (e.g., elasticity and firmness) of actual (e.g., current) skin.

 本開示において「身体補正」とは、対象者の身体の欠点又は皮膚の欠点を、マスクし、覆い隠し又はカバーして、身体又は皮膚の欠点を視覚的及び/又は触覚的に改善することを意味するが、人間を手術、治療又は診断する方法は包含しない。ここで、「身体の欠点」とは、例えば、対象者がしみ若しくは傷と感じ、又は当業者、例えば、皮膚科医、エステティシャン又は整形外科医が、しみ又は傷と考える対象者の身体のこのような部分を意味することができる。「身体の欠点」には、皮膚の欠点及び身体の軟部組織の弛み(例えば、皮膚の緩み又は弛み、乳房、臀部、腹部、顎、頸部などの弛み)などが包含される。また、「皮膚の欠点」には、対象者がしみ又は傷と感じる対象者の皮膚のこれらの項目が包含される。皮膚の欠点の例としては、焔状母斑又は火炎状母斑(例えば、単純性血管腫若しくは正中火炎状母斑)、肝斑、しわ、しみ、にきび、ほくろ、傷跡、刺青、あざ、皮膚の変形、母斑、日焼け、老化、不均一な皮膚の色合い、弛んだ皮膚、皮膚の粗さ、色素沈着過度、毛穴の拡大、毛細管拡張症、赤み、てかり、セルライト、妊娠線、又は皮膚の弾力の低下が挙げられる。 In this disclosure, "body correction" means to mask, conceal or cover a body or skin imperfection of a subject to visually and/or tactilely improve the body or skin imperfection, but does not include methods of surgery, treatment or diagnosis of a human. Here, "body imperfection" can mean, for example, such part of the subject's body that the subject perceives as a blemish or blemish, or that a person skilled in the art, e.g., a dermatologist, esthetician or plastic surgeon, would consider to be a blemish or blemish. "Body imperfection" includes skin imperfections and loose soft tissues of the body (e.g., loose or sagging skin, looseness of breasts, buttocks, abdomen, chin, neck, etc.), and the like. Also, "skin imperfection" includes those items of the subject's skin that the subject perceives as a blemish or blemish. Examples of skin imperfections include nevus flammeus or nevus flameus (e.g., hemangioma simplex or midline nevus flammeus), melasma, wrinkles, age spots, acne, moles, scars, tattoos, birthmarks, skin deformities, birthmarks, sun damage, aging, uneven skin tone, loose skin, rough skin, hyperpigmentation, enlarged pores, telangiectasias, redness, shine, cellulite, stretch marks, or reduced skin elasticity.

 本開示において「水中油型組成物」とは、水を含む分散媒中において油滴が分散している状態の組成物を意図する。かかる組成物としては、例えば、水と油に分離した状態の液体を振とうさせることによって水を含む分散媒中に油滴を強制的に分散させた組成物、及び乳化剤を配合して水を含む分散媒中に油滴を分散させた乳化組成物が包含され得る。 In this disclosure, the term "oil-in-water composition" refers to a composition in which oil droplets are dispersed in a water-containing dispersion medium. Examples of such compositions include a composition in which oil droplets are forcibly dispersed in a water-containing dispersion medium by shaking a liquid in a state in which the water and oil are separated, and an emulsion composition in which an emulsifier is added to disperse oil droplets in a water-containing dispersion medium.

 本開示において「粘度」とは、剪断応力又は引張応力のいずれかによって変形させられている流体の抵抗の尺度を指す。例えば、塗布型皮膜形成剤における第1剤及び第2剤の粘度は、基板の上に形成される層の厚さ、展延性、並びに均一性及び/又は一様性に影響を与える。粘度は、動的粘度(別名、絶対粘度、代表的な単位はPa・s、ポアズ、P、cPである。)又は運動学的粘度(代表的な単位はcm/s、ストーク、St、cstである。)のいずれかとして報告することができ、この運動学的粘度は、動的粘度を測定された流体の密度で割ったものである。本明細書に開示される成分の粘度範囲は、一般に、各成分の供給業者によって、レオメーター又はキャノン・フェンスケ(Cannon-Fenske)チューブ粘度計を用いて測定される運動学的粘度の単位(例えば、cst)として提供されるが、流体の粘度は、例えば、レオメーター(例えば、線形剪断レオメーター若しくは動的剪断レオメーター)又は粘度計(粘度測定計、例えば、毛細管粘度計もしくは回転粘度計とも呼ばれる)を用いて測定することもできる。 In this disclosure, "viscosity" refers to a measure of the resistance of a fluid to being deformed by either shear or tensile stress. For example, the viscosity of the first and second parts of a paint-on film former affects the thickness, spreadability, and uniformity and/or uniformity of the layer formed on a substrate. Viscosity can be reported as either dynamic viscosity (also known as absolute viscosity, typical units are Pa·s, poise, P, cP) or kinematic viscosity (typical units are cm 2 /s, stokes, St, cst), which is the dynamic viscosity divided by the density of the measured fluid. The viscosity ranges of the components disclosed herein are generally provided by the suppliers of each component in units of kinematic viscosity (e.g., cst) measured using a rheometer or a Cannon-Fenske tube viscometer, although the viscosity of a fluid can also be measured using, for example, a rheometer (e.g., a linear shear rheometer or a dynamic shear rheometer) or a viscometer (a viscometric meter, also called, for example, a capillary viscometer or a rotational viscometer).

 本開示において「ミクロゲル」とは、水相中で水膨潤性の三次元的に架橋したミクロゲルを形成して、膨潤したミクロゲル粒子同士の摩擦により増粘するタイプの増粘剤を意図する。ミクロゲルは、典型的には、溶媒を含み得る。 In this disclosure, the term "microgel" refers to a type of thickener that forms a water-swellable, three-dimensionally crosslinked microgel in an aqueous phase and thickens due to friction between the swollen microgel particles. The microgel may typically contain a solvent.

 本開示における「架橋」には、一般に「硬化」と称する概念も包含される。 In this disclosure, "crosslinking" also includes the concept commonly referred to as "curing."

 本開示において「体表」とは、体の皮膚表面を意味する。 In this disclosure, "body surface" means the skin surface of the body.

《水中油型組成物》
 本開示の水中油型組成物(単に「組成物」と称する場合がある。)は、皮膜を構成する架橋反応性成分を含む第1剤及びこの架橋反応性成分を架橋させる架橋成分を含む第2剤を含む塗布型皮膜形成剤の第2剤として使用することができ、得られる皮膜のテカリ等の不具合を低減又は防止することができる。
Oil-in-water Composition
The oil-in-water composition of the present disclosure (sometimes simply referred to as the "composition") can be used as the second agent of a spread-type film-forming agent that includes a first agent containing a crosslinkable reactive component that constitutes a film, and a second agent containing a crosslinking component that crosslinks the crosslinkable reactive component, and can reduce or prevent defects such as shine in the resulting film.

 得られた皮膜のテカリの低減効果は、後述する実施例における光沢度の試験によって評価することができる。本開示の水中油型組成物を用いて調製した皮膜は、例えば、反射角(「受光角」と称する場合もある。)45°又は50°における光沢度を100以下、95以下、90以下、85以下、80以下、75以下、又は70以下を達成することができる。かかる光沢度の下限値については特に制限はないが、例えば、30以上、35以上、40以上、45以上、又は50以上とすることができる。 The effect of reducing shine of the obtained film can be evaluated by a gloss test in the examples described below. A film prepared using the oil-in-water composition of the present disclosure can achieve a gloss at a reflection angle (sometimes called the "light receiving angle") of 45° or 50° of 100 or less, 95 or less, 90 or less, 85 or less, 80 or less, 75 or less, or 70 or less. There is no particular restriction on the lower limit of the gloss, but it can be, for example, 30 or more, 35 or more, 40 or more, 45 or more, or 50 or more.

〈分散媒〉
 本開示の水中油型組成物における分散媒は、水及びミクロゲルを含んでいる。
<Dispersion medium>
The dispersion medium in the oil-in-water composition of the present disclosure comprises water and a microgel.

(水)
 水の配合量としては特に制限はなく、例えば、塗布ムラの改善効果、使用性、架橋反応性等の観点から、組成物の全量に対し、10質量%以上、15質量%以上、20質量%以上、30質量%以上、40質量%以上、50質量%以上、60質量%以上、70質量%以上、又は80質量%以上とすることができ、また、90質量%以下、80質量%以下、70質量%以下、60質量%以下、又は50質量%以下とすることができる。
(water)
The amount of water to be blended is not particularly limited, and from the viewpoints of, for example, the effect of improving coating unevenness, usability, crosslinking reactivity, and the like, the amount of water can be 10 mass % or more, 15 mass % or more, 20 mass % or more, 30 mass % or more, 40 mass % or more, 50 mass % or more, 60 mass % or more, 70 mass % or more, or 80 mass % or more, and can be 90 mass % or less, 80 mass % or less, 70 mass % or less, 60 mass % or less, or 50 mass % or less, relative to the total amount of the composition.

 本開示の水中油型組成物で使用し得る水としては、特に限定されるものではないが、例えば、化粧料又は医薬部外品において使用される水を使用することができる。例えば、イオン交換水、蒸留水、超純水、及び水道水を使用することができる。 Water that can be used in the oil-in-water composition of the present disclosure is not particularly limited, but may be, for example, water used in cosmetics or quasi-drugs. For example, ion-exchanged water, distilled water, ultrapure water, and tap water can be used.

(ミクロゲル)
 ミクロゲルの配合量としては特に制限はなく、例えば、塗布ムラの改善効果、使用性、架橋反応性等の観点から、組成物の全量に対し、0.1質量%以上、0.3質量%以上、0.5質量%以上、0.7質量%以上、又は1.0質量%以上とすることができ、また、10質量%以下、8.0質量%以下、5.0質量%以下、又は3.0質量%以下とすることができる。
(Microgel)
The amount of the microgel is not particularly limited, and from the viewpoints of, for example, the effect of improving coating unevenness, usability, crosslinking reactivity, and the like, the amount can be 0.1 mass % or more, 0.3 mass % or more, 0.5 mass % or more, 0.7 mass % or more, or 1.0 mass % or more relative to the total amount of the composition, and can be 10 mass % or less, 8.0 mass % or less, 5.0 mass % or less, or 3.0 mass % or less.

 ミクロゲルとしては特に制限はなく、例えば、自身が水相中でミクロゲル粒子を形成するものであってもよく、或いは、予め作製したゲル状物を粉砕してミクロゲル粒子としたものであってもよい。ミクロゲルは単独で又は二種以上組み合わせて使用することができる。 There are no particular limitations on the microgel, and it may be, for example, one that itself forms microgel particles in the aqueous phase, or one that is made by crushing a gel-like material prepared in advance into microgel particles. Microgels may be used alone or in combination of two or more kinds.

 ミクロゲル粒子は、塗布ムラの改善効果、使用性、架橋反応性等の観点から、球状粒子であることが好ましい。ここで、ミクロゲル粒子における「球状」とは、真球、略球状、回転楕円体を含み、表面に凹凸等があっても、粒子の全体形状が球状と判断できるものであれば、本開示でいう「球状」に該当する。具体的には、ミクロゲル粒子における「球状粒子」とは、真球に限定するものではなく、粒子の短径/長径の比(楕円率)が、3.0以下、2.5以下、2.0以下、又は1.5以下の粒子を包含し得る。かかる比の下限値としては、例えば、1.0以上、1.0超、又は1.2以上とすることができる。 The microgel particles are preferably spherical particles from the viewpoints of the effect of improving coating unevenness, usability, crosslinking reactivity, etc. Here, "spherical" in the case of microgel particles includes true spheres, nearly spherical, and spheroids, and even if the surface is uneven, the particle falls under the "spherical" category in this disclosure as long as the overall shape of the particle can be determined to be spherical. Specifically, the "spherical particles" in the case of microgel particles are not limited to true spheres, and can include particles whose minor axis/major axis ratio (ellipticity) is 3.0 or less, 2.5 or less, 2.0 or less, or 1.5 or less. The lower limit of such a ratio can be, for example, 1.0 or more, more than 1.0, or 1.2 or more.

 ミクロゲル粒子の大きさとしては特に制限はなく、例えば、塗布ムラの改善効果、使用性、架橋反応性等の観点から、100μm以下、70μm以下、50μm以下、30μm以下、10μm以下、5.0μm以下、又は1.0μm以下の面積円相当粒子径を呈することが好ましい。かかる粒子径の下限値としては、例えば、0.01μm以上、0.05μm以上、0.1μm以上、又は0.5μm以上とすることができる。ここで、面積円相当粒子径とは、例えば、透過型電子顕微鏡で観察したミクロゲル粒子の投影面積と同じ面積を有する円形状の粒子に換算した場合の粒子径を意図することができる。かかる面積円相当粒子径は、10個以上の粒子の平均値と規定することができる。 There is no particular limit to the size of the microgel particles, and from the viewpoints of, for example, the effect of improving coating unevenness, usability, crosslinking reactivity, etc., it is preferable that the microgel particles have an equivalent circle diameter of 100 μm or less, 70 μm or less, 50 μm or less, 30 μm or less, 10 μm or less, 5.0 μm or less, or 1.0 μm or less. The lower limit of such particle diameter can be, for example, 0.01 μm or more, 0.05 μm or more, 0.1 μm or more, or 0.5 μm or more. Here, the equivalent circle diameter can mean, for example, the particle diameter when converted into a circular particle having the same area as the projected area of the microgel particle observed with a transmission electron microscope. Such equivalent circle diameter can be defined as the average value of 10 or more particles.

 ミクロゲルを構成する材料としては特に制限はなく、例えば、(ジメチルアクリルアミド/アクリロイルジメチルタウリンNa)クロスポリマー、(アクリロイルジメチルタウリンアンモニウム/VP)コポリマー、(アクリロイルジメチルタウリンアンモニウム/メタクリル酸ベヘネス-25)クロスポリマー及びカンテンからなる群から選択される少なくとも一種を挙げることができる。なかでも、塗布ムラを改善する観点から、(ジメチルアクリルアミド/アクリロイルジメチルタウリンNa)クロスポリマーが好ましい。 The material constituting the microgel is not particularly limited, and examples thereof include at least one selected from the group consisting of (dimethylacrylamide/sodium acryloyldimethyltaurate) crosspolymer, (ammonium acryloyldimethyltaurate/VP) copolymer, (ammonium acryloyldimethyltaurate/beheneth-25 methacrylate) crosspolymer, and Kanten. Among these, (dimethylacrylamide/sodium acryloyldimethyltaurate) crosspolymer is preferred from the viewpoint of improving coating unevenness.

〈油滴〉
 水中油型組成物における油相又は分散相としての油滴は、油分、及び架橋成分としての触媒を含んでいる。
<Oil Droplets>
The oil phase or oil droplets as the dispersed phase in the oil-in-water composition contain an oil component and a catalyst as a cross-linking component.

(油分)
 油分の配合量としては特に制限はなく、例えば、使用性、架橋反応性等の観点から、組成物の全量に対し、0.01質量%以上、0.03質量%以上、0.05質量%以上、0.07質量%以上、0.1質量%以上、0.3質量%以上、0.5質量%以上、0.7質量%以上、1.0質量%以上、3.0質量%以上、5.0質量%以上、7.0質量%以上、10質量%以上、15質量%以上、又は20質量%以上とすることができ、また、50質量%以下、40質量%以下、30質量%以下、20質量%以下、15質量%以下、又は10質量%以下とすることができる。
(Oil content)
The amount of the oil to be blended is not particularly limited, and from the standpoint of usability, crosslinking reactivity, and the like, for example, it can be 0.01 mass% or more, 0.03 mass% or more, 0.05 mass% or more, 0.07 mass% or more, 0.1 mass% or more, 0.3 mass% or more, 0.5 mass% or more, 0.7 mass% or more, 1.0 mass% or more, 3.0 mass% or more, 5.0 mass% or more, 7.0 mass% or more, 10 mass% or more, 15 mass% or more, or 20 mass% or more, relative to the total amount of the composition, and can be 50 mass% or less, 40 mass% or less, 30 mass% or less, 20 mass% or less, 15 mass% or less, or 10 mass% or less.

 油分としては特に制限はなく、例えば、液体油脂、固体油脂、ロウ類、炭化水素油、シリコーン油、及び極性油を挙げることができる。油分は単独で又は二種以上組み合わせて使用することができる。なかでも、後述する第1剤によって形成される第1剤層との親和性等の観点から、シリコーン油が好ましい。油分中のシリコーン油の割合としては特に制限はなく、例えば、油分の全量に対し、50質量%以上、60質量%以上、70質量%以上、80質量%以上、又は90質量%以上とすることができる。かかる割合の上限値としては特に制限はないが、例えば、100質量%以下、100質量%未満、98質量%以下、又は95質量%以下とすることができる。 The oil is not particularly limited, and examples thereof include liquid oils, solid oils, waxes, hydrocarbon oils, silicone oils, and polar oils. The oils can be used alone or in combination of two or more. Among them, silicone oil is preferred from the viewpoint of affinity with the first agent layer formed by the first agent described below. The proportion of silicone oil in the oil is not particularly limited, and can be, for example, 50% by mass or more, 60% by mass or more, 70% by mass or more, 80% by mass or more, or 90% by mass or more relative to the total amount of oil. There is no particular limit to the upper limit of such a proportion, but it can be, for example, 100% by mass or less, less than 100% by mass, 98% by mass or less, or 95% by mass or less.

a.第1の不飽和オルガノポリシロキサン
 本開示の組成物は、油分として、シリコーン油の一種である第1の不飽和オルガノポリシロキサンを含むことができる。第1の不飽和オルガノポリシロキサンは、皮膜の構成材料として機能させることができ、また、触媒に対する分散剤として機能させることもできる。
The composition of the present disclosure may contain a first unsaturated organopolysiloxane, which is a type of silicone oil, as an oil component. The first unsaturated organopolysiloxane may function as a constituent material of the coating, and may also function as a dispersant for the catalyst.

 第1の不飽和オルガノポリシロキサンとしては特に制限はなく、例えば、少なくとも2つの炭素-炭素二重結合又は少なくとも1つの炭素-炭素三重結合を分子内に有する一種以上のオルガノポリシロキサンを挙げることができる。かかる不飽和オルガノポリシロキサンとして好ましくは、平均して少なくとも2つのアルケニル官能基を有し、かつ25℃で10,000~2,000,000cstの粘度を有する一種以上のオルガノポリシロキサンを挙げることができる。ここで、本開示では、「炭素-炭素二重結合」及び「炭素-炭素三重結合」を、単に「二重結合」及び「三重結合」と称する場合がある。第1の不飽和オルガノポリシロキサンは、単独で又は二種以上組み合わせて使用することができる。 The first unsaturated organopolysiloxane is not particularly limited, and may be, for example, one or more organopolysiloxanes having at least two carbon-carbon double bonds or at least one carbon-carbon triple bond in the molecule. Such unsaturated organopolysiloxanes are preferably one or more organopolysiloxanes having an average of at least two alkenyl functional groups and a viscosity of 10,000 to 2,000,000 cst at 25°C. Here, in this disclosure, the "carbon-carbon double bond" and the "carbon-carbon triple bond" may be simply referred to as "double bond" and "triple bond". The first unsaturated organopolysiloxane may be used alone or in combination of two or more kinds.

 このようなオルガノポリシロキサンは、不飽和部(二重結合又は三重結合)を、ポリマーの末端単位に、ポリマーの非末端モノマー単位に、又はこれらの組合せにおいて含んでもよく、なかでも、ポリマーの非末端モノマー単位に含むことが好ましい。 Such organopolysiloxanes may contain unsaturated portions (double bonds or triple bonds) in the terminal units of the polymer, in the non-terminal monomer units of the polymer, or in a combination of these, and it is particularly preferred that they are contained in the non-terminal monomer units of the polymer.

 ある実施態様では、オルガノポリシロキサン中の二重結合含有モノマー単位は、平均して、40モノマー単位以上、200モノマー単位以上、400モノマー単位以上、1,000モノマー単位以上、又は2,000モノマー単位以上離れていてもよい。 In some embodiments, the double bond-containing monomer units in the organopolysiloxane may be spaced apart, on average, by 40 monomer units or more, 200 monomer units or more, 400 monomer units or more, 1,000 monomer units or more, or 2,000 monomer units or more.

 ある実施態様では、二重結合又は三重結合を有するオルガノポリシロキサンの二重結合又は三重結合含有モノマー単位の量は、例えば、0.01質量%以上又は0.03質量%以上にすることができ、2質量%以下又は0.6質量%以下にすることができる。 In one embodiment, the amount of double- or triple-bond-containing monomer units in the organopolysiloxane having a double bond or triple bond can be, for example, 0.01% by weight or more or 0.03% by weight or more, and 2% by weight or less or 0.6% by weight or less.

 ある実施態様では、二重結合又は三重結合を有するオルガノポリシロキサンのビニル当量は、例えば、1キログラム当たり、0.005以上又は0.01以上にすることができ、0.5以下又は0.25以下にすることができる。オルガノポリシロキサン中の不飽和部二重結合又は三重結合の近似モル量は、オルガノポリシロキサンの平均分子量に基づいて計算することができる。ここで、本明細書に開示される各成分の平均分子量又は分子質量は、一般に、各成分の供給業者によって提供され、ダルトン(Da)又はそれと等価のg/molの単位で表すことができる。 In some embodiments, the vinyl equivalent of the organopolysiloxane having double or triple bonds can be, for example, 0.005 or more, or 0.01 or more, and 0.5 or less, or 0.25 or less per kilogram. The approximate molar amount of unsaturated double or triple bonds in the organopolysiloxane can be calculated based on the average molecular weight of the organopolysiloxane. Here, the average molecular weight or molecular mass of each component disclosed herein is generally provided by the supplier of each component and can be expressed in units of Daltons (Da) or its equivalent in g/mol.

 ある実施態様では、不飽和オルガノポリシロキサンの不飽和部の含有量は、0.001mmol/g以上、0.005mmol/g以上、0.010mmol/g以上、0.050mmol/g以上、又は0.10mmol/g以上にすることができ、5.0mmol/g以下、3.0mmol/g以下、1.0mmol/g以下、0.50mmol/g以下、0.40mmol/g以下、0.30mmol/g以下、0.25mmol/g以下、0.20mmol/g以下、又は0.15mmol/g以下にすることができる。 In one embodiment, the content of unsaturated portions of the unsaturated organopolysiloxane can be 0.001 mmol/g or more, 0.005 mmol/g or more, 0.010 mmol/g or more, 0.050 mmol/g or more, or 0.10 mmol/g or more, and can be 5.0 mmol/g or less, 3.0 mmol/g or less, 1.0 mmol/g or less, 0.50 mmol/g or less, 0.40 mmol/g or less, 0.30 mmol/g or less, 0.25 mmol/g or less, 0.20 mmol/g or less, or 0.15 mmol/g or less.

 ある実施態様では、第1の不飽和オルガノポリシロキサンは、25℃で、10,000~2,000,000cstの粘度を有することができる。かかる粘度の下限値としては、20,000cst以上、40,000cst以上、60,000cst以上、80,000cst以上、又は100,000cst以上であることが好ましく、125,000cst以上又は150,000cst以上であることがより好ましい。粘度の上限値としては、1,000,000cst以下、500,000cst以下、450,000cst以下、400,000cst以下、350,000cst以下、300,000cst以下、又は250,000cst以下であることが好ましく、200,000cst以下又は180,000cst以下であることがより好ましく、165,000cst以下であることがさらに好ましい。 In one embodiment, the first unsaturated organopolysiloxane can have a viscosity of 10,000 to 2,000,000 cst at 25° C. The lower limit of the viscosity is preferably 20,000 cst or more, 40,000 cst or more, 60,000 cst or more, 80,000 cst or more, or 100,000 cst or more, and more preferably 125,000 cst or more or 150,000 cst or more. The upper limit of the viscosity is preferably 1,000,000 cst or less, 500,000 cst or less, 450,000 cst or less, 400,000 cst or less, 350,000 cst or less, 300,000 cst or less, or 250,000 cst or less, more preferably 200,000 cst or less or 180,000 cst or less, and even more preferably 165,000 cst or less.

 ある実施態様では、第1の不飽和オルガノポリシロキサンは、60,000Da~500,000Daの平均分子量を有することができる。かかる平均分子量の下限値としては、72,000Da以上、84,000Da以上、96,000Da以上、又は100,000Da以上であることが好ましく、140,000Da以上又は150,000Da以上であることがより好ましい。平均分子量の上限値としては、200,000Da以下、190,000Da以下、180,000Da、又は170,000Da以下であることが好ましく、160,000Da以下であることがより好ましく、155,000Da以下がさらに好ましい。 In one embodiment, the first unsaturated organopolysiloxane can have an average molecular weight of 60,000 Da to 500,000 Da. The lower limit of the average molecular weight is preferably 72,000 Da or more, 84,000 Da or more, 96,000 Da or more, or 100,000 Da or more, and more preferably 140,000 Da or more or 150,000 Da or more. The upper limit of the average molecular weight is preferably 200,000 Da or less, 190,000 Da or less, 180,000 Da or less, or 170,000 Da or less, more preferably 160,000 Da or less, and even more preferably 155,000 Da or less.

 第1の不飽和オルガノポリシロキサンとして、例えば、ビニル基を有するオルガノポリシロキサン、ビニル末端化されたオルガノポリシロキサン、及びビニル化された分岐鎖を有するオルガノポリシロキサンからなる群から選択される少なくとも一種の不飽和オルガノポリシロキサンを使用することができる。 As the first unsaturated organopolysiloxane, for example, at least one unsaturated organopolysiloxane selected from the group consisting of organopolysiloxanes having vinyl groups, vinyl-terminated organopolysiloxanes, and vinylated branched organopolysiloxanes can be used.

 その具体例としては、ビニル末端ポリジメチルシロキサン、ビニル末端ジフェニルシロキサン-ジメチルシロキサンコポリマー、ビニル末端ポリフェニルメチルシロキサン、ビニルフェニルメチル末端ビニルフェニルシロキサン-フェニルメチルシロキサンコポリマー、ビニル末端トリフルオロプロピルメチルシロキサン-ジメチルシロキサンコポリマー、ビニル末端ジエチルシロキサン-ジメチルシロキサンコポリマー、ビニルメチルシロキサン-ジメチルシロキサンコポリマー、トリメチルシロキシ末端ビニルメチルシロキサン-ジメチルシロキサンコポリマー、シラノール末端ビニルメチルシロキサン-ジメチルシロキサンコポリマー、ビニルメチルシロキサンホモポリマー、ビニルT-構造ポリマー、ビニルQ-構造ポリマー、モノビニル末端ポリジメチルシロキサン、ビニルメチルシロキサンターポリマー、及びビニルメトキシシランホモポリマーを挙げることができる。第1の不飽和オルガノポリシロキサンは、単独で又は二種以上組み合わせて使用することができる。なかでも、ビニル末端ポリジメチルシロキサンが好ましく、ビニルジメチコン(ジビニルジメチコン)がより好ましい。本開示において「末端」とは、片末端及び両末端のいずれかを意図している。これらを区別する場合には、例えば、「ビニル片末端」、「ビニル両末端」と表記することができる。 Specific examples thereof include vinyl-terminated polydimethylsiloxane, vinyl-terminated diphenylsiloxane-dimethylsiloxane copolymer, vinyl-terminated polyphenylmethylsiloxane, vinylphenylmethyl-terminated vinylphenylsiloxane-phenylmethylsiloxane copolymer, vinyl-terminated trifluoropropylmethylsiloxane-dimethylsiloxane copolymer, vinyl-terminated diethylsiloxane-dimethylsiloxane copolymer, vinylmethylsiloxane-dimethylsiloxane copolymer, trimethylsiloxy-terminated vinylmethylsiloxane-dimethylsiloxane copolymer, silanol-terminated vinylmethylsiloxane-dimethylsiloxane copolymer, vinylmethylsiloxane homopolymer, vinyl T-structure polymer, vinyl Q-structure polymer, monovinyl-terminated polydimethylsiloxane, vinylmethylsiloxane terpolymer, and vinylmethoxysilane homopolymer. The first unsaturated organopolysiloxane can be used alone or in combination of two or more. Among these, vinyl-terminated polydimethylsiloxane is preferred, and vinyl dimethicone (divinyl dimethicone) is more preferred. In this disclosure, "terminal" refers to either one terminal or both terminals. When distinguishing between these, it can be written as "vinyl one terminal" or "vinyl both terminals", for example.

b.第1のヒドリド官能化ポリシロキサン
 本開示の組成物は、油分として、シリコーン油の一種である第1のヒドリド官能化ポリシロキサンを含むことができる。第1のヒドリド官能化ポリシロキサンは、皮膜の構成材料として機能させることができる。
b. First hydride-functionalized polysiloxane The composition of the present disclosure may include a first hydride-functionalized polysiloxane, which is a type of silicone oil, as an oil component. The first hydride-functionalized polysiloxane may function as a constituent material of the coating.

 第1のヒドリド官能化ポリシロキサンとしては特に制限はなく、例えば、以下の式1の化合物を挙げることができる。第1のヒドリド官能化ポリシロキサンは単独で又は二種以上組み合わせて使用することができる:
The first hydride-functionalized polysiloxane is not particularly limited, and may be, for example, a compound represented by the following formula 1. The first hydride-functionalized polysiloxane may be used alone or in combination of two or more kinds:

 式1中、R1b、R2b、R3b、R4b、R5b、R6b、R7b、R8b、R9b及びR10bは、それぞれ独立して、水素、C1-20アルキル、C2-20アルケニル、C5-10アリール、ヒドロキシル、又はC1-20アルコキシから選択され、m及びnは、それぞれ独立して、10~6,000の整数である。但し、R1b、R2b、R3b、R4b、R5b、R6b、R7b、R8b、R9b及びR10bの少なくとも1つは水素である。 In formula 1, R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b are each independently selected from hydrogen, C 1-20 alkyl, C 2-20 alkenyl, C 5-10 aryl, hydroxyl, or C 1-20 alkoxy, and m and n are each independently an integer from 10 to 6,000, provided that at least one of R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b is hydrogen.

 いくつかの実施態様において、R1b、R2b、R3b、R4b、R5b、R6b、R7b、R8b、R9b及びR10bの少なくとも1つは水素であり、残りはC1-20アルキルである。 In some embodiments, at least one of R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b is hydrogen, and the remainder are C 1-20 alkyl.

 いくつかの実施形態において、R1b、R2b、R3b、R4b、R5b、R6b、R7b、R8b、R9b及びR10bの少なくとも2つは水素である(例えば、官能化ヒドリドポリシロキサン分子当たり2個のSi-H単位)。 In some embodiments, at least two of R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b are hydrogen (e.g., two Si—H units per functionalized hydridopolysiloxane molecule).

 他の実施形態において、R1b、R2b、R3b、R4b、R5b、R6b、R7b、R8b、R9b及びR10bの少なくとも3つは水素(例えば、官能化ヒドリドポリシロキサン分子当たり3個のSi-H単位)である。 In other embodiments, at least three of R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b are hydrogen (e.g., three Si—H units per functionalized hydridopolysiloxane molecule).

 いくつかの実施形態において、R1b、R2b、R3b、R4b、R5b、R6b、R7b、R8b、R9b及びR10bの少なくとも2つは水素(例えば、官能化ヒドリドポリシロキサン分子当たり2個のSi-H単位)であり、残りはC1-20アルキルである。 In some embodiments, at least two of R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b are hydrogen (e.g., two Si—H units per functionalized hydridopolysiloxane molecule), and the remainder are C 1-20 alkyl.

 他の実施形態において、R1b、R2b、R3b、R4b、R5b、R6b、R7b、R8b、R9b及びR10bの少なくとも3つは水素(例えば、官能化ヒドリドポリシロキサン分子当たり3個のSi-H単位)であり、残りはC1-20アルキルである。 In other embodiments, at least three of R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b are hydrogen (e.g., three Si—H units per functionalized hydridopolysiloxane molecule), and the remainder are C 1-20 alkyl.

 いくつかの実施形態において、R4b、R5b、R9b及びR10bの少なくとも2つは水素(例えば、官能化ヒドリドポリシロキサン分子当たり2個のSi-H単位)であり、残りはC1-20アルキルである。 In some embodiments, at least two of R 4b , R 5b , R 9b and R 10b are hydrogen (eg, two Si—H units per functionalized hydridopolysiloxane molecule), and the remainder are C 1-20 alkyl.

 他の実施形態において、R4b、R5b、R9b及びR10bの少なくとも3つは水素(例えば、官能化ヒドリドポリシロキサン分子当たり3個のSi-H単位)であり、残りはC1-20アルキルである。 In other embodiments, at least three of R 4b , R 5b , R 9b and R 10b are hydrogen (eg, three Si—H units per functionalized hydridopolysiloxane molecule), and the remainder are C 1-20 alkyl.

 いくつかの実施態様において、m及びnの合計は、10~1,300、10~1,100、10~600、15~500、15~400、20~300、20~200、25~100、25~75、30~50、又は40~45の整数である。 In some embodiments, the sum of m and n is an integer between 10 and 1,300, between 10 and 1,100, between 10 and 600, between 15 and 500, between 15 and 400, between 20 and 300, between 20 and 200, between 25 and 100, between 25 and 75, between 30 and 50, or between 40 and 45.

 いくつかの実施態様において、第1のヒドリド官能化ポリシロキサンとして、非末端及び/又は末端で水素化されたオルガノポリシロキサンを挙げることができ、少なくとも2つのSi-H単位を分子内に有する一種以上のオルガノポリシロキサンから構成され、好ましくは、平均して少なくとも2つのSi-H単位を有し、かつ25℃で2~100,000cstの粘度を有する一種以上のオルガノポリシロキサンを挙げることができる。 In some embodiments, the first hydride-functionalized polysiloxane can be a non-terminally and/or terminally hydrogenated organopolysiloxane, which is composed of one or more organopolysiloxanes having at least two Si-H units in the molecule, preferably one or more organopolysiloxanes having an average of at least two Si-H units and having a viscosity of 2 to 100,000 cst at 25°C.

 ある実施態様では、Si-H単位を有するオルガノポリシロキサンは、このようなSi-H単位を、ポリマーの末端単位に、ポリマーの非末端モノマー単位に、又はこれらの組合せにおいて含んでもよい。なかでも、Si-H単位は、ポリマーの非末端モノマー単位に含むことが好ましい。この場合の第1のヒドリド官能化ポリシロキサンは、アルキル末端化されていてもよい。例えば、式1中、R2b及びR7bの1つ又は両方が、C1-20アルキルであってもよい。 In an embodiment, the organopolysiloxane having Si—H units may contain such Si—H units in a terminal unit of the polymer, in a non-terminal monomer unit of the polymer, or in a combination thereof. Of these, it is preferred that the Si—H units are contained in a non-terminal monomer unit of the polymer. In this case, the first hydride-functionalized polysiloxane may be alkyl-terminated. For example, in formula 1, one or both of R 2b and R 7b may be a C 1-20 alkyl.

 一実施態様において、式1中、R1b、R2b、R3b、R6b、R7b及びR8bの1つ、2つ、3つ、4つ、5つ又は6つが、C1-20アルキルであってもよい。 In one embodiment, in formula 1, one, two, three, four, five or six of R 1b , R 2b , R 3b , R 6b , R 7b and R 8b may be C 1-20 alkyl.

 一実施態様において、R1b、R2b、R3b、R4b、R5b、R6b、R7b、R8b及びR10bは、それぞれC1-20アルキル、例えば、Cアルキル(例えば、メチル)であり、R9bは水素であってもよい。 In one embodiment, R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b and R 10b are each C 1-20 alkyl, for example C 1 alkyl (for example methyl), and R 9b may be hydrogen.

 一実施態様において、R1b、R2b、R3b、R4b、R5b、R6b、R7b、R8b及びR9bは、それぞれC1-20アルキル、例えば、Cアルキル(例えば、メチル)であり、R10bは水素であってもよい。 In one embodiment, R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b and R 9b are each C 1-20 alkyl, for example C 1 alkyl (for example methyl), and R 10b may be hydrogen.

 ある実施態様では、オルガノポリシロキサン中のSi-H含有モノマー単位は、平均して、1モノマー単位以上、2モノマー単位以上、5モノマー単位以上、10モノマー単位以上、20モノマー単位以上、40モノマー単位以上、200モノマー単位以上、400モノマー単位以上、1,000モノマー単位以上、又は2,000モノマー単位以上離れていてもよい。 In some embodiments, the Si-H containing monomer units in the organopolysiloxane may be spaced apart, on average, by 1 monomer unit or more, 2 monomer units or more, 5 monomer units or more, 10 monomer units or more, 20 monomer units or more, 40 monomer units or more, 200 monomer units or more, 400 monomer units or more, 1,000 monomer units or more, or 2,000 monomer units or more.

 ある実施態様では、Si-H単位を有するオルガノポリシロキサンのSi-H含有モノマー単位量は、0.003質量%以上、0.01質量%以上、0.1質量%以上、1質量%以上、3質量%以上、5質量%以上、10質量%以上、20質量%以上、又は26質量%以上にすることができ、また、50質量%以下、45質量%以下、40質量%以下、35質量%以下、30質量%以下、又は27質量%以下にすることができる。 In one embodiment, the amount of Si-H-containing monomer units in the organopolysiloxane having Si-H units can be 0.003% by weight or more, 0.01% by weight or more, 0.1% by weight or more, 1% by weight or more, 3% by weight or more, 5% by weight or more, 10% by weight or more, 20% by weight or more, or 26% by weight or more, and can be 50% by weight or less, 45% by weight or less, 40% by weight or less, 35% by weight or less, 30% by weight or less, or 27% by weight or less.

 ある実施態様では、Si-H単位を有するオルガノポリシロキサンのSi-H含有量は、0.1mmol/g以上、0.5mmol/g以上、1mmol/g以上、2mmol/g以上、3mmol/g以上、又は4mmol/g以上にすることができ、20mmol/g以下、10mmol/g以下、9mmol/g以下、8mmol/g以下、7mmol/g以下、6mmol/g以下、又は5mmol/g以下にすることができる。オルガノポリシロキサン中のSi-H単位の近似モル量は、オルガノポリシロキサンの平均分子量に基づいて計算することができる。 In some embodiments, the Si-H content of the organopolysiloxane having Si-H units can be 0.1 mmol/g or more, 0.5 mmol/g or more, 1 mmol/g or more, 2 mmol/g or more, 3 mmol/g or more, or 4 mmol/g or more, and can be 20 mmol/g or less, 10 mmol/g or less, 9 mmol/g or less, 8 mmol/g or less, 7 mmol/g or less, 6 mmol/g or less, or 5 mmol/g or less. The approximate molar amount of Si-H units in the organopolysiloxane can be calculated based on the average molecular weight of the organopolysiloxane.

 ある実施態様では、第1のヒドリド官能化ポリシロキサンは、25℃で、2~500,000cstの粘度を有することができる。かかる粘度の下限値としては、3cst以上、4cst以上、5cst以上、10cst以上、12cst以上、15cst以上、20cst以上、25cst以上、又は30cst以上であることが好ましく、40cst以上であることがより好ましい。粘度の上限値としては、200,000cst以下、100,000cst以下、50,000cst以下、20,000cst以下、10,000cst以下、5,000cst以下、2,000cst以下、又は1,000cst以下であることが好ましく、500cst以下であることがより好ましい。ヒドリド官能化ポリシロキサンの粘度としては、25℃で、45~100cst、又は45~50cstの範囲が特に好ましい。 In one embodiment, the first hydride-functionalized polysiloxane can have a viscosity of 2 to 500,000 cst at 25° C. The lower limit of the viscosity is preferably 3 cst or more, 4 cst or more, 5 cst or more, 10 cst or more, 12 cst or more, 15 cst or more, 20 cst or more, 25 cst or more, or 30 cst or more, and more preferably 40 cst or more. The upper limit of the viscosity is preferably 200,000 cst or less, 100,000 cst or less, 50,000 cst or less, 20,000 cst or less, 10,000 cst or less, 5,000 cst or less, 2,000 cst or less, or 1,000 cst or less, and more preferably 500 cst or less. The viscosity of the hydride-functionalized polysiloxane is particularly preferably in the range of 45 to 100 cst or 45 to 50 cst at 25°C.

 ある実施態様では、ヒドリド官能化ポリシロキサンは、400~500,000Daの平均分子量を有することができる。かかる平均分子量の下限値としては、500Da以上、800Da以上、900Da以上、1,000Da以上、1,200Da以上、1,400Da以上、1,600Da以上、1,800Da以上、2,000Da以上、又は2,200Da以上であることが好ましく、2,300Da以上であることがより好ましい。平均分子量の上限値としては、250,000Da以下、140,000Da以下、100,000Da以下、72,000Da以下、62,700Da以下、60,000Da以下、50,000Da以下、49,500Da以下、36,000Da以下、28,000Da以下、25,000Da以下、20,000Da以下、15,000Da以下、10,000Da以下、5,000Da以下、又は4,000Da以下であることが好ましく、2,500Da以下であることがより好ましい。 In one embodiment, the hydride-functionalized polysiloxane can have an average molecular weight of 400 to 500,000 Da. The lower limit of such average molecular weight is preferably 500 Da or more, 800 Da or more, 900 Da or more, 1,000 Da or more, 1,200 Da or more, 1,400 Da or more, 1,600 Da or more, 1,800 Da or more, 2,000 Da or more, or 2,200 Da or more, and more preferably 2,300 Da or more. The upper limit of the average molecular weight is preferably 250,000 Da or less, 140,000 Da or less, 100,000 Da or less, 72,000 Da or less, 62,700 Da or less, 60,000 Da or less, 50,000 Da or less, 49,500 Da or less, 36,000 Da or less, 28,000 Da or less, 25,000 Da or less, 20,000 Da or less, 15,000 Da or less, 10,000 Da or less, 5,000 Da or less, or 4,000 Da or less, and more preferably 2,500 Da or less.

 第1のヒドリド官能化ポリシロキサンは、次のものに限定されないが、例えば、ヒドリド末端ポリジメチルシロキサン、ヒドリド末端ポリフェニル-(ジメチルヒドロシロキシ)シロキサン、ヒドリド末端メチルヒドロシロキサン-フェニルメチルシロキサンコポリマー、トリメチルシロキシ末端メチルヒドロシロキサン-ジメチルシロキサンコポリマー、ポリメチルヒドロシロキサン、トリメチルシロキシ末端ポリエチルヒドロシロキサン、トリエチルシロキサン、メチルヒドロシロキサン-フェニルオクチルメチルシロキサンコポリマー、及びメチルヒドロシロキサン-フェニルオクチルメチルシロキサンターポリマーからなる群から選択される少なくとも一種を採用することができる。なかでも、ヒドリド末端ポリジメチルシロキサンが好ましく、ハイドロゲンジメチコンがより好ましい。 The first hydride-functionalized polysiloxane may be, but is not limited to, at least one selected from the group consisting of hydride-terminated polydimethylsiloxane, hydride-terminated polyphenyl-(dimethylhydrosiloxy)siloxane, hydride-terminated methylhydrosiloxane-phenylmethylsiloxane copolymer, trimethylsiloxy-terminated methylhydrosiloxane-dimethylsiloxane copolymer, polymethylhydrosiloxane, trimethylsiloxy-terminated polyethylhydrosiloxane, triethylsiloxane, methylhydrosiloxane-phenyloctylmethylsiloxane copolymer, and methylhydrosiloxane-phenyloctylmethylsiloxane terpolymer. Among these, hydride-terminated polydimethylsiloxane is preferred, and hydrogen dimethicone is more preferred.

c.その他のシリコーン油
 第1の不飽和オルガノポリシロキサン及び第1のヒドリド官能化ポリシロキサン以外のその他のシリコーン油としては特に制限はなく、例えば、ジメチルポリシロキサン(ジメチコン)、メチルフェニルポリシロキサン、メチルハイドロジェンポリシロキサン等の鎖状シリコーン;オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン等の環状シリコーンなどを使用することができる。その他のシリコーン油は単独で又は二種以上組み合わせて使用することができる。
c. Other silicone oils The other silicone oils other than the first unsaturated organopolysiloxane and the first hydride-functionalized polysiloxane are not particularly limited, and for example, chain silicones such as dimethylpolysiloxane (dimethicone), methylphenylpolysiloxane, and methylhydrogenpolysiloxane; cyclic silicones such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, and dodecamethylcyclohexasiloxane, etc. can be used. The other silicone oils can be used alone or in combination of two or more kinds.

(触媒)
 触媒としては特に制限はなく、例えば、皮膜を構成する架橋反応性成分である不飽和オルガノポリシロキサン及びヒドリド官能化ポリシロキサンに対し、物理的及び/又は化学的な架橋反応を引き起こし、促進し、又は開始させることが可能な任意の物質を挙げることができる。触媒は、プロセスの間又はプロセスの終了時に、恒久的な物理的及び/又は化学的変化を受けてもよいし、受けなくてもよい。
(catalyst)
The catalyst is not particularly limited, and may be, for example, any substance capable of causing, promoting, or initiating a physical and/or chemical crosslinking reaction of the unsaturated organopolysiloxane and hydride-functionalized polysiloxane, which are crosslinking reactive components constituting the coating. The catalyst may or may not undergo permanent physical and/or chemical changes during or at the end of the process.

 触媒は、次のものに限定されないが、体温以下で架橋を開始させ及び/又は促進することができる金属触媒、例えば、第VIII族の金属触媒、例えば、白金触媒、ロジウム触媒、パラジウム触媒、コバルト触媒、ニッケル触媒、ルテニウム触媒、オスミウム触媒、及びイリジウム触媒、並びに第IVA族の金属触媒、例えば、ゲルマニウム触媒及びスズ触媒を挙げることができる。なかでも、白金触媒、ロジウム触媒、又はスズ触媒が好ましい。触媒は、単独で又は二種以上組み合わせて使用することができる。 The catalyst may be, but is not limited to, a metal catalyst capable of initiating and/or promoting crosslinking at or below body temperature, such as Group VIII metal catalysts, for example, platinum catalysts, rhodium catalysts, palladium catalysts, cobalt catalysts, nickel catalysts, ruthenium catalysts, osmium catalysts, and iridium catalysts, and Group IVA metal catalysts, for example, germanium catalysts and tin catalysts. Of these, platinum catalysts, rhodium catalysts, and tin catalysts are preferred. The catalysts may be used alone or in combination of two or more.

 白金触媒としては、例えば、白金カルボニルシクロビニルメチルシロキサン錯体、白金ジビニルテトラメチルジシロキサン錯体、白金シクロビニルメチルシロキサン錯体、白金オクタンアルデヒド/オクタノール錯体、及び他のPt(0)触媒、例えば、カールシュテット触媒、白金-アルコール錯体、白金-アルコキシド錯体、白金-エーテル錯体、白金-アルデヒド錯体、白金-ケトン錯体、白金-ハロゲン錯体、白金-硫黄錯体、白金-窒素錯体、白金-リン錯体、白金-炭素二重結合錯体、白金炭素三重結合錯体、白金-イミド錯体、白金-アミド錯体、白金-エステル錯体、白金-リン酸エステル錯体、白金-チオールエステル錯体、白金孤立電子対錯体、白金-芳香族錯体、白金π-電子錯体、及びこれらの組合せが挙げられる。なかでも、白金カルボニルシクロビニルメチルシロキサン錯体、白金ジビニルテトラメチルジシロキサン錯体、白金シクロビニルメチルシロキサン錯体、及び白金オクタンアルデヒド/オクタノール錯体からなる群から選択される少なくとも一種が好ましい。 Platinum catalysts include, for example, platinum carbonylcyclovinylmethylsiloxane complexes, platinum divinyltetramethyldisiloxane complexes, platinum cyclovinylmethylsiloxane complexes, platinum octanaldehyde/octanol complexes, and other Pt(0) catalysts, such as Karstedt's catalyst, platinum-alcohol complexes, platinum-alkoxide complexes, platinum-ether complexes, platinum-aldehyde complexes, platinum-ketone complexes, platinum-halogen complexes, platinum-sulfur complexes, platinum-nitrogen complexes, platinum-phosphorus complexes, platinum-carbon double bond complexes, platinum-carbon triple bond complexes, platinum-imido complexes, platinum-amide complexes, platinum-ester complexes, platinum-phosphate ester complexes, platinum-thiol ester complexes, platinum lone pair complexes, platinum-aromatic complexes, platinum π-electron complexes, and combinations thereof. Among these, at least one selected from the group consisting of platinum carbonylcyclovinylmethylsiloxane complex, platinum divinyltetramethyldisiloxane complex, platinum cyclovinylmethylsiloxane complex, and platinum octanaldehyde/octanol complex is preferred.

 ロジウム触媒としては、例えば、三塩化トリス(ジブチルスルフィド)ロジウム及び三塩化ロジウム水和物が挙げられる。 Rhodium catalysts include, for example, tris(dibutylsulfide)rhodium trichloride and rhodium trichloride hydrate.

 スズ触媒としては、例えば、オクタン酸スズ(II)、ネオデカン酸スズ(II)、ジブチルスズジイソオクチルマレエート、ジ-n-ブチルビス(2,4-ペンタンジオネート)スズ、ジ-n-ブチルブトキシクロロスズ、ジブチルスズジラウレート、ジメチルスズジネオデカノエート、ジメチルヒドロキシ(オレエート)スズ、及びオレイン酸スズ(II)が挙げられる。 Examples of tin catalysts include tin(II) octanoate, tin(II) neodecanoate, dibutyltin diisooctylmaleate, di-n-butyl bis(2,4-pentanedionate)tin, di-n-butylbutoxychlorotin, dibutyltin dilaurate, dimethyltin dineodecanoate, dimethylhydroxy(oleate)tin, and tin(II) oleate.

 これらの触媒の中でも、白金触媒がより好ましく、白金ジビニルテトラメチルジシロキサン錯体が特に好ましい。 Among these catalysts, platinum catalysts are more preferred, with platinum divinyltetramethyldisiloxane complexes being particularly preferred.

 水中油型組成物中の触媒の配合量については、要する皮膜性能等に応じて適宜調整すればよく、特に制限はない。例えば、触媒の配合量としては、組成物の全量に対し、0.001質量%以上、0.005質量%以上、又は0.010質量%以上とすることができ、1.0質量%以下、0.10質量%以下、又は0.050質量%以下とすることができる。 The amount of catalyst in the oil-in-water composition may be adjusted appropriately according to the required film performance, and is not particularly limited. For example, the amount of catalyst may be 0.001% by mass or more, 0.005% by mass or more, or 0.010% by mass or more, and 1.0% by mass or less, 0.10% by mass or less, or 0.050% by mass or less, based on the total amount of the composition.

(乳化剤)
 いくつかの実施態様において、本開示の水中油型組成物は乳化剤を含むことができる。本開示における乳化剤とは、乳化機能(界面活性能)を有する剤を意図し、一般に界面活性剤と称する剤も包含することができる。また、乳化剤を含む水中油型組成物は、水中油型乳化組成物と称することができる。
(emulsifier)
In some embodiments, the oil-in-water composition of the present disclosure can contain an emulsifier.The emulsifier in the present disclosure refers to an agent having emulsifying function (surface activity), and can also include agents generally called surfactants.In addition, the oil-in-water composition containing an emulsifier can be called an oil-in-water emulsion composition.

 乳化剤の配合量としては特に制限はなく、例えば、乳化安定性等の観点から、組成物の全量に対し、0.01質量%以上、0.05質量%以上、0.1質量%以上、又は0.2質量%以上とすることができる。乳化剤の配合量の上限値としては特に制限はないが、例えば、皮膜の耐久性等の観点から、乳化剤の配合量は、5.0質量%以下、4.0質量%以下、3.0質量%以下、2.0質量%以下、又は1.0質量%以下であることが好ましい。 There is no particular limit to the amount of emulsifier used, and from the standpoint of emulsion stability, for example, it can be 0.01 mass% or more, 0.05 mass% or more, 0.1 mass% or more, or 0.2 mass% or more relative to the total amount of the composition. There is no particular limit to the upper limit of the amount of emulsifier used, but from the standpoint of film durability, for example, it is preferable that the amount of emulsifier used is 5.0 mass% or less, 4.0 mass% or less, 3.0 mass% or less, 2.0 mass% or less, or 1.0 mass% or less.

 乳化剤としては、例えば、アニオン性、カチオン性、両性、又は非イオン性の乳化剤を使用することができる。乳化剤は単独で又は二種以上組み合わせて使用することができる。 As the emulsifier, for example, anionic, cationic, amphoteric, or nonionic emulsifiers can be used. The emulsifiers can be used alone or in combination of two or more kinds.

 具体的には、乳化剤として、例えば、炭化水素系界面活性剤、シリコーン系界面活性剤、高分子乳化剤、及び両親媒性粉末からなる群から選択される少なくとも一種を挙げることができる。 Specific examples of the emulsifier include at least one selected from the group consisting of hydrocarbon surfactants, silicone surfactants, polymeric emulsifiers, and amphiphilic powders.

 炭化水素系界面活性剤としては、例えば、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンステリルエーテル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレン多価アルコール脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビタン脂肪酸エステル、グリコール脂肪酸エステル、グリセリン脂肪酸エステル、ソルビタン脂肪酸エステル、ショ糖脂肪酸エステル、及びポリグリセリン脂肪酸エステルを挙げることができる。 Examples of hydrocarbon surfactants include polyoxyethylene alkyl ethers, polyoxyethylene steryl ethers, polyoxyethylene fatty acid esters, polyoxyethylene polyhydric alcohol fatty acid esters, polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan fatty acid esters, glycol fatty acid esters, glycerin fatty acid esters, sorbitan fatty acid esters, sucrose fatty acid esters, and polyglycerin fatty acid esters.

 シリコーン系界面活性剤としては、例えば、ポリエーテル変性シリコーン、及びアルキル共変性ポリエーテル変性シリコーンを挙げることができる。なお、シリコーン系界面活性剤が、該活性剤を1質量%含む水溶液における25℃での表面張力が30.0mN/m以下を呈する場合には、このシリコーン系界面活性剤は、後述するシリコーン系表面張力調整剤とみなすことができる。 Examples of silicone surfactants include polyether-modified silicones and alkyl-co-modified polyether-modified silicones. If a silicone surfactant exhibits a surface tension of 30.0 mN/m or less at 25°C in an aqueous solution containing 1% by mass of the surfactant, the silicone surfactant can be considered a silicone surface tension adjuster, as described below.

 乳化剤のなかでも、組成物中における触媒の均一な分散性(乳化性)、及び触媒の保存安定性等の観点から、高分子乳化剤が好ましい。高分子乳化剤は、一般的な乳化剤(界面活性剤)に比べ、典型的には、分子量が大きく、乳化能力の低い乳化剤(界面活性剤)を意図することができる。高分子乳化剤は上述した乳化剤と併用してもよい。 Among emulsifiers, polymer emulsifiers are preferred from the viewpoints of uniform dispersion (emulsifying ability) of the catalyst in the composition and storage stability of the catalyst. Polymer emulsifiers typically have a larger molecular weight and are intended to be emulsifiers (surfactants) with lower emulsifying ability than general emulsifiers (surfactants). Polymer emulsifiers may be used in combination with the emulsifiers mentioned above.

 高分子乳化剤の重量平均分子量は、乳化性等の観点から、500以上、700以上、1,000以上、1,500以上、又は2,000以上とすることができる。高分子乳化剤の重量平均分子量の上限値については特に制限はなく、例えば、1,000,000以下、100,000以下、10,000以下、又は5,000以下とすることができる。なお、乳化剤の重量平均分子量は、乳化剤をN,N-ジメチルホルムアミド(DMF)に溶解させて0.5%溶液を作製し、これを用いて以下の条件でGPC(ゲルパーミエーションクロマトグラフィー)により測定して求めたポリスチレン換算値である:
 カラム:α-M(昭和電工株式会社製)を2本直列に連結して使用した。
 溶離液:60mmol/LのHPOと50mmol/LのLiBrのDMF溶液
 流速 :1.0mL/分
 カラム温度:40℃
 検出器:RI
 検量線:ポリスチレンを用いて作成した。
The weight average molecular weight of the polymer emulsifier may be 500 or more, 700 or more, 1,000 or more, 1,500 or more, or 2,000 or more from the viewpoint of emulsifying properties, etc. The upper limit of the weight average molecular weight of the polymer emulsifier is not particularly limited, and may be, for example, 1,000,000 or less, 100,000 or less, 10,000 or less, or 5,000 or less. The weight average molecular weight of the emulsifier is a polystyrene-equivalent value obtained by dissolving the emulsifier in N,N-dimethylformamide (DMF) to prepare a 0.5% solution, and using this to measure by GPC (gel permeation chromatography) under the following conditions:
Column: Two α-M columns (Showa Denko KK) were connected in series.
Eluent: 60 mmol/L H 3 PO 4 and 50 mmol/L LiBr in DMF Flow rate: 1.0 mL/min Column temperature: 40° C.
Detector: RI
Calibration curve: Prepared using polystyrene.

 高分子乳化剤としては特に制限はなく、例えば、(アクリレーツ/アクリル酸アルキル(C10-30))クロスポリマー、(アクリロイルジメチルタウリンアンモニウム/メタクリル酸ベヘネス-25)クロスポリマー、(アクリル酸ヒドロキシエチル/アクリロイルジメチルタウリンNa)コポリマー、PEG変性クロスポリマー/コポリマーシロキサン、ポリエーテル変性クロスポリマー/コポリマーシロキサン、ステアロキシヒドロキシプロピルメチルセルロース、及びポリオキシエチレンからなる群から選択される少なくとも一種を挙げることができる。なかでも、乳化安定性等の観点から、(アクリレーツ/アクリル酸アルキル(C10-30))クロスポリマーが好ましい。 The polymer emulsifier is not particularly limited, and examples thereof include at least one selected from the group consisting of (acrylates/alkyl acrylate (C10-30)) crosspolymer, (ammonium acryloyldimethyltaurate/beheneth-25 methacrylate) crosspolymer, (hydroxyethyl acrylate/sodium acryloyldimethyltaurate) copolymer, PEG-modified crosspolymer/copolymer siloxane, polyether-modified crosspolymer/copolymer siloxane, stearoxyhydroxypropylmethylcellulose, and polyoxyethylene. Among these, from the viewpoint of emulsion stability, etc., (acrylates/alkyl acrylate (C10-30)) crosspolymer is preferred.

 高分子乳化剤の配合量は、組成物中における触媒の均一な分散性(乳化性)等の観点から、組成物の全量に対し、0.01質量%以上、0.05質量%以上、0.1質量%以上、又は0.2質量%以上とすることができ、また、30質量%以下、25質量%以下、20質量%以下、15質量%以下、10質量%以下、5質量%以下、3質量%以下、又は1質量%以下とすることができる。 The amount of polymer emulsifier may be 0.01% by mass or more, 0.05% by mass or more, 0.1% by mass or more, or 0.2% by mass or more relative to the total amount of the composition, from the viewpoint of uniform dispersion (emulsification) of the catalyst in the composition, and may be 30% by mass or less, 25% by mass or less, 20% by mass or less, 15% by mass or less, 10% by mass or less, 5% by mass or less, 3% by mass or less, or 1% by mass or less.

 高分子乳化剤以外の一般的な乳化剤(界面活性剤)の重量平均分子量としては、500未満、450以下、又は400以下とすることができ、また、100以上、150以上、又は200以上とすることができる。 The weight average molecular weight of a typical emulsifier (surfactant) other than a polymer emulsifier can be less than 500, 450 or less, or 400 or less, and can be 100 or more, 150 or more, or 200 or more.

 高分子乳化剤以外の一般的な乳化剤(界面活性剤)のHLBとしては、2.0以上、3.0以上、又は4.0以上とすることができ、また、10.0以下、9.0以下、又は8.0以下とすることができる。 The HLB of common emulsifiers (surfactants) other than polymer emulsifiers can be 2.0 or more, 3.0 or more, or 4.0 or more, and can be 10.0 or less, 9.0 or less, or 8.0 or less.

〈シリコーン系表面張力調整剤〉
 本開示の水中油型組成物は、シリコーン系表面張力調整剤(単に「表面張力調整剤」と称する場合がある。)を含む。そして、かかる表面張力調整剤は、該表面張力調整剤を1質量%含む水溶液における25℃での表面張力が30.0mN/m以下を呈する。表面張力調整剤は単独で又は二種以上組み合わせて使用することができる。なお、表面張力は、ウィルヘルミプレートを用い、25℃にて3回測定して得られた値の平均値である。
<Silicone-based surface tension adjuster>
The oil-in-water composition of the present disclosure contains a silicone-based surface tension modifier (sometimes simply referred to as a "surface tension modifier"). Such a surface tension modifier exhibits a surface tension of 30.0 mN/m or less at 25°C in an aqueous solution containing 1% by mass of the surface tension modifier. The surface tension modifier may be used alone or in combination of two or more kinds. The surface tension is the average value of values obtained by measuring three times at 25°C using a Wilhelmy plate.

 表面張力調整剤の表面張力は、塗布ムラの改善効果等の観点から、29.0mN/m以下、28.5mN/m以下、28.0mN/m以下、27.5mN/m以下、又は27.0mN/m以下であることが好ましい。かかる表面張力の下限値としては、例えば、20.0mN/m以上、21.0mN/m以上、22.0mN/m以上、23.0mN/m以上、24.0mN/m以上、又は25.0mN/m以上とすることができる。 From the viewpoint of improving coating unevenness, the surface tension of the surface tension adjuster is preferably 29.0 mN/m or less, 28.5 mN/m or less, 28.0 mN/m or less, 27.5 mN/m or less, or 27.0 mN/m or less. The lower limit of such surface tension can be, for example, 20.0 mN/m or more, 21.0 mN/m or more, 22.0 mN/m or more, 23.0 mN/m or more, 24.0 mN/m or more, or 25.0 mN/m or more.

 表面張力調整剤の配合量は、塗布ムラの改善効果等の観点から、組成物の全量に対し、0.01質量%以上、0.03質量%以上、0.05質量%以上、0.07質量%以上、又は0.1質量%以上であることが好ましい。かかる配合量の上限値としては、例えば、10質量%以下、7.0質量%以下、5.0質量%以下、3.0質量%以下、又は1.0質量%以下とすることができる。 From the viewpoint of improving coating unevenness, the amount of the surface tension modifier is preferably 0.01% by mass or more, 0.03% by mass or more, 0.05% by mass or more, 0.07% by mass or more, or 0.1% by mass or more, based on the total amount of the composition. The upper limit of the amount can be, for example, 10% by mass or less, 7.0% by mass or less, 5.0% by mass or less, 3.0% by mass or less, or 1.0% by mass or less.

 表面張力調整剤としては、所定の表面張力を有するシリコーン系の剤(シリコーン鎖などのシリコーン成分を含む剤)である限り、特に制限はなく、例えば、上述したような乳化能(界面活性能)を有するシリコーン系界面活性剤であってもよく、或いは、乳化能を有さない剤であってもよい。表面張力調整剤が、乳化能を有するシリコーン系界面活性剤である場合には、表面張力調整剤は油滴と分散媒との界面などに含まれ得るが、乳化能を有さない剤である場合には、表面張力調整剤は分散媒に含まれ得る。このように、表面張力調整剤は、上述した分散媒及び/又は油滴に含まれ得る。 There are no particular limitations on the surface tension modifier, so long as it is a silicone-based agent (an agent containing a silicone component such as a silicone chain) with a predetermined surface tension, and it may be, for example, a silicone-based surfactant with emulsifying ability (surface activity ability) as described above, or an agent without emulsifying ability. When the surface tension modifier is a silicone-based surfactant with emulsifying ability, the surface tension modifier may be contained in the interface between the oil droplets and the dispersion medium, but when it is an agent without emulsifying ability, the surface tension modifier may be contained in the dispersion medium. In this way, the surface tension modifier may be contained in the dispersion medium and/or the oil droplets described above.

 表面張力調整剤の具体例としては、塗布ムラの改善効果の観点から、ポリオキシエチレン・メチルポリシロキサン共重合体、ジメチルポリシロキサン・メチル(ポリオキシエチレン)シロキサン共重合体、及びビスPEG-18メチルエーテルジメチルシランからなる群から選択される少なくとも一種が好ましい。なかでも、シリコーン系界面活性剤である、ポリオキシエチレン・メチルポリシロキサン共重合体及びジメチルポリシロキサン・メチル(ポリオキシエチレン)シロキサン共重合体がより好ましく、ポリオキシエチレン・メチルポリシロキサン共重合体がさらに好ましく、PEG-10メチルエーテルジメチコン及びPEG-11メチルエーテルジメチコンが特に好ましい。 Specific examples of surface tension adjusters are preferably at least one selected from the group consisting of polyoxyethylene-methylpolysiloxane copolymer, dimethylpolysiloxane-methyl(polyoxyethylene)siloxane copolymer, and bisPEG-18 methyl ether dimethylsilane, from the viewpoint of improving coating unevenness. Among these, silicone surfactants such as polyoxyethylene-methylpolysiloxane copolymer and dimethylpolysiloxane-methyl(polyoxyethylene)siloxane copolymer are more preferred, polyoxyethylene-methylpolysiloxane copolymer is even more preferred, and PEG-10 methyl ether dimethicone and PEG-11 methyl ether dimethicone are particularly preferred.

〈無孔質粒子〉
 いくつかの実施態様において、本開示の水中油型組成物は、無孔質粒子を含む。無孔質粒子を含む組成物を第2剤として使用すると、得られる皮膜のテカリをより低減又は防止することができる。特に、塗布型皮膜形成剤の第1剤を体表に適用して第1剤層を形成した後に、第2剤を適用するときに、無孔質粒子を含む水中油型組成物を第2剤として使用することが好ましい。この場合、第2剤中に含まれる無孔質粒子が、皮膜の表面付近に配置されやすくなるため、皮膜のテカリをより一層低減又は防止することができる。無孔質粒子は単独で又は二種以上組み合わせて使用することができる。ここで、「無孔質」とは、実質的に無孔質であることを意味し、孔が全く存在しない場合に限定されるものではない。本開示の無孔質粒子とは、例えば、BET法(気体吸着法)によって測定したBET比表面積が、100m/g以下、80m/g以下、50m/g以下、30m/g以下、又は25m/g以下を呈する粒子を意図することができる。かかるBET比表面積の下限値としては特に制限はなく、例えば、0m/g以上、0m/g超、1m/g以上、又は2m/g以上とすることができる。
<Non-porous particles>
In some embodiments, the oil-in-water composition of the present disclosure comprises non-porous particles. When a composition comprising non-porous particles is used as the second agent, the shine of the resulting film can be further reduced or prevented. In particular, when the first agent of the coating-type film-forming agent is applied to the body surface to form a first agent layer, and then the second agent is applied, it is preferable to use an oil-in-water composition comprising non-porous particles as the second agent. In this case, the non-porous particles contained in the second agent are easily arranged near the surface of the film, so that the shine of the film can be further reduced or prevented. The non-porous particles can be used alone or in combination of two or more kinds. Here, "non-porous" means substantially non-porous, and is not limited to the case where there are no holes at all. The non-porous particles of the present disclosure may refer to particles having a BET specific surface area measured by the BET method (gas adsorption method) of 100 m 2 /g or less, 80 m 2 /g or less, 50 m 2 /g or less, 30 m 2 /g or less, or 25 m 2 /g or less. There is no particular restriction on the lower limit of the BET specific surface area, and it may be, for example, 0 m 2 /g or more, more than 0 m 2 /g, 1 m 2 /g or more, or 2 m 2 /g or more.

 無孔質粒子の配合量は、テカリを抑制する観点から、組成物の全量に対し、1.0質量%以上、2.0質量%以上、3.0質量%以上、4.0質量%以上、5.0質量%以上、6.0質量%以上、7.0質量%以上、8.0質量%以上、又は9.0質量%以上であることが好ましい。かかる配合量の上限値としては、例えば、塗布ムラ等の不具合を防止する観点から、20質量%以下、15質量%以下、13質量%以下、12質量%以下、11質量%以下、又は10質量%以下とすることが好ましい。 The amount of non-porous particles is preferably 1.0% by mass or more, 2.0% by mass or more, 3.0% by mass or more, 4.0% by mass or more, 5.0% by mass or more, 6.0% by mass or more, 7.0% by mass or more, 8.0% by mass or more, or 9.0% by mass or more, based on the total amount of the composition, from the viewpoint of suppressing shine. The upper limit of such amount is preferably 20% by mass or less, 15% by mass or less, 13% by mass or less, 12% by mass or less, 11% by mass or less, or 10% by mass or less, from the viewpoint of preventing defects such as uneven application, for example.

 無孔質粒子の大きさとしては特に制限はなく、例えば、テカリを抑制する観点から、1.0μm以上、1.5μm以上、2.0μm以上、2.5μm以上、3.0μm以上、又は3.5μm以上、10μm以下、9.0μm以下、8.0μm以下、7.0μm以下、6.0μm以下、又は5.0μm以下の面積円相当粒子径を呈することが好ましい。ここで、面積円相当粒子径とは、例えば、透過型電子顕微鏡で観察した無孔質粒子の投影面積と同じ面積を有する円形状の粒子に換算した場合の粒子径を意図することができる。かかる面積円相当粒子径は、10個以上の粒子の平均値と規定することができる。 There are no particular limitations on the size of the nonporous particles, and from the viewpoint of suppressing shine, for example, it is preferable for the nonporous particles to have an equivalent circle diameter of 1.0 μm or more, 1.5 μm or more, 2.0 μm or more, 2.5 μm or more, 3.0 μm or more, or 3.5 μm or more, 10 μm or less, 9.0 μm or less, 8.0 μm or less, 7.0 μm or less, 6.0 μm or less, or 5.0 μm or less. Here, the equivalent circle diameter can mean, for example, the particle diameter when converted into a circular particle having the same area as the projected area of the nonporous particle observed under a transmission electron microscope. Such equivalent circle diameter can be defined as the average value of 10 or more particles.

 無孔質粒子としては、例えば、中実の無孔質粒子であってもよく、或いは中空の無孔質粒子であってもよい。テカリを抑制する観点から、中実の無孔質粒子が好ましい。無孔質粒子は、テカリを抑制する観点から、球状粒子であることが好ましく、1.4~1.6の屈折率を呈する粒子であることが好ましい。ここで、無孔質粒子における「球状」とは、真球、略球状、回転楕円体を含み、表面に凹凸等があっても、粒子の全体形状が球状と判断できるものであれば、本開示でいう「球状」に該当する。具体的には、無孔質粒子におけるにおける「球状粒子」とは、真球に限定するものではなく、粒子の短径/長径の比(楕円率)が、1.5以下、1.2以下、又は1.1以下の粒子を包含し得る。かかる比の下限値としては、例えば、1.0以上、1.0超、又は1.2以上とすることができる。 The nonporous particles may be, for example, solid nonporous particles or hollow nonporous particles. From the viewpoint of suppressing shine, solid nonporous particles are preferred. From the viewpoint of suppressing shine, the nonporous particles are preferably spherical particles, and preferably particles exhibiting a refractive index of 1.4 to 1.6. Here, the term "spherical" in nonporous particles includes true spheres, nearly spherical shapes, and spheroids, and even if the surface is uneven, the particle falls under the category of "spherical" in this disclosure as long as the overall shape of the particle can be determined to be spherical. Specifically, the term "spherical particles" in nonporous particles is not limited to true spheres, and may include particles whose minor axis/major axis ratio (ellipticity) is 1.5 or less, 1.2 or less, or 1.1 or less. The lower limit of such a ratio may be, for example, 1.0 or more, more than 1.0, or 1.2 or more.

 無孔質粒子の材料としては特に制限はなく、無機質材料であってもよく、或いは樹脂材料であってもよい。かかる材料の具体例としては、無機酸化物(例えば、酸化亜鉛、酸化チタン、酸化アルミニウム、及び酸化ケイ素)、窒化ホウ素、炭酸マグネシウム、水酸化マグネシウム、硫酸バリウム、カオリン、パーライト、タルク、マイカ、シリコーン樹脂、ポリアミド樹脂、及び(メタ)アクリル樹脂などを挙げることができる。なかでも、テカリを抑制する観点から、無機質材料が好ましく、無機酸化物がより好ましく、酸化ケイ素(シリカ)が特に好ましい。 The material of the non-porous particles is not particularly limited, and may be an inorganic material or a resin material. Specific examples of such materials include inorganic oxides (e.g., zinc oxide, titanium oxide, aluminum oxide, and silicon oxide), boron nitride, magnesium carbonate, magnesium hydroxide, barium sulfate, kaolin, perlite, talc, mica, silicone resin, polyamide resin, and (meth)acrylic resin. Among these, from the viewpoint of suppressing shine, inorganic materials are preferred, inorganic oxides are more preferred, and silicon oxide (silica) is particularly preferred.

 無孔質粒子は、表面処理剤で疎水化処理された粒子であってもよく、或いは、疎水化処理されていない粒子であってもよい。疎水化処理する場合、かかる処理としては特に制限はなく、例えば、ジメチルシリル化処理、及びトリメチルシリル化処理などを挙げることができる。 The nonporous particles may be particles that have been hydrophobized with a surface treatment agent, or may not be hydrophobized. If hydrophobization is performed, there are no particular limitations on the treatment, and examples include dimethylsilylation treatment and trimethylsilylation treatment.

 本開示の水中油型組成物に多孔質粒子を配合すると、塗布ムラが生じやすくなり、その結果、皮膜のテカリ等の不具合が生じる場合がある。したがって、水中油型組成物に多孔質粒子を配合するときには、多孔質粒子は、塗布ムラ及びテカリ等の不具合を抑制する観点から、組成物の全量に対し、10質量%以下、8.0質量%以下、5.0質量%以下、3.0質量%以下、1.0質量%以下、0.5質量%以下、又は0.1質量%以下の割合で配合することが好ましく、多孔質粒子は水中油型組成物に配合しないことがより好ましい。なお、多孔質粒子とは、本開示の無孔質粒子よりも表面に多数の孔を有する粒子を意図し、例えば、BET法(気体吸着法)によって測定したBET比表面積が、300m/g以上、500m/g以上、又は700m/g以上を呈する粒子を意図し得る。 When porous particles are blended into the oil-in-water composition of the present disclosure, uneven application may occur, and as a result, problems such as shininess of the film may occur.Therefore, when porous particles are blended into the oil-in-water composition, from the viewpoint of suppressing problems such as uneven application and shininess, the porous particles are preferably blended at a ratio of 10% by mass or less, 8.0% by mass or less, 5.0% by mass or less, 3.0% by mass or less, 1.0% by mass or less, 0.5% by mass or less, or 0.1% by mass or less with respect to the total amount of the composition, and it is more preferable that the porous particles are not blended into the oil-in-water composition.Note that the porous particles refer to particles having a larger number of holes on the surface than the non-porous particles of the present disclosure, and may refer to particles having a BET specific surface area measured by the BET method (gas adsorption method) of 300 m 2 /g or more, 500 m 2 /g or more, or 700 m 2 /g or more.

《塗布型皮膜形成剤》
 上述した本開示の水中油型組成物は、第1剤及び第2剤を含む塗布型皮膜形成剤(単に「形成剤」と称する場合がある。)の第2剤として好適に使用することができる。かかる形成剤は、例えば、第1剤を体表に塗布して第1剤層を形成した後、第2剤を第1剤層に塗布して第1剤層を架橋させることによって、皮膜を形成することができる。本開示の塗布型皮膜形成剤によって得られる皮膜は、身体補正機能を有する身体補正皮膜であってもよく、或いは、身体補正機能を有さない皮膜であってもよい。
<<Coating-type film-forming agent>>
The oil-in-water composition of the present disclosure can be suitably used as the second agent of a coating-type film-forming agent (sometimes simply referred to as a "forming agent") that includes a first agent and a second agent. Such a forming agent can form a film, for example, by coating the first agent on a body surface to form a first agent layer, and then coating the second agent on the first agent layer to crosslink the first agent layer. The film obtained by the coating-type film-forming agent of the present disclosure may be a body correcting film having a body correcting function, or may be a film without a body correcting function.

 いくつかの実施態様において、塗布型皮膜形成剤の第1剤の塗布性能は、B型粘度計(芝浦システム株式会社製、ビスメトロン(商標))を用いた粘度で評価することができる。25℃、60回転/分(ローターNo.3又はNo.4)の条件で測定した本開示の塗布型皮膜形成剤における第1剤の粘度(例えば作製直後の粘度)は、例えば、100mPa・s以上、500mPa・s以上、1,000mPa・s以上、2,000mPa・s以上、5,000mPa・s以上、7,500mPa・s以上、10,000mPa・s以上、又は15,000mPa・s以上にすることができ、1,000,000mPa・s以下、750,000mPa・s以下、500,000mPa・s以下、250,000mPa・s以下、200,000mPa・s以下、175,000mPa・s以下、150,000mPa・s以下、125,000mPa・s以下、100,000mPa・s以下、又は80,000mPa・s以下にすることができる。なかでも、滑らかな塗布性能及び皮膚からの液だれ抑制等の観点から、塗布型皮膜形成剤の第1剤は、例えば、作製直後において、20,000mPa・s以下、15,000mPa・s以下、又は10,000mPa・s以下の粘度を有することが好ましく、3,000mPa・s以上、5,000mPa・s以上、又は7,000mPa・s以上の粘度を有することが好ましい。 In some embodiments, the application performance of the first agent of the spread-type film-forming agent can be evaluated by viscosity using a Brookfield viscometer (Shibaura Systems Co., Ltd., Vismetron (trademark)). The viscosity of the first agent in the spread-type film-forming agent of the present disclosure (e.g., the viscosity immediately after preparation) measured under conditions of 25°C and 60 rpm (rotor No. 3 or No. 4) is, for example, 100 mPa·s or more, 500 mPa·s or more, 1,000 mPa·s or more, 2,000 mPa·s or more, 5,000 mPa·s or more, 7,500 mPa·s or more, 10,000 mPa·s or more, or 15,000 mPa·s or more. The viscosity can be 1,000,000 mPa·s or more, and can be 1,000,000 mPa·s or less, 750,000 mPa·s or less, 500,000 mPa·s or less, 250,000 mPa·s or less, 200,000 mPa·s or less, 175,000 mPa·s or less, 150,000 mPa·s or less, 125,000 mPa·s or less, 100,000 mPa·s or less, or 80,000 mPa·s or less. In particular, from the viewpoint of smooth application performance and suppression of dripping from the skin, the first agent of the paint-on film-forming agent preferably has a viscosity of 20,000 mPa·s or less, 15,000 mPa·s or less, or 10,000 mPa·s or less immediately after preparation, and preferably has a viscosity of 3,000 mPa·s or more, 5,000 mPa·s or more, or 7,000 mPa·s or more.

 いくつかの実施態様において、塗布型皮膜形成剤の第2剤の塗布性能は、B型粘度計(芝浦システム株式会社製、ビスメトロン(商標))を用いた粘度で評価することができる。25℃、10回転/分(ローターNo.7)の条件で測定した本開示の塗布型皮膜形成剤における第2剤の粘度(例えば作製直後の粘度)は、例えば、10,000mPa・s以上、20,000mPa・s以上、30,000mPa・s以上、40,000mPa・s以上、又は50,000mPa・s以上にすることができ、1,000,000mPa・s以下、750,000mPa・s以下、500,000mPa・s以下、250,000mPa・s以下、200,000mPa・s以下、175,000mPa・s以下、150,000mPa・s以下、125,000mPa・s以下、120,000mPa・s以下、115,000mPa・s以下、又は110,000mPa・s以下にすることができる。なかでも、塗布ムラの改善、及びテカリを抑制する観点から、塗布型皮膜形成剤の第2剤は、例えば、作製直後において、20,000mPa・s以上、30,000mPa・s以上、40,000mPa・s以上、又は50,000mPa・s以上の粘度を有することが好ましく、200,000mPa・s以下、175,000mPa・s以下、150,000mPa・s以下、125,000mPa・s以下、120,000mPa・s以下、115,000mPa・s以下、又は110,000mPa・s以下の粘度を有することが好ましい。 In some embodiments, the application performance of the second agent of the paint-on film-forming agent can be evaluated by viscosity using a Brookfield viscometer (Shibaura Systems Co., Ltd., Vismetron (trademark)). The viscosity of the second agent in the paint-on film-forming agent of the present disclosure (e.g., the viscosity immediately after preparation) measured under conditions of 25°C and 10 revolutions per minute (rotor No. 7) can be, for example, 10,000 mPa·s or more, 20,000 mPa·s or more, 30,000 mPa·s or more, 40,000 mPa·s or more, or 50,000 mPa·s or more, and can be 1,000,000 mPa·s or more. The viscosity can be set to 750,000 mPa.s or less, 500,000 mPa.s or less, 250,000 mPa.s or less, 200,000 mPa.s or less, 175,000 mPa.s or less, 150,000 mPa.s or less, 125,000 mPa.s or less, 120,000 mPa.s or less, 115,000 mPa.s or less, or 110,000 mPa.s or less. In particular, from the viewpoint of improving coating unevenness and suppressing shine, the second agent of the paint-on film-forming agent preferably has a viscosity of 20,000 mPa·s or more, 30,000 mPa·s or more, 40,000 mPa·s or more, or 50,000 mPa·s or more immediately after preparation, and preferably has a viscosity of 200,000 mPa·s or less, 175,000 mPa·s or less, 150,000 mPa·s or less, 125,000 mPa·s or less, 120,000 mPa·s or less, 115,000 mPa·s or less, or 110,000 mPa·s or less.

〈第1剤〉
 本開示の塗布型皮膜形成剤を構成する第1剤は、第2の不飽和オルガノポリシロキサン及び第2のヒドリド官能化ポリシロキサンからなる群から選択される少なくとも一種を含んでいる。但し、第1剤が、第2の不飽和オルガノポリシロキサン及び第2のヒドリド官能化ポリシロキサンのうち、第2の不飽和オルガノポリシロキサンのみを含む場合には、上述した水中油型組成物から構成される第2剤は、上述した第1のヒドリド官能化ポリシロキサンを含み、また、第1剤が、第2の不飽和オルガノポリシロキサン及び第2のヒドリド官能化ポリシロキサンのうち、第2のヒドリド官能化ポリシロキサンのみを含む場合には、第2剤は、第1の不飽和オルガノポリシロキサンを含んでいる。
<First Agent>
The first agent constituting the paint-on type film-forming agent of the present disclosure contains at least one selected from the group consisting of the second unsaturated organopolysiloxane and the second hydride-functionalized polysiloxane. However, when the first agent contains only the second unsaturated organopolysiloxane among the second unsaturated organopolysiloxane and the second hydride-functionalized polysiloxane, the second agent composed of the above-mentioned oil-in-water composition contains the above-mentioned first hydride-functionalized polysiloxane, and when the first agent contains only the second hydride-functionalized polysiloxane among the second unsaturated organopolysiloxane and the second hydride-functionalized polysiloxane, the second agent contains the first unsaturated organopolysiloxane.

 第1剤の剤型としては特に制限はなく、例えば、油相で構成された単相系、非乳化型の水中油型若しくは油中水型の二相系の形態、又は水中油型乳化組成物若しくは油中水型乳化組成物の形態で構成された二相系であってもよい。ここで、油相で構成された単相系とは、典型的には無水の形態である。本開示において「無水」とは、組成物中に水が含まれていないことを意図することに加え、水の含有量が低量、即ち、10質量%以下、5質量%以下、2質量%以下、1質量%以下、又は0.1質量%以下であることも意図する。また、非乳化型の二相系とは、水と油に分離した状態の液体を振とうさせることによって、油を含む分散媒中に水滴を強制的に分散させた油中水型の組成物、又は水を含む分散媒中に油滴を強制的に分散させた水中油型の組成物が包含され得る。 The dosage form of the first agent is not particularly limited, and may be, for example, a single-phase system composed of an oil phase, a non-emulsified oil-in-water or water-in-oil two-phase system, or a two-phase system composed of an oil-in-water emulsion composition or a water-in-oil emulsion composition. Here, a single-phase system composed of an oil phase is typically an anhydrous form. In this disclosure, "anhydrous" not only means that the composition does not contain water, but also means that the water content is low, i.e., 10% by mass or less, 5% by mass or less, 2% by mass or less, 1% by mass or less, or 0.1% by mass or less. In addition, a non-emulsified two-phase system may include a water-in-oil composition in which water droplets are forcibly dispersed in a dispersion medium containing oil by shaking a liquid in a state in which the water and oil are separated, or an oil-in-water composition in which oil droplets are forcibly dispersed in a dispersion medium containing water.

 これらの各剤型は、架橋反応性成分と、任意に、後述するような、油分、乳化剤、及び水などの公知の材料とを用い、常法によって適宜調製することができる。 Each of these formulations can be prepared appropriately by conventional methods using a crosslinking reactive component and, optionally, known materials such as oils, emulsifiers, and water, as described below.

 第1剤は、体表に塗布等によって適用され得るため、塗布性能の観点から、体温以下のガラス転移温度を有することが好ましい。例えば、ガラス転移温度は、37℃以下、25℃以下、10℃以下、又は0℃以下にすることができる。ガラス転移温度の下限値については特に制限はないが、例えば、-30℃以上、-20℃以上、又は-10℃以上とすることができる。ここで、「ガラス転移温度」とは、固体状態から液体状態への転移が起こる温度を指し、例えば、ASTM D3418-03に準拠した示差走査熱量計(DSC)を用いて測定することができる。 The first agent can be applied to the body surface by painting or the like, so from the viewpoint of application performance, it preferably has a glass transition temperature below body temperature. For example, the glass transition temperature can be 37°C or lower, 25°C or lower, 10°C or lower, or 0°C or lower. There is no particular restriction on the lower limit of the glass transition temperature, but it can be, for example, -30°C or higher, -20°C or higher, or -10°C or higher. Here, "glass transition temperature" refers to the temperature at which a transition from a solid state to a liquid state occurs, and can be measured, for example, using a differential scanning calorimeter (DSC) in accordance with ASTM D3418-03.

(第2の不飽和オルガノポリシロキサン)
 第2の不飽和オルガノポリシロキサンとしては、上述した第1の不飽和オルガノポリシロキサンと同一の材料を使用することができる。
(Second Unsaturated Organopolysiloxane)
As the second unsaturated organopolysiloxane, the same material as the above-mentioned first unsaturated organopolysiloxane can be used.

 第1剤中における第2の不飽和オルガノポリシロキサンの配合量については、要する皮膜性能等に応じて適宜調整すればよく、特に制限はない。例えば、第2の不飽和オルガノポリシロキサンの配合量としては、第1剤全体に対し、5質量%以上、10質量%以上、20質量%以上、30質量%以上、35質量%以上、又は40質量%以上とすることができ、90質量%以下、80質量%以下、70質量%以下、60質量%以下、50質量%以下、又は45質量%以下とすることができる。 The amount of the second unsaturated organopolysiloxane in the first agent can be adjusted appropriately according to the required film performance, etc., and is not particularly limited. For example, the amount of the second unsaturated organopolysiloxane can be 5% by mass or more, 10% by mass or more, 20% by mass or more, 30% by mass or more, 35% by mass or more, or 40% by mass or more, and can be 90% by mass or less, 80% by mass or less, 70% by mass or less, 60% by mass or less, 50% by mass or less, or 45% by mass or less, based on the entire first agent.

(第2のヒドリド官能化ポリシロキサン)
 第2のヒドリド官能化ポリシロキサンとしては、上述した第1のヒドリド官能化ポリシロキサンと同一の材料を使用することができる。
Second Hydride-Functionalized Polysiloxane
The second hydride-functionalized polysiloxane can be the same material as the first hydride-functionalized polysiloxane described above.

 第1剤中における第2のヒドリド官能化ポリシロキサンの配合量については、要する皮膜性能等に応じて適宜調整すればよく、特に制限はない。例えば、第2のヒドリド官能化ポリシロキサンの配合量としては、第1剤全体に対し、1質量%以上、3質量%以上、又は5質量%以上とすることができ、75質量%以下、60質量%以下、50質量%以下、40質量%以下、30質量%以下、20質量%以下、又は10質量%以下とすることができる。 The amount of the second hydride-functionalized polysiloxane in the first agent can be adjusted appropriately according to the required film performance, etc., and is not particularly limited. For example, the amount of the second hydride-functionalized polysiloxane can be 1 mass% or more, 3 mass% or more, or 5 mass% or more, and 75 mass% or less, 60 mass% or less, 50 mass% or less, 40 mass% or less, 30 mass% or less, 20 mass% or less, or 10 mass% or less, based on the entire first agent.

(他のポリマー)
 第1剤は、任意に、第2の不飽和オルガノポリシロキサン及び第2のヒドリド官能化ポリシロキサン以外の他のポリマーを含むことができる。他のポリマーは単独で又は二種以上組み合わせて使用することができる。
(Other polymers)
The first agent may optionally contain other polymers other than the second unsaturated organopolysiloxane and the second hydride-functionalized polysiloxane. The other polymers may be used alone or in combination of two or more.

 ある実施態様では、他のポリマーは、25℃で、0.7cst~50,000cstの粘度を有することができる。かかる粘度の下限値としては、1cst以上、6cst以上、10cst以上、20cst以上、50cst以上、100cst以上、200cst以上、300cst以上、400cst以上、750cst以上、1,000cst以上、1,500cst以上、2,000cst以上、2,500cst以上、3,000cst以上、3,500cst以上、又は4000cst以上とすることができる。粘度の上限値としては、45,000cst以下、40,000cst以下、35,000cst以下、30,000cst以下、25,000cst以下、20,000cst以下、15,000cst以下、12,000cst以下、10,000cst以下、5,000cst以下、4,000cst以下、2,000cst以下、1,500cst以下、又は1,000cst以下とすることができる。 In one embodiment, the other polymer can have a viscosity of 0.7 cst to 50,000 cst at 25° C. The lower limit of such viscosity can be 1 cst or more, 6 cst or more, 10 cst or more, 20 cst or more, 50 cst or more, 100 cst or more, 200 cst or more, 300 cst or more, 400 cst or more, 750 cst or more, 1,000 cst or more, 1,500 cst or more, 2,000 cst or more, 2,500 cst or more, 3,000 cst or more, 3,500 cst or more, or 4,000 cst or more. The upper limit of the viscosity can be 45,000 cst or less, 40,000 cst or less, 35,000 cst or less, 30,000 cst or less, 25,000 cst or less, 20,000 cst or less, 15,000 cst or less, 12,000 cst or less, 10,000 cst or less, 5,000 cst or less, 4,000 cst or less, 2,000 cst or less, 1,500 cst or less, or 1,000 cst or less.

 ある実施態様において、他のポリマーは、180Da~80,000Daの平均分子量を有することができる。かかる平均分子量の下限値としては、500Da以上、800Da以上、1,500Da以上、3,000Da以上、6,000Da以上、9,400Da以上、10,000Da以上、15,000Da以上、20,000Da以上、30,000Da以上、40,000Da以上、50,000Da以上、55,000Da以上、60,000Da以上、又は62,000Da以上とすることができる。平均分子量の上限値としては、75,000Da以下、70,000Da以下、65,000Da以下、又は63,000Da以下とすることができる。 In some embodiments, the other polymer can have an average molecular weight of 180 Da to 80,000 Da. The lower limit of the average molecular weight can be 500 Da or more, 800 Da or more, 1,500 Da or more, 3,000 Da or more, 6,000 Da or more, 9,400 Da or more, 10,000 Da or more, 15,000 Da or more, 20,000 Da or more, 30,000 Da or more, 40,000 Da or more, 50,000 Da or more, 55,000 Da or more, 60,000 Da or more, or 62,000 Da or more. The upper limit of the average molecular weight can be 75,000 Da or less, 70,000 Da or less, 65,000 Da or less, or 63,000 Da or less.

 他のポリマーとして、好ましくは、平均して少なくとも1つのアルケニル官能基を有し、かつ25℃で0.7~50,000cstの粘度を有する一種以上のオルガノポリシロキサンを挙げることができる。 The other polymer may preferably be one or more organopolysiloxanes having, on average, at least one alkenyl functional group and a viscosity of 0.7 to 50,000 cst at 25°C.

 具体的には、他のポリマーとして、例えば、ビニル末端ポリジメチルシロキサン、ビニル末端ジフェニルシロキサン-ジメチルシロキサンコポリマー、ビニル末端ポリフェニルメチルシロキサン、ビニルフェニルメチル末端ビニルフェニルシロキサン-フェニルメチルシロキサンコポリマー、ビニル末端トリフルオロプロピルメチルシロキサン-ジメチルシロキサンコポリマー、ビニル末端ジエチルシロキサン-ジメチルシロキサンコポリマー、ビニルメチルシロキサン-ジメチルシロキサンコポリマー、トリメチルシロキシ末端ビニルメチルシロキサン-ジメチルシロキサンコポリマー、シラノール末端ビニルメチルシロキサン-ジメチルシロキサンコポリマー、ビニル末端ビニルゴム、ビニルメチルシロキサンホモポリマー、ビニルT-構造ポリマー、ビニルQ-構造ポリマー、不飽和有機ポリマー(例えば、不飽和脂肪アルコール、不飽和脂肪酸、不飽和脂肪エステル、不飽和脂肪アミド、不飽和脂肪ウレタン、不飽和脂肪ウレア、セラミド、クロセチン、レシチン、及びスフィンゴシンが挙げられる。)、モノビニル末端ポリジメチルシロキサン、ビニルメチルシロキサンターポリマー、ビニルメトキシシランホモポリマー、ビニル末端ポリアルキルシロキサンポリマー、及びビニル末端ポリアルコキシシロキサンポリマーから選択される少なくとも一種を採用することができる。なかでも、ビニル末端ポリジメチルシロキサンが好ましく、ジビニルジメチコン、1,3-ジビニルテトラメチルジシロキサンがより好ましい。 Specific examples of other polymers include vinyl-terminated polydimethylsiloxane, vinyl-terminated diphenylsiloxane-dimethylsiloxane copolymer, vinyl-terminated polyphenylmethylsiloxane, vinylphenylmethyl-terminated vinylphenylsiloxane-phenylmethylsiloxane copolymer, vinyl-terminated trifluoropropylmethylsiloxane-dimethylsiloxane copolymer, vinyl-terminated diethylsiloxane-dimethylsiloxane copolymer, vinylmethylsiloxane-dimethylsiloxane copolymer, trimethylsiloxy-terminated vinylmethylsiloxane-dimethylsiloxane copolymer, silanol-terminated vinylmethylsiloxane-dimethylsiloxane copolymer, At least one selected from vinyl siloxane copolymer, vinyl-terminated vinyl rubber, vinyl methyl siloxane homopolymer, vinyl T-structure polymer, vinyl Q-structure polymer, unsaturated organic polymer (e.g., unsaturated fatty alcohol, unsaturated fatty acid, unsaturated fatty ester, unsaturated fatty amide, unsaturated fatty urethane, unsaturated fatty urea, ceramide, crocetin, lecithin, and sphingosine), monovinyl-terminated polydimethyl siloxane, vinyl methyl siloxane terpolymer, vinyl methoxy silane homopolymer, vinyl-terminated polyalkyl siloxane polymer, and vinyl-terminated polyalkoxy siloxane polymer can be used. Among these, vinyl-terminated polydimethyl siloxane is preferred, and divinyl dimethicone and 1,3-divinyl tetramethyl disiloxane are more preferred.

 第1剤中における他のポリマーの配合量については、要する皮膜性能等に応じて適宜調整すればよく、特に制限はない。例えば、他のポリマーの配合量としては、第1剤全体に対し、0.01質量%以上、0.1質量%以上、0.3質量%以上、又は0.5質量%以上とすることができ、20質量%以下、15質量%以下、又は10質量%以下にすることができる。 The amount of the other polymer in the first agent is not particularly limited and may be adjusted as appropriate depending on the required film performance, etc. For example, the amount of the other polymer may be 0.01% by mass or more, 0.1% by mass or more, 0.3% by mass or more, or 0.5% by mass or more relative to the entire first agent, and may be 20% by mass or less, 15% by mass or less, or 10% by mass or less.

〈第2の不飽和オルガノポリシロキサン、第2のヒドリド官能化ポリシロキサン、他のポリマーにおける官能基比率〉
 ある実施態様では、第2のヒドリド官能化ポリシロキサン由来のSi-H官能基と、第2の不飽和オルガノポリシロキサン由来のアルケニル官能基とのモル比は、60:1~1:5であることが好ましく、45:1~15:1であることがより好ましい。
<Functional Group Ratios in the Second Unsaturated Organopolysiloxane, the Second Hydride-Functionalized Polysiloxane, and the Other Polymers>
In one embodiment, the molar ratio of Si—H functional groups from the second hydride-functionalized polysiloxane to alkenyl functional groups from the second unsaturated organopolysiloxane is preferably from 60:1 to 1:5, more preferably from 45:1 to 15:1.

 ある実施態様では、第2のヒドリド官能化ポリシロキサン由来のSi-H官能基と、他のポリマー由来のアルケニル官能基とのモル比は、60:1~1:5であることが好ましく、45:1~15:1であることがより好ましい。 In one embodiment, the molar ratio of Si-H functional groups from the second hydride-functionalized polysiloxane to alkenyl functional groups from the other polymer is preferably from 60:1 to 1:5, more preferably from 45:1 to 15:1.

 ある実施態様では、第2の不飽和オルガノポリシロキサン由来のアルケニル官能基と、他のポリマー由来のアルケニル官能基とのモル比は、100:1~1:100であることが好ましく、10:1~1:10であることがより好ましい。 In one embodiment, the molar ratio of the alkenyl functional groups derived from the second unsaturated organopolysiloxane to the alkenyl functional groups derived from the other polymer is preferably from 100:1 to 1:100, and more preferably from 10:1 to 1:10.

〈第2剤〉
 本開示の塗布型皮膜形成剤は、第2剤として、上述した本開示の水中油型組成物を使用する。
<Second Agent>
The spreadable film-forming agent of the present disclosure uses the oil-in-water composition of the present disclosure described above as the second agent.

 また、第2剤は、第1剤に配合可能な上述した他のポリマーを、同様に配合することができる。 The second agent can also contain other polymers that can be blended into the first agent, as described above.

 第2剤において、第1の不飽和オルガノポリシロキサン及び他のポリマーが使用される場合には、これらの官能基比率は、上述した、第2の不飽和オルガノポリシロキサン及び他のポリマーにおける官能基比率と同様の比率を採用することができる。 When the first unsaturated organopolysiloxane and other polymers are used in the second agent, the functional group ratios thereof can be the same as the functional group ratios in the second unsaturated organopolysiloxane and other polymers described above.

〈任意成分〉
 本開示の塗布型皮膜形成剤は、第1剤及び/又は第2剤に対し、本開示の効果に悪影響を及ぼさない範囲で、各種成分を適宜配合することができる。
<Optional ingredients>
In the paint-type film-forming agent of the present disclosure, various components can be appropriately blended into the first agent and/or the second agent within a range that does not adversely affect the effects of the present disclosure.

 任意成分としては特に制限はないが、例えば、感触改質剤、粘着改質剤、展延性促進剤、希釈剤、接着改質剤、乳化剤(界面活性剤)、エモリエント剤、溶媒、成膜剤、ヒューメクタント、保存料、繊維、顔料、染料、水相又は油相を増粘させる成分(増粘剤)、保護コロイド剤、充填剤、皮膚透過促進剤、光学改質剤、散乱剤、分散剤、吸着剤、磁気材料、気体輸送改質剤、液体輸送改質剤、pH改質剤、増感改質剤、審美的改質剤を挙げることができる。任意成分は、単独で又は二種以上組み合わせて使用することができる。なかでも、ヘキサメタリン酸ソーダ等の分散剤を無孔質粒子とともに第2剤に配合すると、テカリをより抑制することができる。 The optional components are not particularly limited, but examples include feel modifiers, adhesion modifiers, spreadability promoters, diluents, adhesion modifiers, emulsifiers (surfactants), emollients, solvents, film-forming agents, humectants, preservatives, fibers, pigments, dyes, components that thicken the aqueous or oil phase (thickeners), protective colloids, fillers, skin permeation enhancers, optical modifiers, scattering agents, dispersants, adsorbents, magnetic materials, gas transport modifiers, liquid transport modifiers, pH modifiers, sensitization modifiers, and aesthetic modifiers. The optional components can be used alone or in combination of two or more. In particular, when a dispersant such as sodium hexametaphosphate is blended with non-porous particles in the second agent, shine can be further suppressed.

 ある実施態様では、本開示の組成物は、第1剤及び/又は第2剤に対し、一種以上の薬剤をさらに配合することができる。このような薬剤としては、例えば、化粧剤、治療剤、刺激応答剤、及び薬物送達剤を挙げることができる。 In some embodiments, the compositions of the present disclosure may further comprise one or more drugs in addition to the first agent and/or the second agent. Such drugs may include, for example, cosmetic agents, therapeutic agents, stimuli-responsive agents, and drug delivery agents.

 好適な化粧剤としては、例えば、保湿剤、紫外線吸収剤、皮膚保護剤、皮膚鎮静剤、皮膚美白剤、皮膚光沢剤、皮膚軟化剤、皮膚平滑化剤、皮膚漂白剤、皮膚角質除去剤、皮膚引き締め剤、美容剤、ビタミン、抗酸化剤、細胞シグナル伝達剤、細胞調節剤、細胞相互作用剤、皮膚日焼け剤、老化防止剤、しわ防止剤、スポットリデューサー、α-ヒドロキシ酸、β-ヒドロキシ酸、及びセラミドを挙げることができる。 Suitable cosmetic agents include, for example, moisturizers, UV absorbers, skin protectants, skin soothing agents, skin whitening agents, skin brighteners, skin emollients, skin smoothing agents, skin bleaching agents, skin exfoliants, skin tightening agents, beauty agents, vitamins, antioxidants, cell signaling agents, cell regulating agents, cell interacting agents, skin tanning agents, anti-aging agents, anti-wrinkle agents, spot reducers, alpha-hydroxy acids, beta-hydroxy acids, and ceramides.

 好適な治療剤としては、例えば、疼痛緩和剤、鎮痛薬、抗掻痒剤、抗座瘡剤(例えば、β-ヒドロキシ酸、サリチル酸、過酸化ベンゾイル)、抗炎症剤、抗ヒスタミン薬、コルチコステロイド、NSAID(非ステロイド性抗炎症薬)、防腐剤、抗生物質、抗細菌剤、抗真菌剤、抗ウイルス剤、抗アレルギー剤、抗刺激物質、虫除け剤、光線療法剤、血液凝固剤、抗新生物薬、免疫系増進剤、免疫系抑制剤、コールタール、アントラリン、フルオシノニド、メトトレキセート、シクロスポリン、ピメクロリムス、タクロリムス、アザチオプリン、フルオロウラシル、セラミド、反対刺激剤、及び皮膚冷却化合物を挙げることができる。 Suitable therapeutic agents include, for example, pain relievers, analgesics, antipruritic agents, antiacne agents (e.g., beta-hydroxy acids, salicylic acid, benzoyl peroxide), anti-inflammatory agents, antihistamines, corticosteroids, NSAIDs (nonsteroidal anti-inflammatory drugs), antiseptics, antibiotics, antibacterial agents, antifungal agents, antiviral agents, antiallergy agents, antiirritants, insect repellents, phototherapy agents, blood clotting agents, antineoplastic agents, immune system enhancers, immune system suppressants, coal tar, anthralin, fluocinonide, methotrexate, cyclosporine, pimecrolimus, tacrolimus, azathioprine, fluorouracil, ceramides, counterirritants, and skin cooling compounds.

 好適な薬剤としては、例えば、抗酸化剤、ビタミン、ビタミンD類似体、レチノイド、ミネラル、ミネラルオイル、ワセリン、脂肪酸、植物抽出物、ポリペプチド、抗体、タンパク質、糖、ヒューメクタント、及びエモリエント剤を挙げることができる。 Suitable agents can include, for example, antioxidants, vitamins, vitamin D3 analogs, retinoids, minerals, mineral oil, petrolatum, fatty acids, plant extracts, polypeptides, antibodies, proteins, sugars, humectants, and emollients.

《塗布型皮膜形成剤の使用方法》
 本開示の塗布型皮膜形成剤は、例えば、化粧用又は医療用として使用することができる。ここで、本開示の塗布型皮膜形成剤の使用方法には、人間を手術、治療又は診断する方法は包含しない。
How to use the coating agent
The spreadable film-forming agent of the present disclosure can be used, for example, for cosmetic or medical purposes. Here, the method of using the spreadable film-forming agent of the present disclosure does not include methods for surgery, treatment, or diagnosis of humans.

 本開示の塗布型皮膜形成剤の使用方法としては特に制限はなく、例えば、第1剤を体表に適用して第1剤層を形成した後に、該第1剤層上に第2剤を適用し、架橋させて被膜を形成する方法;第2剤を体表に適用して第2剤層を形成した後に、該第2剤層上に第1剤を適用し、架橋させて被膜を形成する方法;又は、第1剤及び第2剤を混合して混合物を調製した後に、該混合物を体表に適用し、架橋させて被膜を形成する方法を挙げることができる。むらの少ない均一な皮膜を得る観点から、かかる使用方法としては、第1剤を体表に適用して第1剤層を形成した後に、この第1剤層上に第2剤を適用し、架橋させて皮膜を形成する方法が好ましい。ここで、第1剤及び第2剤については、上述した材料などを同様に使用することができる。 The method of using the coating-type film-forming agent of the present disclosure is not particularly limited, and examples of the method include a method in which the first agent is applied to the body surface to form a first agent layer, and then the second agent is applied on the first agent layer and crosslinked to form a film; a method in which the second agent is applied to the body surface to form a second agent layer, and then the first agent is applied on the second agent layer and crosslinked to form a film; or a method in which the first agent and the second agent are mixed to prepare a mixture, and then the mixture is applied to the body surface and crosslinked to form a film. From the viewpoint of obtaining a uniform film with few unevenness, a preferred method of use is a method in which the first agent is applied to the body surface to form a first agent layer, and then the second agent is applied on the first agent layer and crosslinked to form a film. Here, the materials described above can be used for the first agent and the second agent in the same manner.

 この方法は、1回で済ませてもよく、或いは、形成した皮膜に対して、かかる方法を複数回(例えば2回以上又は3回以上)実施してもよい。複数回実施する場合には、該方法は、例えば、以下のいずれかの操作を含み得る:
 形成した皮膜に対して第1剤を適用して第1剤層を形成した後に、該第1剤層上に第2剤を適用し、皮膜をさらに形成する操作、又は、
 形成した皮膜に対して第2剤を適用して第2剤層を形成した後に、該第2剤層上に第1剤を適用し、皮膜をさらに形成する操作、又は
 第1剤及び第2剤を混合して混合物を調製した後に、形成した皮膜に対して該混合物を適用し、皮膜をさらに形成する操作。
This method may be performed once, or may be performed multiple times (e.g., two or more times, or three or more times) on the formed coating. When performed multiple times, the method may include, for example, any of the following operations:
Applying a first agent to the formed coating to form a first agent layer, and then applying a second agent onto the first agent layer to further form a coating; or
An operation in which a second agent is applied to the formed coating to form a second agent layer, and then a first agent is applied onto the second agent layer to further form a coating; or an operation in which the first agent and the second agent are mixed to prepare a mixture, and then the mixture is applied to the formed coating to further form a coating.

 いくつかの実施態様では、第1剤、第2剤、又は第1剤及び第2剤を含む混合物を体表に適用する前に、化粧料を体表に適用してもよく;第1剤を体表に適用して第1剤層を形成し、該第1剤層上に化粧料を適用した後に、該化粧料を覆うように前記第2剤を適用してもよく;第2剤を体表に適用して第2剤層を形成し、該第2剤層上に化粧料を適用した後に、該化粧料を覆うように第1剤を適用してもよく;又は、皮膜を形成した後に、該皮膜に化粧料を適用してもよい。 In some embodiments, a cosmetic may be applied to the body surface before applying the first agent, the second agent, or a mixture containing the first agent and the second agent to the body surface; a first agent may be applied to the body surface to form a first agent layer, a cosmetic may be applied onto the first agent layer, and then the second agent may be applied to cover the cosmetic; a second agent may be applied to the body surface to form a second agent layer, a cosmetic may be applied onto the second agent layer, and then the first agent may be applied to cover the cosmetic; or a film may be formed, and then the cosmetic may be applied to the film.

 化粧料としては特に制限はなく、例えば、美容液、化粧水、乳液等のスキンケア化粧料、サンスクリーン化粧料(日焼け止め化粧料)、下地用化粧料、若しくはファンデーション、グロス、口紅、アイシャドー、マニキュア等のメーキャップ化粧料、又はこれらの化粧料の機能を2つ以上複合した化粧料を使用することができる。 There are no particular limitations on the cosmetics that can be used, and examples of such cosmetics include skin care cosmetics such as serums, lotions, and emulsions, sunscreen cosmetics (sun protection cosmetics), base cosmetics, and make-up cosmetics such as foundations, glosses, lipsticks, eye shadows, and nail polishes, or cosmetics that combine the functions of two or more of these cosmetics.

 また、いくつかの実施態様において、本開示の塗布型皮膜形成剤の使用方法は、美容方法として利用することもできる。例えば、乾燥にさらされた皮膚は、知らず知らずのうちに水分が奪われ、肌表面の角質層の水分量が保てない状態になる場合がある。肌の水分が足りなくなると、肌自らがつくりだす保湿成分(天然保湿因子:Natural Moisturizing Factor (NMF))がうまくつくりだせなくなる。その結果、肌表面におけるバリア機能及び保湿機能が低下し、肌はダメージを受けやすくなるため、うるおいを失って肌あれ等を引き起こすと考えられている。 Furthermore, in some embodiments, the method of using the applied film-forming agent of the present disclosure can also be used as a cosmetic method. For example, when skin is exposed to dryness, moisture is unknowingly lost, and the stratum corneum on the skin surface may not be able to maintain its moisture content. When the skin lacks moisture, it is no longer able to effectively produce the moisturizing components (Natural Moisturizing Factors (NMFs)) that it produces itself. As a result, the barrier function and moisturizing function of the skin surface are reduced, making the skin more susceptible to damage, which is thought to cause a loss of moisture and lead to rough skin, etc.

 一方、皮膚に対して本開示の塗布型皮膜形成剤による皮膜を適用すると、皮膜によるオクルージョン効果(肌から水分が抜けることを防ぐ効果)によって皮膚を良好に保湿することができる。その結果、例えば、肌自らがつくりだす保湿成分の生成機能が改善されるとともに、角質層におけるターンオーバーの不調も改善されるため肌あれ等のトラブルが生じがたくなり、美容効果を高めることができる。なお、「美容方法」とは、本開示の塗布型皮膜形成剤を皮膚に適用して皮膜を形成し、皮膚の状態を美しく整えること又は皮膚の状態を美しく整える方法を意味し、人間を手術、治療又は診断する方法とは相違する。 On the other hand, when a film made from the applied film-forming agent of the present disclosure is applied to the skin, the occlusion effect of the film (the effect of preventing moisture from escaping from the skin) allows the skin to be well moisturized. As a result, for example, the skin's own production function of moisturizing ingredients is improved, and turnover problems in the stratum corneum are also improved, making skin problems such as roughness less likely to occur, and improving the cosmetic effect. Note that the term "cosmetic method" refers to applying the applied film-forming agent of the present disclosure to the skin to form a film and beautify the skin's condition, or a method for beautifying the skin's condition, and is different from a method of surgery, treatment, or diagnosis of humans.

 皮膚、化粧料適用層、又は第1剤層若しくは第2剤層に対し、第1剤又は第2剤を適用する方法としては特に制限はなく、例えば、指などで塗り広げる手段、スプレー塗布、転写などを採用することができる。 There are no particular limitations on the method for applying the first or second agent to the skin, the cosmetic application layer, or the first or second agent layer, and for example, methods such as spreading with fingers, spray application, and transfer can be used.

 また、例えば、第1剤及び/又は第2剤が水と油に分離しているときは、塗布ムラの改善等の観点から、これらの剤を振とうして強制的に二相系(水中油型又は油中水型)にすることが好ましい。 Also, for example, when the first and/or second agents are separated into water and oil, it is preferable to shake these agents to forcibly turn them into a two-phase system (oil-in-water type or water-in-oil type) from the viewpoint of improving coating unevenness, etc.

〈適用部位〉
 本開示の塗布型皮膜形成剤は、体のあらゆる部分における皮膚の表面上、即ち、体表上であれば、いかなる箇所に適用することができる。例えば、頭、顔(唇、目元、鼻、頬、額など)、首、耳、手、腕、脚、足、胸、腹、背中、臀部等の皮膚表面に対して適宜適用することができる。ここで、皮膚には、皮膚の表皮の角質が変化して硬化した爪なども含まれる。
<Application area>
The applied film-forming agent of the present disclosure can be applied to any part of the skin surface of any part of the body, that is, any part of the body surface. For example, it can be appropriately applied to the skin surface of the head, face (lips, eyes, nose, cheeks, forehead, etc.), neck, ears, hands, arms, legs, feet, chest, abdomen, back, buttocks, etc. Here, the skin also includes nails that have hardened due to changes in the keratin of the epidermis of the skin.

《塗布型皮膜形成剤を備えるキット》
 本開示の塗布型皮膜形成剤は、かかる形成剤を構成する第1剤及び第2剤を有するキットとして提供することができる。キットは、第1剤及び第2剤以外に、例えば、第1剤等を体表へ塗布しやすくするための部材、上述した各種化粧料などの任意の部材を有していてもよく、或いは、これらの部材と組み合わせて使用されてもよい。
<Kit with a coating-type film-forming agent>
The paint-type film-forming agent of the present disclosure can be provided as a kit having the first and second agents that constitute the agent. In addition to the first and second agents, the kit may also have optional agents such as agents for facilitating application of the first agent or the like to the body surface, or the various cosmetics described above, or may be used in combination with these agents.

 このような任意の部材としては、例えば、使用説明書、へら状のアプリケータ、刷毛、綿棒、カッター、ハサミ、上述した各種化粧料、体表から皮膜を除去するためのリムーバー、鏡等を挙げることができる。ここで、「使用説明書」とは、キット内に書類の形態で添付されている一般的な使用説明書以外に、例えば、キットを収容する包装容器、又は第1剤等を注入するチューブ等の包装容器に対して使用説明文が印字された状態のものも包含することができる。 Such optional components include, for example, an instruction manual, a spatula-shaped applicator, a brush, a cotton swab, a cutter, scissors, the various cosmetics mentioned above, a remover for removing film from the body surface, a mirror, etc. Here, "instructions for use" can include not only general instructions for use that are attached in the form of a document within the kit, but also, for example, instructions for use printed on a packaging container that contains the kit, or on a packaging container such as a tube for injecting the first agent, etc.

 ある実施態様では、キットは、第1剤及び第2剤の接触を防止するために、例えば、これらの剤が、別々の容器に内包されていてもよく、又は2つ以上の区画を有する容器の各区画内に別々に内包されていてもよい。また、これらの内包されている剤は、1度に1つずつ適用されるように構成されてもよく、又は使用前若しくは使用時に一緒に混合されるように構成されてもよい。 In some embodiments, the kit may include, for example, the first and second agents packaged in separate containers or in separate compartments of a container having two or more compartments to prevent contact between the first and second agents. The packaged agents may be configured to be applied one at a time or to be mixed together before or during use.

《皮膜》
〈厚さ〉
 上述した本開示の塗布型皮膜形成剤を用いて調製した皮膜の厚さとしては特に制限はなく、例えば、通気性、不可視性、圧縮性、皮膚に対する閉塞性等を考慮して適宜調整することができる。皮膜の厚さとしては、例えば、0.5μm以上、1μm以上、10μm以上、30μm以上、40μm以上、50μm以上、70μm以上、又は100μm以上にすることができる。厚さの上限値については特に制限はないが、例えば、1mm以下、800μm以下、500μm以下、300μm以下、150μm以下、100μm以下、90μm以下、80μm以下、70μm以下、60μm以下、又は50μm以下にすることができる。ここで、厚さは、高精度デジマチックマイクロメータ(MDH-25MB、株式会社ミツトヨ製)を使用し、皮膜の任意の部分の厚さを5回測定して算出した平均値として定義することができる。また、皮膜の厚さは、塗布型皮膜形成剤を用いて調製した皮膜を十分に乾燥させた後(例えば、室温雰囲気下で6時間以上乾燥させた後)の厚さを意図する。
Membrane
<thickness>
The thickness of the film prepared using the coating-type film-forming agent of the present disclosure described above is not particularly limited, and can be appropriately adjusted in consideration of, for example, breathability, invisibility, compressibility, occlusion to the skin, etc. The thickness of the film can be, for example, 0.5 μm or more, 1 μm or more, 10 μm or more, 30 μm or more, 40 μm or more, 50 μm or more, 70 μm or more, or 100 μm or more. There is no particular limit to the upper limit of the thickness, but it can be, for example, 1 mm or less, 800 μm or less, 500 μm or less, 300 μm or less, 150 μm or less, 100 μm or less, 90 μm or less, 80 μm or less, 70 μm or less, 60 μm or less, or 50 μm or less. Here, the thickness can be defined as the average value calculated by measuring the thickness of any part of the film five times using a high-precision digital micrometer (MDH-25MB, manufactured by Mitutoyo Corporation). The thickness of the coating refers to the thickness of the coating prepared using the coating-type coating-forming agent after it has been thoroughly dried (for example, after it has been dried in an atmosphere at room temperature for 6 hours or more).

 以下に実施例を挙げて、本発明についてさらに詳しく説明を行うが、本発明はこれらに限定されるものではない。なお、以下、特に断りのない限り、配合量は質量%で示す。また、実施例に記載される評価方法は、実施例に記載される水中油型組成物又は形成剤に限らず、上述した水中油型組成物又は形成剤に対しても同様に実施することができる。 The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these. Unless otherwise specified, the blend amounts are indicated in mass %. The evaluation methods described in the examples are not limited to the oil-in-water compositions or formers described in the examples, and can be similarly carried out on the oil-in-water compositions or formers described above.

《評価試験》
 下記の製造方法により得た各試験サンプルを用いて以下に示す試験を実施し、その結果を、表1~5及び図3~4にまとめる。
"Evaluation test"
The following tests were carried out using the test samples obtained by the manufacturing methods described below, and the results are summarized in Tables 1 to 5 and FIGS.

〈表面張力〉
 表面張力調整剤としての試験材料を、1質量%の配合割合でイオン交換水に添加して表面張力評価用の試験サンプルを調製した。かかる試験サンプルの表面張力を、25℃の雰囲気下、動的接触角測定装置(DCAT21、Data physics社製)を用い、ウィルヘルミプレートを使用するウィルヘルミ法によって3回測定した。表中に記載する表面張力の値は、3回測定して得られた値の平均値である。
<surface tension>
A test sample for surface tension evaluation was prepared by adding the test material as a surface tension regulator to ion-exchanged water at a blending ratio of 1 mass %. The surface tension of the test sample was measured three times by the Wilhelmy method using a dynamic contact angle measuring device (DCAT21, manufactured by Data Physics) in an atmosphere of 25 ° C. The surface tension values listed in the table are the average values obtained by measuring three times.

〈粘度〉
 試験サンプルの粘度は、25℃、ローターNo.7、10rpmの条件で、B型粘度計(ビスメトロン(商標)、芝浦セムテック株式会社社製)を用いて測定した。表中に記載する粘度の値は、3回測定して得られた値の平均値である。
<viscosity>
The viscosity of the test sample was measured using a Brookfield viscometer (Vismetron (trademark), manufactured by Shibaura Semtec Co., Ltd.) at 25° C., rotor No. 7, and 10 rpm. The viscosity values shown in the table are the average values obtained by measuring three times.

〈塗布ムラ評価試験:耐はじき性〉
 専門パネル20名の手の甲に塗布型皮膜形成剤の第1剤を塗布して第1剤層を形成した後、この第1剤層に対して各試験サンプルを塗布したときの塗布ムラについて以下の基準に従い評価した:
(評価基準)
S:20名中19名以上の専門パネルが、試験サンプルは手の甲に均一に塗布されてはじきがないと評価した。
A:20名中17以上18名以下の専門パネルが、試験サンプルは手の甲に均一に塗布されてはじきがないと評価した。
B:20名中14名以上16名以下の専門パネルが、試験サンプルは手の甲に均一に塗布されてはじきがないと評価した。
C:20名中10名以上13名以下の専門パネルが、試験サンプルは手の甲に均一に塗布されてはじきがないと評価した。
D:20名中9名以下の専門パネルが、試験サンプルは手の甲に均一に塗布されてはじきがないと評価した。
<Uneven coating evaluation test: Repelling resistance>
The first agent of the paint-on film-forming agent was applied to the backs of the hands of 20 expert panelists to form a first agent layer, and then each test sample was applied to this first agent layer. The unevenness of the application was evaluated according to the following criteria:
(Evaluation criteria)
S: 19 or more out of 20 expert panelists evaluated that the test sample was evenly applied to the back of the hand with no repellency.
A: 17 to 18 expert panelists out of 20 evaluated that the test sample was evenly applied to the back of the hand and did not repel.
B: 14 to 16 expert panelists out of 20 evaluated that the test sample was evenly applied to the back of the hand and did not repel.
C: 10 to 13 expert panelists out of 20 evaluated that the test sample was evenly applied to the back of the hand and did not repel.
D: Nine or fewer expert panelists out of 20 judged that the test sample was evenly applied to the back of the hand with no repellency.

〈テカリ評価試験:耐テカリ性〉
 塗布ムラ評価試験で形成した皮膜の30分後のテカリについて以下の基準に従い評価した:
(評価基準)
S:20名中19名以上の専門パネルが、皮膜にテカリが生じていないと評価した。
A:20名中17名以上18名以下の専門パネルが、皮膜にテカリが生じていないと評価した。
B:20名中14名以上16名以下の専門パネルが、皮膜にテカリが生じていないと評価した。
C:20名中10名以上13名以下の専門パネルが、皮膜にテカリが生じていないと評価した。
D:20名中9名以下の専門パネルが、皮膜にテカリが生じていないと評価した。
<Shine evaluation test: Shine resistance>
The shine of the film formed in the coating unevenness evaluation test after 30 minutes was evaluated according to the following criteria:
(Evaluation criteria)
S: 19 or more out of 20 expert panelists evaluated that the film was not shiny.
A: 17 to 18 of 20 expert panelists evaluated that the film was not shiny.
B: 14 to 16 of 20 expert panelists evaluated that the film was not shiny.
C: 10 to 13 expert panelists out of 20 evaluated that the film was not shiny.
D: Nine or less out of 20 expert panelists evaluated that the film was not shiny.

〈光沢度〉
 黒色の人工皮革(サプラーレ(商標)、出光ファインテクノ社製)に対し、塗布型皮膜形成剤の第1剤を塗布して第1剤層を形成した後、この第1剤層に対して第2剤としての試験サンプルを塗布して、室温で6時間乾燥後の膜厚が約100μmの皮膜を形成し、光沢度評価用の試験サンプルを調製した。得られた試験サンプルをゴニオフォトメーター(Gonio SPECTROPHOTOMETER GSP-1B、村上色彩技術研究所社製)にセットし、反射角-25°~75°の範囲における光沢度を測定した。
<Glossiness>
A first agent of a coating-type film-forming agent was applied to black artificial leather (Saplare (trademark), Idemitsu Fine Techno Co., Ltd.) to form a first agent layer, and then a test sample was applied as a second agent to this first agent layer to form a film having a thickness of about 100 μm after drying at room temperature for 6 hours, thereby preparing a test sample for evaluating gloss. The obtained test sample was set in a goniophotometer (Gonio SPECTROPHOTOMETER GSP-1B, Murakami Color Research Laboratory Co., Ltd.) and the gloss was measured in the reflection angle range of -25° to 75°.

《試験例1:表面張力調整剤の影響》
 試験例1では、塗布型皮膜形成剤の第1剤層に適用する第2剤に配合する表面張力調整剤の相違による塗布ムラの影響について検討した。その結果を表1に示す。なお、参考例1~8の試験サンプルは、表面張力調整剤と水のみが含まれ、触媒等の成分が含まれていないため、参考例として表記している。
Test Example 1: Effect of Surface Tension Adjuster
In Test Example 1, the effect of different surface tension modifiers in the second agent applied to the first agent layer of the paint-on film-forming agent on coating unevenness was examined. The results are shown in Table 1. Note that the test samples of Reference Examples 1 to 8 contain only a surface tension modifier and water, and do not contain any catalyst or other components, and are therefore listed as Reference Examples.

〈第1剤:油相で構成された単相系〉
 第2の不飽和オルガノポリシロキサンとして165,000cstのジビニルジメチコン30質量部、第2のヒドリド官能化ポリシロキサンとして45cstのハイドロゲンジメチコン7質量部、充填剤としてシリル化シリカ6質量部、並びに油分としてジメチコン及びトリシロキサンの混合物57質量部を均一に混合して第1剤を調製した。
<First agent: Single-phase system composed of oil phase>
The first agent was prepared by uniformly mixing 30 parts by weight of 165,000 cst divinyl dimethicone as the second unsaturated organopolysiloxane, 7 parts by weight of 45 cst hydrogen dimethicone as the second hydride-functionalized polysiloxane, 6 parts by weight of silylated silica as a filler, and 57 parts by weight of a mixture of dimethicone and trisiloxane as an oil.

〈第2剤〉
 表1に示す処方を用い、以下の方法によって水中油型組成物等の第2剤を製造した。ここで、以下に示す番号は、表1の処方の左側の成分を示す番号と一致する。
<Second Agent>
A second agent such as an oil-in-water composition was produced by the following method using the formulation shown in Table 1. Here, the numbers shown below correspond to the numbers indicating the components on the left side of the formulation in Table 1.

(比較例1)
 No.1~No.4及びNo.9~No.11の材料を均一に混合して水相パーツを調製した後、この水相パーツにNo.5~No.8の材料を添加し、均一に混合して、比較例1の水中油型組成物の第2剤を調製した。
(Comparative Example 1)
The materials No. 1 to No. 4 and No. 9 to No. 11 were uniformly mixed to prepare an aqueous phase part, and then the materials No. 5 to No. 8 were added to this aqueous phase part and mixed uniformly to prepare the second agent of the oil-in-water composition of Comparative Example 1.

(参考例1~8)
 水に各表面張力調整剤を配合して参考例1~8の試験サンプルを調製した。
(Reference Examples 1 to 8)
Test samples of Reference Examples 1 to 8 were prepared by mixing each surface tension modifier with water.

〈結果〉
 表1の結果より、表面張力調整剤を含まない比較例1の第2剤は、第1剤層に対して、はじきやすいことが確認できた。一方、参考例1~8を比較した場合、表面張力が30.0mN/m以下のシリコーン系表面張力調整剤を用いるとはじきが改善されることが分かった。
<result>
From the results in Table 1, it was confirmed that the second agent of Comparative Example 1, which does not contain a surface tension modifier, is easily repelled by the first agent layer. On the other hand, when comparing Reference Examples 1 to 8, it was found that the repelling property was improved by using a silicone-based surface tension modifier having a surface tension of 30.0 mN/m or less.

《試験例2:増粘剤の影響》
 試験例2では、塗布型皮膜形成剤における第2剤に配合する増粘剤の相違による塗布ムラの影響について検討した。その結果を表2に示す。なお、表2に示す処方の組成物には表面張力調整剤は含まれていない。
Test Example 2: Effect of thickener
In Test Example 2, the effect of different thickeners in the second agent of a paint-on film-forming agent on coating unevenness was examined. The results are shown in Table 2. Note that the composition of the formulation shown in Table 2 does not contain a surface tension modifier.

〈第1剤〉
 試験例1の第1剤を同様に使用した。
<First Agent>
The first agent of Test Example 1 was used in the same manner.

〈第2剤〉
(比較例2~10)
 表2の処方に変更したこと以外は、比較例1と同様にして、比較例2~10の水中油型組成物の第2剤を調製した。なお、増粘剤は、水相パーツの調製時に配合した。
<Second Agent>
(Comparative Examples 2 to 10)
The second parts of the oil-in-water compositions of Comparative Examples 2 to 10 were prepared in the same manner as Comparative Example 1, except that the formulation was changed to that shown in Table 2. The thickener was added when the aqueous phase part was prepared.

〈結果〉
 表2の比較例4及び6の結果より、ミクロゲルタイプの増粘剤を使用すると、耐はじき性が改善する傾向にあることが分かった。
<result>
The results of Comparative Examples 4 and 6 in Table 2 show that the use of a microgel type thickener tends to improve repellency resistance.

《試験例3:特定の表面張力調整剤及び増粘剤の併用効果》
 試験例3では、塗布型皮膜形成剤の第2剤における、所定の表面張力を有するシリコーン系表面張力調整剤とミクロゲルタイプの増粘剤との併用による塗布ムラの影響について検討した。その結果を表3及び表4に示す。
Test Example 3: Effect of combined use of specific surface tension adjuster and thickener
In Test Example 3, the effect of the combination of a silicone-based surface tension regulator having a specified surface tension and a microgel-type thickener in the second agent of a paint-on film-forming agent on uneven application was investigated. The results are shown in Tables 3 and 4.

〈第1剤〉
 試験例1の第1剤を同様に使用した。
<First Agent>
The first agent of Test Example 1 was used in the same manner.

〈第2剤〉
(実施例1~9及び比較例11~13)
 表3及び表4の処方に変更したこと以外は、比較例1と同様にして、実施例1~9及び比較例11~13の水中油型組成物の第2剤を調製した。なお、表面張力調整剤及び増粘剤は、水相パーツの調製時に配合した。
<Second Agent>
(Examples 1 to 9 and Comparative Examples 11 to 13)
Except for changing the formulations to those shown in Tables 3 and 4, the second parts of the oil-in-water compositions of Examples 1 to 9 and Comparative Examples 11 to 13 were prepared in the same manner as in Comparative Example 1. The surface tension modifier and thickener were added when the aqueous phase part was prepared.

〈結果〉
 表3及び表4の結果から明らかなように、表面張力が30.0mN/m以下のシリコーン系表面張力調整剤とミクロゲル型増粘剤とを併用すると、耐はじき性が大幅に向上することが確認できた。
<result>
As is clear from the results in Tables 3 and 4, it was confirmed that the use of a silicone-based surface tension modifier having a surface tension of 30.0 mN/m or less in combination with a microgel-type thickener significantly improves repellency resistance.

《試験例4:特定の表面張力調整剤及び増粘剤、並びに粒子の併用効果》
 試験例4では、塗布型皮膜形成剤の第2剤における、所定の表面張力を有するシリコーン系表面張力調整剤とミクロゲルタイプの増粘剤と粒子の併用による塗布ムラ及びテカリへの影響について検討した。その結果を表5及び表6に示す。なお、表5中の参考比較例とは、この組成も特定の表面張力調整剤及び増粘剤を含んでいるため、本来は実施例になり得るものであるが、多孔質粒子を含む組成と無孔質粒子を含む組成とを比べるために使用する例であるため、参考比較例と表記している。
Test Example 4: Effect of combined use of specific surface tension adjusters, thickeners, and particles
In Test Example 4, the effect of using a silicone-based surface tension regulator having a specific surface tension and a microgel-type thickener and particles in the second agent of a coating-type film-forming agent on coating unevenness and shininess was examined.The results are shown in Tables 5 and 6.Note that the reference comparative example in Table 5 is actually an example because this composition also contains a specific surface tension regulator and thickener, but it is an example used to compare a composition containing porous particles with a composition containing non-porous particles, so it is referred to as a reference comparative example.

〈第1剤〉
 試験例1の第1剤を同様に使用した。
<First Agent>
The first agent of Test Example 1 was used in the same manner.

〈第2剤〉
(実施例10~21及び参考比較例1~4)
 表5及び6の処方に変更したこと以外は、比較例1と同様にして、実施例10~21及び参考比較例1~4の水中油型組成物の第2剤を調製した。なお、表面張力調整剤、増粘剤及び粒子は、水相パーツの調製時に配合した。
<Second Agent>
(Examples 10 to 21 and Reference Comparative Examples 1 to 4)
Except for changing the formulations to those shown in Tables 5 and 6, the second agents of the oil-in-water compositions of Examples 10 to 21 and Reference Comparative Examples 1 to 4 were prepared in the same manner as in Comparative Example 1. The surface tension modifier, thickener, and particles were added during the preparation of the aqueous phase part.

〈結果〉
 表5及び表6の結果から明らかなように、塗布型皮膜形成剤の第2剤として使用される水中油型乳化組成物に対し、表面張力が30.0mN/m以下のシリコーン系表面張力調整剤とミクロゲル型増粘剤に加えて、さらに無孔質粒子を配合すると、耐テカリ性がより向上することが確認できた。
<result>
As is clear from the results in Tables 5 and 6, it was confirmed that when nonporous particles are further blended into an oil-in-water emulsion composition used as the second agent in a spread-type film-forming agent, in addition to a silicone-based surface tension modifier having a surface tension of 30.0 mN/m or less and a microgel-type thickener, the shine resistance is further improved.

 また、表5の参考比較例1~4の結果より、水中油型乳化組成物に対して多孔質粒子を配合すると、耐はじき性が悪くなることが分かった。 In addition, the results of Reference Comparative Examples 1 to 4 in Table 5 show that the incorporation of porous particles into an oil-in-water emulsion composition reduces repellency resistance.

 また、実施例17及び20の結果より、分散剤を配合すると耐テカリ性がより向上することもわかった。 The results of Examples 17 and 20 also show that the addition of a dispersant further improves shine resistance.

《試験例5:皮膜の光沢度》
 試験例5では、塗布型皮膜形成剤の第1剤として、試験例1の第1剤を同様に使用し、塗布型皮膜形成剤の第2剤として、比較例1及び実施例20の水中油型組成物を使用して、上述した光沢度の評価を実施した。その結果を図3及び図4に示す。
Test Example 5: Glossiness of the coating
In Test Example 5, the first agent of Test Example 1 was used as the first agent of the paint-on film-forming agent, and the oil-in-water compositions of Comparative Example 1 and Example 20 were used as the second agent of the paint-on film-forming agent, and the gloss evaluation was carried out as described above. The results are shown in Figures 3 and 4.

〈結果〉
 図3及び図4より明らかなように、比較例1に比べ、実施例20の水中油型組成物を第2剤として使用した方が、光沢度、すなわちテカリが低下していることが確認できた。図3より、無孔質粒子を含む実施例20は、比較例1に比べて光沢度を30%程度も減少させ得ることが分かった。なお、反射角45°における、比較例1及び実施例20の光沢度はそれぞれ、111.6及び79.5であり、反射角50°における、比較例1及び実施例20の光沢度はそれぞれ、109.3及び82.1であった。
<result>
As is clear from Figures 3 and 4, it was confirmed that the gloss, i.e., shine, was lower when the oil-in-water composition of Example 20 was used as the second agent compared to Comparative Example 1. From Figure 3, it was found that Example 20 containing nonporous particles can reduce the gloss by about 30% compared to Comparative Example 1. The gloss of Comparative Example 1 and Example 20 at a reflection angle of 45° was 111.6 and 79.5, respectively, and the gloss of Comparative Example 1 and Example 20 at a reflection angle of 50° was 109.3 and 82.1, respectively.

Claims (16)

 水及びミクロゲルを含む分散媒、
 前記分散媒中に分散している油滴、並びに
 シリコーン系表面張力調整剤
を含む、水中油型組成物であって、
 前記油滴は、油分、及び架橋成分としての触媒を含み、
 前記表面張力調整剤は、該表面張力調整剤を1質量%含む水溶液における25℃での表面張力が30.0mN/m以下であり、
 皮膜を構成する架橋反応性成分を含む第1剤及び前記架橋反応性成分を架橋させる架橋成分を含む第2剤を含む塗布型皮膜形成剤の第2剤として用いられる、
水中油型組成物。
A dispersion medium comprising water and a microgel;
an oil-in-water composition comprising oil droplets dispersed in the dispersion medium; and a silicone-based surface tension modifier,
The oil droplets contain an oil component and a catalyst as a cross-linking component,
The surface tension modifier has a surface tension of 30.0 mN/m or less at 25° C. in an aqueous solution containing the surface tension modifier at 1% by mass,
It is used as the second agent of a coating-type film-forming agent including a first agent containing a crosslinking reactive component that constitutes a film and a second agent containing a crosslinking component that crosslinks the crosslinking reactive component,
Oil-in-water compositions.
 前記ミクロゲルが、(ジメチルアクリルアミド/アクリロイルジメチルタウリンNa)クロスポリマー、(アクリロイルジメチルタウリンアンモニウム/VP)コポリマー、(アクリロイルジメチルタウリンアンモニウム/メタクリル酸ベヘネス-25)クロスポリマー、及びカンテンからなる群から選択される少なくとも一種である、請求項1に記載の組成物。 The composition according to claim 1, wherein the microgel is at least one selected from the group consisting of (dimethylacrylamide/sodium acryloyldimethyltaurate) crosspolymer, (ammonium acryloyldimethyltaurate/VP) copolymer, (ammonium acryloyldimethyltaurate/beheneth-25 methacrylate) crosspolymer, and agar.  前記表面張力調整剤が、ポリオキシエチレン・メチルポリシロキサン共重合体、ジメチルポリシロキサン・メチル(ポリオキシエチレン)シロキサン共重合体、及びビスPEG-18メチルエーテルジメチルシランからなる群から選択される少なくとも一種である、請求項1又は2に記載の組成物。 The composition according to claim 1 or 2, wherein the surface tension modifier is at least one selected from the group consisting of polyoxyethylene-methylpolysiloxane copolymer, dimethylpolysiloxane-methyl(polyoxyethylene)siloxane copolymer, and bisPEG-18 methyl ether dimethylsilane.  無孔質粒子を含む、請求項1又は2に記載の組成物。 The composition of claim 1 or 2, comprising non-porous particles.  前記油分が、第1の不飽和オルガノポリシロキサン又は第1のヒドリド官能化ポリシロキサンを含む、請求項1又は2に記載の組成物。 The composition of claim 1 or 2, wherein the oil comprises a first unsaturated organopolysiloxane or a first hydride-functionalized polysiloxane.  高分子乳化剤を含む、請求項1又は2に記載の組成物。 The composition according to claim 1 or 2, which contains a polymeric emulsifier.  前記触媒が、白金カルボニルシクロビニルメチルシロキサン錯体、白金ジビニルテトラメチルジシロキサン錯体、白金シクロビニルメチルシロキサン錯体、及び白金オクタンアルデヒド/オクタノール錯体からなる群から選択される少なくとも一種である、請求項1又は2に記載の組成物。 The composition according to claim 1 or 2, wherein the catalyst is at least one selected from the group consisting of platinum carbonylcyclovinylmethylsiloxane complex, platinum divinyltetramethyldisiloxane complex, platinum cyclovinylmethylsiloxane complex, and platinum octanaldehyde/octanol complex.  第1剤及び第2剤を含む、塗布型皮膜形成剤であって、
 前記第1剤が、第2の不飽和オルガノポリシロキサン及び第2のヒドリド官能化ポリシロキサンからなる群から選択される少なくとも一種を含み、
 前記第2剤が、請求項1に記載の水中油型組成物であり、
 前記第1剤が、前記第2の不飽和オルガノポリシロキサン及び前記第2のヒドリド官能化ポリシロキサンのうち、前記第2の不飽和オルガノポリシロキサンのみを含む場合には、前記第2剤は、前記第1のヒドリド官能化ポリシロキサンを含み、
 前記第1剤が、前記第2の不飽和オルガノポリシロキサン及び前記第2のヒドリド官能化ポリシロキサンのうち、前記第2のヒドリド官能化ポリシロキサンのみを含む場合には、前記第2剤は、前記第1の不飽和オルガノポリシロキサンを含む、
塗布型皮膜形成剤。
A coating-type film-forming agent comprising a first agent and a second agent,
The first agent comprises at least one selected from the group consisting of a second unsaturated organopolysiloxane and a second hydride-functionalized polysiloxane;
The second agent is the oil-in-water composition according to claim 1,
When the first agent contains only the second unsaturated organopolysiloxane among the second unsaturated organopolysiloxane and the second hydride-functionalized polysiloxane, the second agent contains the first hydride-functionalized polysiloxane,
When the first agent contains only the second hydride-functionalized polysiloxane among the second unsaturated organopolysiloxane and the second hydride-functionalized polysiloxane, the second agent contains the first unsaturated organopolysiloxane;
A paint-type film-forming agent.
 前記水中油型組成物が、無孔質粒子を含む、請求項8に記載の形成剤。 The forming agent of claim 8, wherein the oil-in-water composition comprises non-porous particles.  前記第1の不飽和オルガノポリシロキサン及び前記第2の不飽和オルガノポリシロキサンが、ビニル基を有するオルガノポリシロキサン、ビニル末端化されたオルガノポリシロキサン、及びビニル化された分岐鎖を有するオルガノポリシロキサンからなる群から選択される少なくとも一種である、請求項8又は9に記載の形成剤。 The forming agent according to claim 8 or 9, wherein the first unsaturated organopolysiloxane and the second unsaturated organopolysiloxane are at least one selected from the group consisting of organopolysiloxanes having vinyl groups, vinyl-terminated organopolysiloxanes, and vinylated branched organopolysiloxanes.  前記第1の不飽和オルガノポリシロキサン及び前記第2の不飽和オルガノポリシロキサンが、ビニル末端ポリジメチルシロキサン、ビニル末端ジフェニルシロキサン-ジメチルシロキサンコポリマー、ビニル末端ポリフェニルメチルシロキサン、ビニルフェニルメチル末端ビニルフェニルシロキサン-フェニルメチルシロキサンコポリマー、ビニル末端トリフルオロプロピルメチルシロキサン-ジメチルシロキサンコポリマー、ビニル末端ジエチルシロキサン-ジメチルシロキサンコポリマー、ビニルメチルシロキサン-ジメチルシロキサンコポリマー、トリメチルシロキシ末端ビニルメチルシロキサン-ジメチルシロキサンコポリマー、シラノール末端ビニルメチルシロキサン-ジメチルシロキサンコポリマー、ビニルメチルシロキサンホモポリマー、ビニルT-構造ポリマー、ビニルQ-構造ポリマー、モノビニル末端ポリジメチルシロキサン、ビニルメチルシロキサンターポリマー、及びビニルメトキシシランホモポリマーからなる群から選択される少なくとも一種である、請求項10に記載の形成剤。 The forming agent according to claim 10, wherein the first unsaturated organopolysiloxane and the second unsaturated organopolysiloxane are at least one selected from the group consisting of vinyl-terminated polydimethylsiloxane, vinyl-terminated diphenylsiloxane-dimethylsiloxane copolymer, vinyl-terminated polyphenylmethylsiloxane, vinylphenylmethyl-terminated vinylphenylsiloxane-phenylmethylsiloxane copolymer, vinyl-terminated trifluoropropylmethylsiloxane-dimethylsiloxane copolymer, vinyl-terminated diethylsiloxane-dimethylsiloxane copolymer, vinylmethylsiloxane-dimethylsiloxane copolymer, trimethylsiloxy-terminated vinylmethylsiloxane-dimethylsiloxane copolymer, silanol-terminated vinylmethylsiloxane-dimethylsiloxane copolymer, vinylmethylsiloxane homopolymer, vinyl T-structure polymer, vinyl Q-structure polymer, monovinyl-terminated polydimethylsiloxane, vinylmethylsiloxane terpolymer, and vinylmethoxysilane homopolymer.  前記第1のヒドリド官能化ポリシロキサン及び前記第2のヒドリド官能化ポリシロキサンが、非末端及び/又は末端で水酸化されたオルガノポリシロキサンである、請求項8又は9に記載の形成剤。 The forming agent according to claim 8 or 9, wherein the first hydride-functionalized polysiloxane and the second hydride-functionalized polysiloxane are non-terminally and/or terminally hydroxylated organopolysiloxanes.  前記第1のヒドリド官能化ポリシロキサン及び前記第2のヒドリド官能化ポリシロキサンが、ヒドリド末端ポリジメチルシロキサン、ヒドリド末端ポリフェニル-(ジメチルヒドロシロキシ)シロキサン、ヒドリド末端メチルヒドロシロキサン-フェニルメチルシロキサンコポリマー、トリメチルシロキシ末端メチルヒドロシロキサン-ジメチルシロキサンコポリマー、ポリメチルヒドロシロキサン、トリメチルシロキシ末端ポリエチルヒドロシロキサン、トリエチルシロキサン、メチルヒドロシロキサン-フェニルオクチルメチルシロキサンコポリマー、及びメチルヒドロシロキサン-フェニルオクチルメチルシロキサンターポリマーからなる群から選択される少なくとも一種である、請求項12に記載の形成剤。 The forming agent according to claim 12, wherein the first hydride-functionalized polysiloxane and the second hydride-functionalized polysiloxane are at least one member selected from the group consisting of hydride-terminated polydimethylsiloxane, hydride-terminated polyphenyl-(dimethylhydrosiloxy)siloxane, hydride-terminated methylhydrosiloxane-phenylmethylsiloxane copolymer, trimethylsiloxy-terminated methylhydrosiloxane-dimethylsiloxane copolymer, polymethylhydrosiloxane, trimethylsiloxy-terminated polyethylhydrosiloxane, triethylsiloxane, methylhydrosiloxane-phenyloctylmethylsiloxane copolymer, and methylhydrosiloxane-phenyloctylmethylsiloxane terpolymer.  請求項8又は9に記載の前記第1剤及び前記第2剤が、別々の容器に内包されている、又は2つ以上の区画を有する容器の各区画内に別々に内包されているキット。 A kit in which the first agent and the second agent according to claim 8 or 9 are contained in separate containers, or are contained separately in each compartment of a container having two or more compartments.  請求項8又は9に記載の形成剤の使用方法であって、
 前記第1剤を体表に適用して第1剤層を形成した後に、該第1剤層上に前記第2剤を適用し、架橋させて皮膜を形成する、
 前記第2剤を体表に適用して第2剤層を形成した後に、該第2剤層上に前記第1剤を適用し、架橋させて皮膜を形成する、又は、
 前記第1剤及び前記第2剤を混合して混合物を調製した後に、該混合物を体表に適用し、架橋させて皮膜を形成する、
使用方法。
A method for using the forming agent according to claim 8 or 9, comprising the steps of:
The first agent is applied to a body surface to form a first agent layer, and then the second agent is applied onto the first agent layer and crosslinked to form a film.
The second agent is applied to the body surface to form a second agent layer, and then the first agent is applied onto the second agent layer and crosslinked to form a film; or
After preparing a mixture by mixing the first agent and the second agent, the mixture is applied to a body surface and crosslinked to form a film.
how to use.
 前記第1剤、前記第2剤、又は前記混合物を体表に適用する前に、化粧料を体表に適用する、
 前記第1剤を体表に適用して第1剤層を形成し、該第1剤層上に化粧料を適用した後に、該化粧料を覆うように前記第2剤を適用する、
 前記第2剤を体表に適用して第2剤層を形成し、該第2剤層上に化粧料を適用した後に、該化粧料を覆うように前記第1剤を適用する、又は、
 皮膜を形成した後に、該皮膜に化粧料を適用する、
請求項15に記載の使用方法。
applying a cosmetic to a body surface before applying the first agent, the second agent, or the mixture to the body surface;
The first agent is applied to a body surface to form a first agent layer, a cosmetic is applied onto the first agent layer, and then the second agent is applied so as to cover the cosmetic.
The second agent is applied to a body surface to form a second agent layer, a cosmetic is applied onto the second agent layer, and then the first agent is applied to cover the cosmetic; or
After forming the film, a cosmetic is applied to the film.
16. The method of use according to claim 15.
PCT/JP2024/000054 2023-01-19 2024-01-05 Oil-in-water composition for second agent of coating-type film-forming agent Ceased WO2024154597A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024571701A JPWO2024154597A1 (en) 2023-01-19 2024-01-05
CN202480005779.8A CN120417873A (en) 2023-01-19 2024-01-05 The second part of the spreadable film-forming agent is an oil-in-water composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2023-006530 2023-01-19
JP2023006530 2023-01-19

Publications (1)

Publication Number Publication Date
WO2024154597A1 true WO2024154597A1 (en) 2024-07-25

Family

ID=91955897

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2024/000054 Ceased WO2024154597A1 (en) 2023-01-19 2024-01-05 Oil-in-water composition for second agent of coating-type film-forming agent

Country Status (3)

Country Link
JP (1) JPWO2024154597A1 (en)
CN (1) CN120417873A (en)
WO (1) WO2024154597A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013536861A (en) * 2010-08-31 2013-09-26 リビング プルーフ,インコーポレーテッド Dermal composition and method of use thereof
US20180296591A1 (en) * 2011-09-21 2018-10-18 Shiseido Americas Corporation Compositions and methods for treating conditions of compromised skin barrier function
WO2022124079A1 (en) * 2020-12-07 2022-06-16 株式会社 資生堂 Oil-in-water type emulsion composition containing platinum catalyst and method of using same
WO2022215531A1 (en) * 2021-04-07 2022-10-13 株式会社 資生堂 Oil-in-water composition for second agent for coating-type body corrective film formation agent
WO2022215533A1 (en) * 2021-04-07 2022-10-13 株式会社 資生堂 Second agent of coating-type body corrective film-forming agent comprising first and second agents, and lubricant layer-forming agent to be applied to body corrective film

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013536861A (en) * 2010-08-31 2013-09-26 リビング プルーフ,インコーポレーテッド Dermal composition and method of use thereof
US20180296591A1 (en) * 2011-09-21 2018-10-18 Shiseido Americas Corporation Compositions and methods for treating conditions of compromised skin barrier function
WO2022124079A1 (en) * 2020-12-07 2022-06-16 株式会社 資生堂 Oil-in-water type emulsion composition containing platinum catalyst and method of using same
WO2022215531A1 (en) * 2021-04-07 2022-10-13 株式会社 資生堂 Oil-in-water composition for second agent for coating-type body corrective film formation agent
WO2022215533A1 (en) * 2021-04-07 2022-10-13 株式会社 資生堂 Second agent of coating-type body corrective film-forming agent comprising first and second agents, and lubricant layer-forming agent to be applied to body corrective film

Also Published As

Publication number Publication date
CN120417873A (en) 2025-08-01
JPWO2024154597A1 (en) 2024-07-25

Similar Documents

Publication Publication Date Title
CN105916489B (en) cosmetic composition
US8597628B2 (en) Cosmetic water-in-oil emulsion compositions
JP5457034B2 (en) Swellable silicone composition and preparation method thereof
US20240156692A1 (en) Oil-in-water composition for second agent for coating-type body corrective film formation agent
CN110730653B (en) Cosmetic composition comprising pullulan derivatives
JP7720830B2 (en) Composition for forming artificial skin and method of using same
WO2022215533A1 (en) Second agent of coating-type body corrective film-forming agent comprising first and second agents, and lubricant layer-forming agent to be applied to body corrective film
JP2005041795A (en) Oily cosmetic for unevenness correction
WO2022124079A1 (en) Oil-in-water type emulsion composition containing platinum catalyst and method of using same
JP2003055134A (en) External preparation composition
US9931293B2 (en) Cosmetic compositions for minimizing skin imperfections
CN109310891B (en) Crosslinked polyorganosiloxanes and personal care compositions comprising the same
JP7739294B2 (en) Primer for applied body correction film and method of use
WO2024154597A1 (en) Oil-in-water composition for second agent of coating-type film-forming agent
US11497704B2 (en) Agent for forming film on skin
US20240358624A1 (en) Application type body-correcting-film forming agent
JP6832853B2 (en) Cosmetic composition and preparation method
WO2024142934A1 (en) Application-type coating formation agent and kit that includes said formation agent
WO2025105223A1 (en) Film-forming agent for application and kit including said forming agent
WO2024090246A1 (en) Lip application-type film-forming agent and method for using said film-forming agent
WO2025105304A1 (en) Coating-type film-forming agent, kit including said forming agent, and method of using said forming agent
WO2024090233A1 (en) Method for using application-type film-forming agent
JP2025119949A (en) Cosmetic and application-type film-forming cosmetic containing said cosmetic
WO2023037983A1 (en) Method for enhancing skin permeation of water-soluble drug
JP2010111626A (en) Sunscreen cosmetic

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24744520

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2024571701

Country of ref document: JP

Ref document number: 202480005779.8

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 202480005779.8

Country of ref document: CN

NENP Non-entry into the national phase

Ref country code: DE